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ABSTRACT
Despite optimal surgical management the functional outcome following peripheral 
nerve injury remains poor. Experimental adjuvant treatments have been 
developed to enhance peripheral nerve regeneration including the use of bio­
engineered conduits, cellular transplantation, the addition of growth factors and 
modulation of the extra-cellular matrix.
Transplantation of cultured Schwann cells (SCs) improves regeneration through 
bio-engineered conduits. To improve the localisation of transplanted cells in 
combination with fluorescent immunohistochemical techniques SCs were 
retrovirally transduced with green fluorescent protein (GFP). GFP-SCs were 
found to have similar growth and vitality characteristics in comparison with non­
transduced cells and following in vivo transplantation were easily identified and 
enhanced nerve regeneration.
Bone marrow stromal cells (MSCs) are capable of unorthodox plasticity. Their 
abundance, ease of access and culture make them potential substitutes for SC 
transplantation. Following exposure to glial growth factor, MSCs exhibited 
phenotypical and morphological characteristics of SCs. Following in vivo 
transplantation these cells were also found to confer a beneficial effect on nerve 
regeneration.
3
Neurotrophic factors enhance nerve regeneration however delivery at the site of 
injury is problematic. The use of gene therapy to provide growth factors at the 
site of injury may overcome this problem. A splice variant of the IGF-1 gene, 
Mechano-Growth Factor (MGF) was delivered to the site of peripheral nerve 
injury and functional and histological measures of regeneration were assessed at 
14 weeks. It was found that delivery of the MGF cDNA at the site of injury 
improved target muscle function and total axon number in regenerating nerves.
Extracellular matrix macromolecules are important constituents of the peripheral 
nerve. The addition of fibronectin, laminin, and collagen substrata were found to 
enhance SC growth in vitro. Coating nerve guidance fibres with these molecules 
within a peripheral nerve conduit was also found to enhance nerve regeneration 
and influence the expression of the cell adhesion molecules NCAM and N- 
cadherin.
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Chapter 1
Introduction
“There is a single light o f  science, and to brighten it anywhere is to 
brighten it everywhere ”
Isaac Asimov
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1.1 The clinical importance of peripheral nerve injury
In England alone in the period 2005-2006 there were approximately 4,300 
peripheral nerve injuries requiring emergency hospital admission and subsequent 
surgical intervention within the NHS (Hospital Episode Statistics 2005-2006, 
Department of Health -  www.hesonline.nhs.uk). These injuries are most 
commonly seen in young adult males following accidental and self-inflicted 
lacerations, road traffic accidents, penetrating trauma, falls and industrial 
accidents, with nerves of the upper limb especially at the level of the wrist, palm 
and digits being more frequently affected than those of the lower limb (Evans, 
2001; Noble et al. 1998). It is unfortunate that the greatest expansion in our 
knowledge of the clinical presentation of peripheral nerve injury, the development 
of surgical management paradigms and the prognosis of functional recovery is as 
a result of modem warfare when serious injuries present more frequently 
(Sunderland, 1978). Despite great technical developments in surgical technique, 
functional recovery from such injuries remains poor, often leading to economic 
implications for an otherwise fit and healthy individual. Peripheral nerve injuries 
require specialist care by plastic surgeons who perform over 50,000 nerve repairs 
each year in the United States alone (Evans, 2001). In the most severe nerve 
injuries it is necessary to replace irreparably damaged nerve tissue with an 
autologous graft. In a series of over 1,000 peripheral injuries treated at a regional 
plastic surgery unit in the south-east of England it was found that approximately 
7% of the total number of injuries assessed required nerve grafting. It was also 
shown that when there was a delay in referral of a nerve injury to a specialist
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centre up to 63% of these injuries required either a primary or secondary grafting 
procedure (McAllistair et al. 1996).
1.2 Anatomy of the peripheral nerve
The peripheral nervous system is a highly specialised and organised structure 
which is responsible for relaying information to and from the central nervous 
system. The fundamental unit is the peripheral nerve fibre which is composed of 
a cytoplasmic extension of a sensory, motor or sympathetic neuron (the axon) 
supported by Schwann cells, and extracellular matrix components which compose 
the basal lamina and an inner endoneurial sheath. Axons vary from a few 
millimetres to a metre in length and from 0.2pm to 20pm in diameter. An axon 
consists of a cytoskeleton formed by neurofilaments and neurotubules, contained 
within a membrane, the axolemma. Within this there is a viscous fluid, the 
axoplasm, and a number of subcellular structures including mitochondria, 
endoplasmic reticulum, and granular vesicular structures. Axons not only conduct 
electrical impulses from and to the central nervous system but they also permit the 
retrograde or anterograde transport of proteins to and from the cell body 
respectively (Sunderland, 1978). Schwann cells (SCs), the glial cells of the 
peripheral nervous system, surround and support axons. In unmyelinated axons, 
chains of SCs support and separate multiple small diameter axons by enveloping 
them with extensions of the cell cytoplasm. In a myelinated fibre SCs produce a 
multilayered sheath of myelin which surrounds an individual axon. The SC 
nucleus and cytoplasm lies outside the myelin sheath and rests externally on a 
basement membrane. At regular points the SC cytoplasm comes into direct
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contact with the axon, slightly constricting the axon at these points to form the 
nodes of Ranvier. Nodes of Ranvier provide entry points for extracellular ions 
which facilitate the saltatory propagation of impulses from node to node 
(Sunderland, 1978). Nerve fibres, separated by endoneurial sheaths, are grouped 
together to form fascicles that are surrounded by a perineural sheath. Each nerve 
trunk is composed of a number of fascicular bundles which are themselves 
surrounded by the epineurium, a loose connective tissue which also supports 
blood vessels and lymphatic vessels (Lundborg, 1988). Fascicular bundles are 
segregated into afferent motor fibres and efferent sensory fibres, correct 
apposition of these fibres is important following axotomy (Terzis & Smith, 1990). 
Nerve fibres can be classified according to their thickness and conduction 
velocities, namely an A group of large myelinated fibres, a B group of small thinly 
myelinated fibres and a C group of unmyelinated fibres (Erlanger & Gasser, 
1924).
1.3 Pathophysiology following peripheral nerve injury
A complex chain of events follow traumatic peripheral nerve injury which, 
depending on the severity of the injury, leads to Wallerian degeneration and 
ultimately axonal regeneration.
1.3.1 Classification of peripheral nerve injuries
The consequences of damage to a nerve fibre depend on the nature, site and 
severity of the injury. Localised damage to nerve fibres was originally classified 
by Seddon in 1947 and Sunderland in 1951 and has now been expanded to include
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6 categories (Brandt & Mackinnon, 1997). The underlying principle behind the 
classification is whether or not the connective tissue surrounding fibres remains 
intact. First-degree injury (neuropraxia): A localised conduction block in which 
axon integrity is maintained although there may be focal demyelination. Full 
recovery is expected. Second-degree injury (axonotmesis): Axonal injury occurs, 
however overall connective tissue architecture and continuity is maintained. The 
distal segment undergoes Wallerian degeneration followed by regeneration from 
the proximal segment. Complete recovery is expected unless end-organ atrophy 
ensues prior to reinnervation. Third-degree injury: As for a second degree injury 
although regeneration impeded by partial scar formation. Fourth-degree injury: 
As for a second degree injury but scarring completely impedes regeneration. 
Fifth-degree injury (neurotmesis): Complete division of a peripheral nerve,
requires surgical apposition for regeneration to proceed. Sixth-degree injury: A 
combination of any of the above levels of injury at multiple sites in the course of a 
nerve.
1.3.2 Wallerian degeneration
The term Wallerian degeneration has been used to describe the histological 
changes seen in the peripheral nerve following crush and axotomy injuries after 
the observations of Waller (1850) and other pioneers in this field including 
Ranvier, Von Biinger and Cajal. A complex cascade of events occur which 
involve changes in the neuronal cell body, the axon and its associated SCs. Upon 
disruption of an axon at the site of injury axoplasm leaks from the cut ends, 
axolemmal membranes collapse and the proximal and distal stumps retract. By
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12-48hrs mitochondria collect in the nodal regions, myelin retracts from the node, 
neurofilaments become disarranged and the axoplasm becomes filled with 
granular material (Williams & Hall, 1971). Wallerian degeneration describes the 
degeneration of axonal architecture extending proximally to the first node of 
Ranvier and distally throughout the entire course of the nerve the purpose of 
which is to provide a permissive environment for nerve regeneration (Waller, 
1850; Stoll et al. 1989). Following the breakdown of axonal and myelin 
constituents at the site of injury SC de-differentiation and proliferation occurs. 
Cellular debris is removed initially by local proliferating SCs, however this is 
accelerated by the infiltration of macrophages (Hall, 1993). Proliferating SCs 
align to form bands of Bunger between the proximal and distal stump, in addition 
to this they upregulate the synthesis of a number of important neurotrophic factors 
(cf. 1.8).
Following injury chromatolysis occurs in the neuronal cell body, this is 
characterised by cytoplasmic swelling, displacement of the cell nucleus to the 
periphery and the appearance of Nissl’s granules (Sterman & Delannoy, 1985). If 
repair is not performed promptly up to 40% of sensory neuronal cells may die 
through apoptosis, this has long-term implications for functional recovery (Hart et 
al. 2002).
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1.3.3 Axonal regeneration
Axons have intrinsic growth capacity following injury. If a neuronal cell body 
survives the initial insult of axotomy upregulation in the synthesis of cytoskeletal 
elements such as actin, tubulin and neurofilaments occurs in preparation for the 
onset of regeneration. At the site of injury several axonal branches sprout from 
the first proximal node of Ranvier within 24hrs. Following nerve injury cAMP 
levels rise which in turn stimulate PKA which in turn promotes the transcription 
of genes responsible for the assembly of cytoskeletal elements (Neumann et al. 
2002). Injury also has a direct effect on the expression of c-Jun which leads to 
increased levels of integrin expression (Raivich et al. 2004). At the front of each 
regenerating axon a ‘regeneration front’ consisting of mobile filopodia (Seckel,
1990) responds to neurotrophic cues (cf. 1.8) and makes contact with the basal 
lamina and the SCs composing the bands of Biinger. Such dependence on 
chemical and physical cues imparts high tissue specificity for regenerating nerve 
fibres (Lundborg et al. 1986). Elongation of the proximal axon and distal 
progression of the regeneration front is associated with the production of 
cytoskeletal elements such as neurotubules and axolemmal membrane (Popov, 
1993). Each axon produces several sprouts, but only one of these sprouts matures 
upon target organ contact, the remaining sprouts degenerate in a process described 
as ‘pruning’. Sustained axonal regeneration is dependent on the creation of a 
‘permissive’ environment. Regeneration within the CNS is poor as the presence 
of certain proteins e.g. myelin-associated glycoprotein (MAG) inhibits axonal 
regeneration. Within the PNS the scavenging of these proteins by SCs and
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macrophages improves the ‘permissive’ nature of the environment for axonal 
regeneration.
1.3.4 Schwann cells and regeneration
An interdependence exists between regenerating axons and SCs. The latter 
provide structural and trophic support to regenerating axons, whilst axon-SC 
contact promotes proliferation, differentiation and maturation of SCs (Maurel & 
Salzer, 2000). It has been shown that preventing SC proliferation at the site of 
injury impairs axonal regeneration (Hall, 1986). Over the first days following 
injury, SCs in the distal nerve stump divide and upregulate the gene expression of 
the low affinity neurotrophin receptor p75; the neuregulin receptors; NCAM and 
LI (Martini & Schachner, 1988; c.f. 1.4); laminin; cytokines (Kurek, 1996); and 
neurotrophic factors (cf. 1.8.2). Collectively these changes produce a population 
of axon-responsive SCs which facilitate axonal growth into the zone of injury. In 
SCs adjacent to regenerating axons a second wave of SC proliferation occurs, this 
precedes the formation of myelin (Pellegrino & Spencer, 1985), and a 1:1 
relationship between myelinating SCs and axons is established (Mirsky & Jessen, 
1999).
1.4 Cell adhesion molecules and the extracellular matrix
Axonal growth is highly stereospecifc, depending upon receptor molecules in the 
regeneration front interacting with extrinsic cues. These cues include soluble 
factors secreted by intermediate and final targets (Lumsden & Cohen, 2004),
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components of the extracellular matrix (Reichardt & Tomaselli, 1991) and 
glycoproteins expressed on the surface of cells (Bixby & Harris, 1991).
1.4.1 Cell adhesion molecules and nerve regeneration
Cell adhesion molecules (CAMS) are important constituents of the receptor 
systems present on neuronal regeneration fronts and include the integrins 
(Reichardt et al. 1991), the immunoglobulin superfamily (Doherty & Walsh,
1992) and the cadherins (Takeichi, 1991). During growth, axon-SC interactions 
are mediated by cell adhesion molecules such as neural cell adhesion molecule 
(NCAM), LI, and N-cadherin, whereas axon-basal lamina contact is mediated by 
laminin and integrin interactions (Bixby & Harris, 1991).
In the developing nerve, expression of the immunoglobulins NCAM and 
LI is seen at axon-SC contact points on the plasma membrane (Rathjen, 1988). 
With maturation this expression is significantly reduced in myelinated fibres but it 
is maintained in unmyelinated fibres (Martini, 1994). Following denervation, N- 
CAM and LI are upregulated on SCs where they are in contact with each other in 
the SC column (Jessen et al. 1987). Upon contact with axons this expression 
becomes localised to the plasma membrane at the point of contact followed by 
temporal down-regulation as myelination develops as seen during development 
(Martini & Schachner, 1988; Rathjen, 1988). LI has been shown to stimulate 
neurite outgrowth in vitro (Seilheimer & Schachner, 1998).
Cadherins are a family of Ca2+-dependent cell-cell adhesion molecules 
which bind specific cells expressing the same cadherin (Takeichi, 1991). N- 
cadherin has been shown to stimulate neurite outgrowth on astrocytes
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(Neugebauer et al. 1988) and on SCs (Letoumeau et al. 1990), and it is found 
localised on the plasma membranes of axons and SCs during regeneration, but not 
between axons and basal lamina or SCs and basal lamina (Shibuya et al. 1995).
CAMs not only mediate adhesion between SCs and between SCs and 
axons but their activation can also trigger cytoplasmic signals via second 
messengers which ultimately lead to axonal growth. Low or high levels of 
intracellular Ca2+ levels can be inhibitory for neurite outgrowth (Kater & Mills,
7 -4-1991). Antagonists of Ca channels can inhibit CAM-dependent neurite 
outgrowth (Doherty et al. 1992) whereas direct activation of Ca2+ channels 
mimics CAM-dependent neurite outgrowth (Saffell et al. 1992).
1.4.2 Extracellular matrix
Signalling from the extracellular matrix, and in particular the basal lamina, plays 
an important role in supporting SCs and axons during development and axonal 
regeneration (Mirsky & Jessen, 1999). The basal lamina contains physiologically 
active molecules such as laminin and fibronectin within a collagen matrix, with 
laminin being the most potent adhesion molecule for promoting axonal outgrowth 
(Ide, 1996). Contact of axons and basal lamina is mediated by laminin-integrin 
binding (Letoumeau et al. 1994) which promotes adhesion and motility of 
regeneration fronts through intracellular signal transductions (Bixby & Jhablava,
1990).
The aim of developing any bio-engineered system is to mimic as closely as 
possible the internal structural and molecular characteristics of the tissue being 
substituted. The addition of extracellular matrix macromolecules (ECMMs) such
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as laminin, collagen and fibronectin to the structural scaffolds of peripheral nerve 
conduits may improve SC attachment and orientation, and as a consequence or 
independently, improve axonal growth. Laminin-coated micropattemed surfaces 
improve SC attachment and significantly improve unidirectional orientation in 
vitro (Thompson & Buettner, 2001) whilst laminin-coated poly (L-lactide) fibres 
promote directional neurite outgrowth in vitro (Rangappa et al. 2000). In vivo 
studies have shown that the addition of laminin to nerve conduits improves 
regeneration (Bailey et al. 1993).
Collagen is an important structural constituent of the extracellular matrix 
and it promotes Schwann cell adhesion, basal lamina deposition and neurite 
ensheathment in vitro (Obremski & Bunge, 1995). Several studies report a 
beneficial effect of using collagen gel matrices and filaments to bridge long nerve 
gaps (Chang et al. 1990; Chamberlain et al. 1998; Yoshii & Oka, 2001; Yoshii et 
al. 2001).
Fibronectin is a glycoprotein constituent of the extracellular matrix and 
addition of exogenous fibronectin stimulates Schwann cell proliferation and 
directional migration in vitro (Baron-Van Evercooren et al. 1982; Ahmed & 
Brown, 1999). Addition of fibronectin to nerve conduit matrices improves long­
term regeneration (Bailey et al. 1993) and augments regeneration in conduits 
containing a mixture of fibronectin and transplanted SCs (Mosahebi et al. 2003). 
Conduits formed from fibronectin mats have been successfully used to guide 
regenerating axons and it has also been shown that these materials can be 
impregnated with neurotrophic factors (Whitworth et al. 1996).
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1.5 Nerve repair
Following division of a peripheral nerve (neurotmesis) direct surgical apposition 
of the epineurium is required. In more complex injuries where nerve tissue is 
extensively damaged a gap may be created which prevents direct apposition of the 
proximal and distal stumps. In such cases nerve reconstruction is required and at 
present involves the interposition of autologous nerve tissue e.g. the sural nerve. 
Autologous nerve grafting was first described by Albert (1878), pioneered by 
Huber (1919) and Bunnell (1927), and achieved widespread acceptance following 
the surgical challenges faced during World War II (Sunderland, 1978). The 
harvesting of autologous nerve tissue for such purposes presents additional 
problems e.g. wound infection, scarring, loss of sensibility in the distribution of 
the donor nerve, neuroma formation, and the fact that there is a limited number of 
donor sites available which can be rapidly exhausted in a patient with multiple 
nerve injuries. With such limitations, attention has been drawn to the concept of 
an ‘off the shelf bio-engineered nerve graft made of a bio-compatible/resorbable 
material. Whilst surgical techniques have been optimised with the introduction of 
the operating microscope, functional recovery in ideal conditions remains poor 
(Mackinnon & Dellon, 1988). Hence research has also focused on experimental 
adjuvant treatments such systemic pharmacotherapy, transplantation of cells, 
administration of growth factors, addition of extracellular matrix macromolecules 
and gene transfer to maximise the regenerative capacity of the peripheral nervous 
system. This thesis concentrates on a number of experimental manipulations 
involving a biocompatible nerve graft.
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1.5.1 Bio-engineered nerve conduits
The development of nerve conduits to span injury gaps has provided great insights 
into the physiological processes that occur in nerve regeneration (Hall, 2001). 
The conduit confines and directs axonal regeneration and prevents the influx of 
inflammatory cells and scarring. Materials used to construct nerve conduits may 
be either biological or synthetic, the latter receiving widespread interest in recent 
years.
Studies of biological materials started with Gluck (1880) who used a 
section of artery to bridge the hypoglossal nerve in a dog, this was followed by the 
use of a vein by Platt (1919) and more recently by Ferrari et al. (1999). The use 
of artery and vein grafts for nerve conduits is however suboptimal because there is 
a limited supply of dispensable autologous vascular material. Muscle grafts have 
been used because it is possible to preserve the basal lamina structure following 
freezing (Glasby et al. 1986), but regeneration is still inferior to autografts and is 
poor over long gaps.
Some non-biological materials have also limited clinical applicability due 
to their lack of degradation. Lundborg et al. (1982) demonstrated good axonal 
regeneration through silicone conduits however long-term problems occurred due 
to irritation and rigidity of the conduit. With the expanding field of material 
science a number of biodegradable materials have emerged which have been used 
to construct conduits including fibronectin (Whitworth et al. 1995), collagen, 
polyglycolic acid (Matsumoto et al. 2000) and poly-3-hydroxybutyrate (Young et 
al. 2002).
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Poly-3-hydroxybutyrate (PHB) is a biopolymer produced from 3- 
hydroxypropionic acid and is found as a natural storage product in many bacteria. 
Following fermentation and solvent extraction, PHB is polymerised into fine 
fibres which can be formed into sheets which in turn can be rolled into conduits. 
PHB is non-antigenic and bio-compatible, being resorbed through hydrolytic 
degradation over a period of approximately 24 months (Holmes, 1988). A 
number of experimental studies have demonstrated the ability of PHB conduits to 
support nerve regeneration in vivo (Hazari et al. 1999; Mosahebi et al. 2001; 
Mosahebi et al. 2002; Mosahebi et al. 2003; Mohanna et al. 2003; Mohanna et al. 
2005). PHB sheets have been used clinically as pericardial patches (Duvemoy et 
al. 1992) and at present the material is being used in a multicentre trial evaluating 
their use as an adjunct to peripheral nerve repair.
1.5.2 Transplantation of Schwann cells
The pivotal role of SCs in nerve regeneration is well described (cf. 1.3.4). In 
experimental studies of regeneration through injury gaps, SC transplantation has 
been shown to improve regeneration, an effect most likely due to release of 
neurotrophic factors, contact guidance through the expression of cell adhesion 
molecules, and to synthesis of extracellular matrix (Guenard et al. 1992; Levi et 
al. 1994; Mosahebi et al. 2001; Mosahebi et al. 2002; Mosahebi et al. 2003; 
Rodriguez et al. 2000). The interaction of transplanted SCs with regenerating 
axons and their distribution throughout the conduit has been described following 
the incorporation of labelling techniques (Mosahebi et al. 2001). The use of
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transplanted SCs as a source of recombinant neurotrophins within conduits also 
represents an attractive therapeutic concept (Sorensen et al. 1998).
1.6 Cell labelling for transplantation studies
Labelling of cells transplanted in a bio-engineered system allows the assessment 
of their survival and integration within the host upon histological analysis. The 
ideal cell label would be stable for long periods of time, not be diluted with cell 
division and not be immunogenic. Cell labelling may be endogenous or 
exogenous. Endogenous cell labelling is integrated with phenotypic expression, 
for example, male cells in female hosts identified by their Y chromosome 
(O'Leary & Blakemore, 1997) allografts or xenografts identified by strain- or 
species-specific antigens (Jacque et al. 1986), or genes for reporter molecules such 
as lacZ introduced into the genome via DNA transfer techniques (Guenard et al. 
1999; Mosahebi et al. 2001). Exogenous labelling involves chemically tagging a 
component of the cell such as the cytoplasm, cell membrane or nucleus with a 
radioactive probe or fluorescent dye such as Hoechst 33342 and PKH26. 
However, these labels are diluted with cell division and leaching can occur from 
transplanted cells resulting in labelling of the hosts cells (Iwashita et al. 2000). In 
addition, some labelling methods have been shown to reduce long-term cell 
viability (Mosahebi et al. 2000). A more stable labelling has been obtained by 
transfection of cultured SCs with the lacZ reporter gene (Mosahebi et al. 2001). 
However a number of problems have been reported upon histological analysis, as 
lacZ expression is confined to the nucleus. Therefore, lacZ expression is only 
detected if the cell body and the nucleus are sectioned during histological
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analysis. The in vivo morphology of a Schwann cell is that of a small cell nucleus 
with disproportionate cytoplasmic processes. In histological sections, it is the SC 
cytoplasm that is more readily detected by immunostaining, hence the absence of 
a detectable nuclear cell body gives the misleading result that fewer labelled cells 
are seen than are actually present. A further drawback is that to identify the lacZ 
label a prolonged chemical process is required, with limited penetration into the 
tissue and moderate disruption of tissue architecture.
Over the past decade bioluminescent protein markers have received great 
interest for their use in labelling and tracking cells, proteins and for measuring 
gene expression. The first described and most widely studied are the green 
fluorescent proteins (GFPs) (Shimomura et al. 1962). To date there are few 
reports describing the use of GFPs as endogenous reporter molecules for 
transplanted SCs.
1.6.1 Bioluminescent proteins
The first written report of bioluminescence was from Pliny the Elder in the first 
century AD, who observed the bright glow of certain jellyfish in the Bay of 
Naples (Johnson & Shimomura, 1978). This chemiluminescence phenomenon 
requires an enzyme and has evolved independently many times in different 
species, as seen in bacteria, unicellular algae, coelenterates, beetles and fishes. 
Chemically, all involve exergonic reactions of molecular oxygen with different 
substrates (luciferins) and enzymes (luciferases) resulting in an energy rich 
intermediate, the breakdown of which provides energy for excitation of an 
accessory protein to produce light. Variation between species occurs in how this
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energy rich intermediate is utilised to produce fluorescence (Wilson & Hastings, 
1998). With the exception of bioluminescent bacteria there is no definitive 
explanation as to why these organisms evolved bioluminescence or fluorescent 
proteins. Green fluorescent protein was discovered by Shimomura (1962) as a 
companion protein to aequorin, a well known chemiluminescent protein that 
produces blue light in the Aequorea jellyfish. They reported that the blue light 
emitted from the aequorin protein caused the excitation of an accessory protein 
(GFP) to emit green light. To date the best described bioluminescent proteins are 
the green fluorescent proteins which are found in a number of marine 
invertebrates (coelenterates), the best characterised arising from the phylum 
Cnidaria which include the hydrozoan, Aequorea victoria (crystal jellyfish), and 
the anthozoan, Renilla reniformis (sea pansy) (Prasher, 1995). Although the 
biochemistry of the GFPs in these species is similar, the mechanism through 
which they are stimulated to emit light is different.
1.6.2 Biochemistry of Green Fluorescent Protein
GFP is a protein of 238 amino acid residues which fold to form an 11 p-stranded 
‘barrel’ surrounding a />hydroxybenzylideneimidazolidinone chromophore 
(Figure 1.1). Substitutions in this amino acid sequence alter folding of the 
protein, absorption and emission spectra (Heim et al. 1994). The emission of 
green light in vivo is due to energy transfer from either aequorin or the Renilla 
luciferase to a GFP molecule (Figure 1.2). The two bioluminescent systems are
2 d "  • ♦activated in vivo by a Ca signal which is initiated by a mechanical or primitive 
neuronal stimulus. Aequorea bioluminescence is activated when Ca2+ binds to
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aequorin which oxidizes bound coelenterazine, transferring the released energy to 
GFP. In contrast, Renilla biolumniscence is controlled by the luciferin-binding 
protein (LBP). Only on binding Ca does the LBP permit the luciferase to 
oxidise coelenterazine and transfer energy to GFP. Isolated Renilla and 
Aequorea GFP can be made to fluoresce in the absence of these energy transfer 
systems by exciting the protein with light of a specific wavelength. The Aequorea 
GFP has two excitation peaks at 395nm and 470nm, while Renilla GFP has a 
single excitation peak at 470nm. It is suggested the difference is due to different 
apoprotein environments of the chromophores. The two GFPs have identical 
emission spectra in the region of green light (}.max=509nm) (San Pietri et al. 1993). 
The quantum yield (probability of re-emitting a photon once the molecule has 
been excited) of GFP is greater than that of aequorin therefore the biological role 
of GFP may be that it is more efficient at producing light from transferred energy 
(Morise et al. 1974).
GFPs are stable proteins meaning their spectral properties are unaffected 
by denaturing conditions. The ‘barrel’ of p-strands surrounding the central 
chromophore protects this light-emitting region of the protein. They are resistant 
to strong acids, alkalis, proteolytic enzymes and temperatures of up to 80°C and 
can even be renatured to functional protein (Prasher, 1995).
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HD
Figure 1.1 (A) The bioluminescent jellyfish Aequorea victoria. (B) Renilla 
reniformis (sea pansy). (C) The three dimensional structure of GFP illustrating 
the central chromophore surrounded by a ‘barrel’ of 11 /?-strands of amino acids. 
(D) The central chromophore structure (Tsien et al. 1993).
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Figure 1.2 The bioluminescent pathways of Renilla and Aequorea. In Renilla, 
coelenterazine acts as a luciferin which when exposed to Ca2+ can be oxidised by 
luciferase. In Aequorea, the photoprotein aequorin oxidises coelenterazine on
0 -4-exposure to Ca . In both cases the energy released on oxidation of coelenterazine 
stimulates green fluorescent protein to emit green light in vivo. The asterisks 
show an excited state luciferin. After Prasher (1995).
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1.6.3 Applications of GFP
The first cloning of GFP cDNA was performed by Prasher (1992). Following 
this, a great deal of interest was generated in GFP when it was shown that 
expression of the cloned gene produces fluorescent protein in a variety of cell 
types (Chalfie et al. 1994; Inouye & Tsuji, 1994). The GFP gene therefore 
contains all the necessary information for the post-translational synthesis of the 
chromophore with no specific enzymes being required to initiate fluorescence. 
GFP has been successfully used as a reporter gene and cell marker (Chalfie et al. 
1994; Ikawa et al. 1999; Takada et al. 1997), as a fusion tag to monitor protein 
localization and fate (Cubitt et al. 1995), and to monitor protein-protein 
interactions using fluorescence resonance energy transfer (FRET) (Tsien et al. 
1993). For histological purposes the biochemical stability of GFP is advantageous 
as it makes the protein resistant to a wide range of temperatures, pH and enzymes 
which may be encountered in various staining protocols. The protein is highly 
soluble and therefore requires formaldehyde fixation prior to cryostat sectioning 
and staining (Jockusch et al. 2003). The use of GFP is advantageous in such 
techniques as transplanted labelled cells can be visualised in combination with 
other fluorochrome-labelled antigens.
Fluorescent protein technology has great potential for the study of bio­
engineered cellular systems. Developments have been aimed at producing a range 
of spectrally distinct fluorescent proteins to allow simultaneous multicolour 
tracking of separate genes, fusion proteins or labelled cells. Mutants of GFP are 
now available with enhanced fluorescence (EGFP) and emission spectra 
corresponding to blue (BFP), cyan (CYP) and yellow light (YFP) (Zimmer, 2002).
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More than 25 fluorescent proteins have been isolated from different marine 
organisms (Labas et al. 2002). These technologies have far-reaching applications 
for the study of bio-engineered nerve grafts. For example, cells could be labelled 
with one fluorescent protein for cell tracking following transplantation whilst 
secondary proteins could be tagged to a particular growth factor(s) enabling the 
measurement of gene expression within transplanted cells.
1.7 Stem cell therapies for peripheral nerve injury
Stem cells are the fundamental cellular building blocks of life, in addition to 
coordinating organ growth from embryo to adulthood they also play an important 
role in tissue regeneration and repair. A large body of literature exists describing 
embryonic stem cells, haematopoietic stem cells, and epithelia which display a 
rapid turnover i.e. the skin and intestinal epithelium (reviewed by Tohill & 
Terenghi, 2004). Discrete stem cell populations have now been identified in more 
static adult tissues such as adipose tissue and neural tissue. Notwithstanding the 
biological complexities of characterising such cells, there is qualified excitement 
at the potential of stem cells to revolutionise our approach to tissue engineering. 
One such area is that of regeneration in the peripheral nervous system.
The transplantation of cultured SCs into bio-engineered conduits has been 
shown to improve nerve regeneration in experimental models of peripheral nerve 
injury (Guenard et al. 1992; Mosahebi et al. 2001; Rodriguez et al. 2000). 
However, the use of autologous cultured SCs for the treatment of acute injuries 
may be impractical due to the technical difficulties and time required in harvesting 
and expanding such cells which may take up to 10 weeks (Mosahebi et al. 2001).
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Such a delay in performing a primary nerve repair following injury would be 
deleterious to clinical outcome. Indeed, it has been shown that the longer the time 
lag between injury and repair the greater the neuronal cell death in the dorsal root 
ganglia and therefore a reduced potential for recovery (Hart et al. 2002).
The ideal Transplantable cell’ should be easily accessible, capable of rapid 
expansion in culture, immunologically inert, capable of long-term survival and 
integration in the host tissue, and amenable to stable transfection and expression 
of exogenous genes (Azizi et al. 1998). In a search for such a cell attention has 
been drawn to the possible use of stem cells.
1.7.1 Basic biology of stem cells
A minimalist definition of the stem cell describes it as a clonogenic cell capable of 
self-renewal and multi-lineage differentiation (Till & McCulloch, 1961). The 
semantics of stem cell biology can cause confusion as there is no universally 
accepted definition of what a stem cell is and no unified theory describing their 
origin, plasticity and function in the adult organism. A number of criteria have 
been proposed to help identify a stem cell. These dictate that the cell must be (i) 
undifferentiated (i.e. lacking a tissue-specific differentiation marker), (ii) capable 
of proliferation, (iii) self-renewable, (iv) able to produce a large number of 
differentiated functional progeny and (v) able to regenerate tissue after injury 
(Loeffler & Potten, 1997).
Multi-potential cells are stem cells of tissues that are capable of 
developing into a restricted number of cell types specific to that tissue (Alison et 
al. 2002). There are two populations of cells within a tissue, those which are post-
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mitotic and responsible for physiological activity, and stem cells which are 
responsible for organ and tissue growth and repair following injury. As an 
organism matures from embryo to adult the number of post-mitotic cells increase 
and the number of stem cells decrease. The proportion and activity of stem cells 
within adult tissue depends on tissue type, i.e. depending on whether the tissue is 
renewing e.g. intestinal epithelium, or static e.g. the CNS (Marshak et al. 2001). 
Under steady-state conditions the stem cell pool remains constant but following 
injury or during disease it can expand rapidly. The haematopoietic system 
displays regenerative capacity more dramatically than any other tissue as huge 
numbers of cells are continuously produced throughout life. It is possible to re­
establish the entire haematopoietic compartment following complete ablation as is 
seen following cytotoxic therapy for haematological malignancies, and it is this 
property which has been exploited to successfully treat such conditions (Thomas,
1991). Embryonic stem cells can be propagated in culture (Thompson et al. 1998) 
however obtaining such cells faces practical, ethical and legislative difficulties 
(McLaren, 2000; Shapiro, 1999). The identification, isolation and expansion of 
truly multipotent adult-derived stem cells remains problematic. Toma et al (2001) 
(Toma et al. 2001) described the isolation and expansion of multipotent stem cells 
from skin however it was not possible to determine the origin of the cells with 
absolute certainty. The problem of isolating clonal stem cells from adult tissues is 
probably the greatest obstacle faced in this field (Donovan & Gearhart, 2001; 
Vogel 2001).
The control of self-renewal and differentiation is most probably influenced 
by extrinsic factors i.e. the environment or niche, and intrinsic cellular factors.
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The environment influences the biochemical and morphological properties of 
stem cells. Stem cells adjust their properties according to their surroundings and 
select specific lineages according to the cues they receive from their niche (Fuchs 
& Segre, 2000). Extrinsic factors include cell-cell interactions (Henderson et al. 
1994; Kopan et al. 1994), locally secreted factors (Reynolds & Weiss, 1996; Gritti 
et al. 1996; Shah et al. 1994; Shah et al. 1996) and the extracellular matrix 
(Quesenberry & Becker, 1998; Jensen et al. 1999).
Intrinsic factors determining self-renewal and division exist. Under 
similar conditions it has been observed that subpopulations of haematopoietic 
stem cells have different capacities for self-renewal depending on telomerase 
activity, with increased telomerase expression correlating with an increased 
capacity for self-renewal (Morrison et al. 1996). Maintenance of the 
undifferentiated state may be determined by the asymmetric inheritance of certain 
proteins which influence gene expression, for example the nuclear protein PIE-1 
inhibits embryonic genes which are responsible for somatic lineage differentiation 
(Seydoux et al. 1996). The role in vivo of asymmetric kinetic genes may be of 
fundamental importance as intrinsic factors controlling self-renewal, however it is 
believed the predominant form of self-renewal in mammals detectable so far is 
symmetric division (Morrison et al. 1997). Manipulation of asymmetric genes in 
vitro may enable great advancement in stem cell expansion (Sherley, 2002).
The control of differentiation is a complex event requiring exit of the cell 
from the undifferentiated state and entry into a determined developmental 
pathway. At present cell determination is seen as a stochastic event initiated by 
intrinsic factors with an outcome biased by extrinsic factors. The challenge at
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present is to identify further intrinsic and extrinsic regulatory mechanisms which 
determine stem cell fate and to define the relationship between these systems.
Developmentally the components of the peripheral nervous system 
originate from the neural crest. In looking for alternatives to SC transplantation in 
bio-engineered conduits it is useful to briefly review reports utilising neural 
progenitor cells in peripheral nerve regeneration.
1.7.2 Neural progenitor cells
There are a limited number of reports describing the use of stem and progenitor 
cells in peripheral nerve transplantation. SCs are derived from the neural crest of 
the neuroectoderm and differentiate and migrate into the peripheral nervous 
system with development (LeDouarin, 1991). The use of neural derived 
progenitors from the fetal rat hippocampus to seed a conduit spanning a 15mm 
gap in the rat sciatic nerve has been described. Significant morphological and 
functional evidence of regeneration with integration and differentiation of 
transplanted neural progenitors into Schwann-like cells was reported (Murakami 
et al. 2003). Neural stem cells have been identified in the adult CNS (Reynolds & 
Weiss, 1992). Such adult-derived stem cells and those isolated from fetal tissues 
have been successfully propagated and differentiated in vitro into all major cell 
types of the nervous system (Morrison et al. 1999). The use of fetal or adult- 
derived neural progenitors fails to avoid the problems encountered with SCs i.e. 
source of donor tissue and the time taken to expand such cells. Morrison et al. 
(1999) identified populations of SC progenitors within the rat fetal sciatic nerve, 
but there has been little evidence to suggest the presence of a stem cell population
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within the adult peripheral nerve, although their existence has been postulated 
within populations of the neurons of dorsal root and autonomic ganglia (Geuna et 
al. 2000). The absence of a population of peripheral nerve stem cells may be 
explained by the inherent plasticity of mature SCs to dedifferentiate and 
proliferate in response to injury (Bunge, 1993).
1.7.3 Olfactory ensheathing cells
Olfactory ensheathing cells (OECs) can be described as peripheral nerve 
progenitor cells as they develop from a peripheral origin, the olfactory placode, 
and retain the ability to self-renew and differentiate. In the adult organism they 
continually regenerate from a long-term pool of progenitors to myelinate the 
olfactory nerves (Ramon-Cueto & Avila, 1998). OECs are considered an 
intermediate glial cell type as they express a number of Schwann cell-specific 
marker molecules including p75, NCAM, GFAP and P0 but not GalC (Wewetzer 
et al. 2002). They have been found to stimulate axonal regeneration in the spinal 
cord (Ramon-Cueto & Nieto-Sampedro 1994; Navarro et al. 1999) and to form 
myelin constituents in vitro (Santos-Silva & Calvacante, 2001) and in vivo 
following peripheral nerve transplantation (Verdu et al. 1999), this indicates their 
peripheral origin as they do not myelinate small diameter olfactory axons. The 
potential for the therapeutic transplantation of OECs as a surrogate for SCs in 
peripheral nerve injury is still debatable, as there are many pragmatic difficulties 
to overcome when applied to the clinical setting. However, OECs do merit 
attention as at present they are the only PNS-progenitor type cells known to exist.
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1.7.4 Bone marrow stromal cells
Until recently, dogma dictated that organ-specific stem cells were restricted to 
differentiate only into cell types from the tissue from which they originate. 
Unlike embryonic cells, organ-specific stem cells were believed to have lost the 
capacity to generate other somatic lineages. However, recent reports have 
suggested that stem cells from one tissue can cross lineage boundaries to 
differentiate into cells of other lineages either in vitro or in vivo after 
transplantation. This plasticity, or ability for cells to trans-differentiate, has 
aroused great interest for its therapeutic potential in tissue engineering. A 
promising candidate to display such plasticity is the bone marrow stromal cell.
Bone marrow contains two distinct populations of progenitor cells: 
haematopoetic progenitors and bone marrow stromal progenitors. Marrow stroma 
has been identified as the site of origin for mesenchymal progenitors for bone, 
cartilage, tendon, adipose tissue and muscle (Caplan, 1994). In addition, the 
stroma has been identified as a supportive tissue for the haematopoietic system, 
enhancing cytokine-induced proliferation of haematopoietic precursors (Verfaillie,
1993). Marrow stromal cells are easily accessible through the aspiration of the 
bone marrow cavity. They readily adhere in tissue culture in comparison to their 
non-adherent haematopoietic counterparts (Bianco, 2001). A number of 
mitogenic factors have been identified which stimulate colony formation and 
proliferation such as PDGF, EGF, bFGF, TGFJ3 and IGF-I (Gronthos, 1995). 
Bone marrow stromal cells have been shown to be inherently heterogeneous in 
terms of growth kinetics, morphology and phenotype. This may be due in part to
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the fact that the actual number of true stem cells is small, being estimated at 2-5 
per 1 x 106 mononuclear cells, with the majority of cell growth arising from 
expanding differentiated colonies under mitogenic influence. With the
development of specific antibodies such as STRO-1 (Simmons, 1991) and 
characterisation (CD45ve, CD34‘ve, CD105+ve, CD73+ve) (Pittenger et al. 1999) for 
human mesenchymal stem cells, their expansion and properties can be studied and 
defined with more certainty.
Marrow stromal cells differentiate according to a hierarchical paradigm 
into osteoblastic, chondroblastic and adipocytic progenitors (Muraglia et al. 
2000). Orthodox plasticity between these lineages has been reported from 
adipocytic and chondrocytic lineages to osteogenic differentiation (Beresford 
1992; Gentili, 1993). Recent reports have described unorthodox plasticity of 
haematopoietic progenitors (Orlic et al. 2001; Lagasse et al. 2000) and bone 
marrow stromal cells in that they have been shown to cross oligolineage 
boundaries which were previously thought to be uncrossable. The potential of 
marrow stromal cells to trans-differentiate from mesenchymal lineages has 
aroused great interest. An early report by Ferrari et al. (1998) described the 
migration of labelled marrow stromal cells to areas of damaged skeletal muscle. 
Trans-differentiation was detected due to the stromal cell expression of myogenic 
markers and their participation in the regeneration of damaged muscle fibres. 
Gojo et al. (2003) demonstrated mesenchymal differentiation into 
cardiomyocytes, endothelial cells and smooth muscle cells following direct 
injection into adult heart, it has also been shown that these cells will migrate to 
zones of myocardial injury following systemic delivery (Barbash et al. 2003)
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although neither authors described any functional improvement. Jiang et al. 
(2002) identified marrow-derived cells in all somatic lineages in chimaeric mice 
following injection of labelled cells into 3-5 day old blastocysts and engraftment 
into many adult tissues following systemic infusion. There is evidence that 
marrow stromal cells are capable of neuronal antigen expression in vitro (Kim et 
al. 2002; Wislet-Gendebien et al. 2003; Dezawa et al. 2001) and in vivo (Kopen et 
al. 1999; Mezey et al. 2000). They have been shown to differentiate into 
astrocytes following direct transplantation into the rodent brain (Azizi et al. 1998 
45; Kopen et al. 1999). Studies have also reported the ability of such cells to 
transdifferentiate into cells displaying similar characterisation to those of 
neuroectodermal cells (Kopen et al. 1999; Mezey et al. 2000). Akiyama et al. 
(2002) described remyelination of spinal cord lesions following intravenous 
delivery of marrow stromal cells and Hofstetter et al. (2001) showed that local 
delivery of MSCs at the site of spinal cord injury was associated with the 
formation of neurofilament bundles at the interface between scar tissue and graft. 
It is not clear what mechanisms govern the in vivo differentiation and migration of 
MSCs within zones of injury however it is likely that the local milieu of growth 
factors, cytokines and local stem cells have some influence. The potential for 
these cells to undergo unorthodox differentiation may be capitalised in the repair 
of peripheral injury.
Two recent reports have described the use of marrow stromal cell 
transplantation in models of peripheral nerve injury. Dezawa et al. (2001) 
described the in vitro expression of the glial cell markers p75 and SI00 by rat 
mesenchymal stromal cells following exposure to a cocktail of growth factors, and
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integration of such cells in the regeneration front upon transplantation into a 
blind-ending tube grafted to the proximal stump of the rat sciatic nerve. Cuevas et 
al. (2002) described the migration and differentiation of marrow stromal cells 
following the injection of cultured undifferentiated cells into the site of a sciatic 
nerve axotomy repair.
1.7.5 Immunotolerance to allogeneic stem cells
An important problem which faces all studies of transplantation is that of host 
rejection of transplanted tissue. In the clinical setting of organ transplantation this 
problem is overcome with the use of immuno-suppressants with the benefits of a 
functioning heart, lung, liver or kidney outweighing the potentially serious 
systemic side-effects of immunosuppression, such as susceptibility to 
opportunistic infection and skin cancer. A number of experimental reports have 
shown that there is an unexpected and fortuitous level of immune-tolerance to 
transplanted stem and progenitor cells. Marrow stromal cells have been shown to 
block the proliferation of allogeneic T-cells in vitro and prolong skin graft 
survival in vivo (Bartholomew, 2002). Saito et al. (2002) demonstrated immune 
tolerance to xenogeneic cells following transplantation in addition to the 
retainment of their ability to engraft and differentiate. The ability of marrow 
stromal cells to induce tolerance may be due to cytokine secretion such as TGFp 
or due to their phenotypical immaturity as they lack MHC class II and other T-cell 
stimulatory surface proteins (Deans & Moseley, 2000; Tse et al. 2001). With 
respect to studies in the nervous system, Hori et al. (2003) has shown that CNS 
progenitor cells may not express MHC class I and II in vitro and that no short
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term evidence of rejection is seen after allogeneic transplantation within the CNS. 
These observations are seemingly a local effect of stem cell transplantation and 
are distinct from the recognized phenomenon that infusion of bone marrow donor 
cells can improve allograft survival and reduce the need for short-term 
immunosuppression. Such macrochimaeric models require significant host 
conditioning prior to transplantation such as central and peripheral T-cell deletion 
(Rifle & Mousson, 2003; Wekerle et al. 2003).
One problem which may be faced when considering host tolerance to 
progenitor cell allografts is the consequence of the up-regulation of 
immunoreactive surface markers following in vitro or in vivo differentiation due 
to the effects growth factors or cytokines. Such effects may offset the benefits of 
immune tolerance to immature cells. Marrow stromal cells might be used as 
primary engrafting cells for differentiation into cells of a de novo tissue, and they 
might also be used as cellular vehicles for transgene expression for the production 
growth factors or cytokines which could ameliorate the immune response to more 
differentiated and functionally mature allogeneic cells (Bartholomew, 2001; 
Studeny, 2002).
1.7.6 Characterisation of MSC in vivo
With growing evidence to support the apparent plasticity of marrow stromal stem 
cells, it seems likely that these cells may become important components of bio­
engineered systems in the future, because of their accessibility, abundance, and 
ease of culture in vitro. There is no doubt that such cells can express neuronal 
cell immunoreactivity under specific mitogenic influences both in vitro and in
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vivo. Micro-array analysis has revealed over 2000 genes expressed by marrow 
stromal cells, many of these genes unrelated to mesenchymal lineages (Tremain et 
al. 2001), hence unlocking dormant genes may be the key to induce plasticity. At 
present there are no universally established protocols to induce neuro-glial 
differentiation of marrow stromal cells. Wislet-Gendebien et al. (2003) recently 
reported that the expression of nestin is a prerequisite for GFAP expression in rat 
MSCs and that this ability is directly proportional to passage number. It is 
important to examine the effects of cellular microenvironments on cell 
differentiation as in vitro experiments have identified a mitogenic effect of a large 
number of unrelated cytokines and growth factors on marrow stromal cells 
(Conget & Minguell, 1999). It is also necessary to identify the factors influencing 
differentiation, such as intrinsic and extrinsic mechanisms, and the interaction 
between the two.
1.8 The role of growth factors in peripheral nerve regeneration
A large number of cytokines and growth factors are involved in the physiological 
processes governing peripheral nerve regeneration. Of principal importance are 
the neurotrophic factors and the neuregulins. The utilisation of such peptides as 
adjuvant treatments to augment nerve regeneration has been studied extensively. 
A consistent problem faced however is how to deliver growth factor peptides over 
a sufficiently long period of time at the site of injury without using delivery 
vehicles that would be clinically impractical. Secondly, with such a large and 
ever expanding range of growth factors identified as to having neurotrophic
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effects it is increasingly difficult to choose which growth factor when applied 
exogenously will have the most beneficial overall effect.
During regeneration a key function of proliferating SCs is the production 
of neurotrophins (Heumann et al. 1987) which exert a trophic influence on the 
regenerating axons of the proximal stump (Reynolds & Woolf, 1993). 
Neurotrophins include nerve growth factor (NGF), brain-derived neurotrophic 
factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4/5 (NT-4/5), glia-derived 
neurotrophic factor (GDNF), ciliary neurotrophic factor (CNTF) and leukaemia 
inhibitory factor (LIF). NGF, BDNF, NT-3 and NT-4/5 all share similar amino 
acid sequencing (Maness et al. 1994) and similar affinity for the p75 low-affinity 
nerve growth factor receptor. Specific trk receptors exist for certain 
neurotrophins, trkA is specific for NGF (Kaplan et al. 1991), trkB for BDNF and 
NT-4/5 (Klein et al. 1992) and trkC for NT-3 (Lamballe et al. 1991). All 3 trk 
receptors are found in subpopulations of sensory neurons (McMahon et al. 1994) 
whilst trkB and trkC are found in spinal motoneurons (Funakoshi et al. 1993). 
Neurotrophins play an important role in maximising neuronal cell survival 
following axotomy. Following peripheral nerve injury up to 40% of the sensory 
neurons of dorsal root ganglia die through apoptosis (Groves et al. 1997), in 
addition trk receptor expression downregulation occurs due to a reduction in local 
neurotrophin availability (Krekoski et al. 1996). SCs at the site of injury 
upregulate the synthesis of some neurotrophins and the p75 receptor however this 
is insufficient to prevent significant neuronal cell death (Funakoshi et al. 1993). 
Sensory neuronal cell death can be reduced and receptor downregulation reversed 
by the exogenous administration of neurotrophins such as GDNF (Munson &
54
McMahon, 1997), NGF, NT-3 (Ljungberg et al. 1999), and LIF (Thompson et al. 
1998). Motonueron survival is enhanced by the administration of BDNF 
(Novikova et al. 1997), NGF (Rich et al. 1989), CNTF (Sendtner et al. 1997) and 
GDNF (Li et al. 1995). CNTF, LIF, NT-3 and GDNF have also been shown to 
enhance neurite outgrowth following axotomy and to enhance target organ muscle 
reinnervation leading to preservation of muscle mass and fibre type expression 
(Sterne et al. 1997).
Neuregulins are a family of proteins that are secreted by developing 
neurons and include the glial growth factors (GGFs) and heregulin. They are 
Schwann cell mitogens and survival factors (Minghetti et al. 1996). They have 
also been shown to play a role in restricting neural crest precursors to a glial cell 
fate (Shah et al. 1994). Recombinant human GGF II has been shown to increase 
Schwann cell motility and proliferation in vitro and to indirectly increase neurite 
outgrowth in vitro (Mahanthappa et al. 1996). Mohanna et al. (2003) showed that 
delivery of GGF at the site of peripheral nerve injury dramatically increases the 
rate of regeneration at early time points. The mechanisms of actions of the 
neurotrophins and the neuregulins demonstrates an important reciprocal 
arrangement between developing or regenerating axons and SCs and the 
specificity of target organ reinnervation. This apparent symbiosis probably 
exists to produce an organised peripheral nerve that has axons matched to the 
appropriate number of SCs, whilst target organ-derived neurotrophins maintain 
the specificity of regeneration.
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1.8.1 Insulin-like growth factors
Insulin-like growth factors (IGF-1/2) are single chain polypeptides that belong to 
the insulin gene family. They are derived from muscle and nerve, act 
predominantly through an IGF receptor and have neurotrophic properties which 
play an important role in the development of the central, autonomic and peripheral 
nervous system and its regeneration following injury (Hansson, 1993; Ishii et al. 
1993; de Pablo & de la Rossa, 1995). IGF-1 enhances neurite outgrowth from 
DRG explants in vitro (Akahori & Horie, 1997), stimulates Schwann cell 
proliferation in vitro (Cheng et al. 1996) and prevents Schwann cell apoptosis in 
vitro and in vivo during embryonic nerve development (Syroid et al. 1999). 
Following axotomy Schwann cell IGF-1 gene expression for both the peptide and 
receptor increases for up to 7 days, thereafter the predominant source of IGF-1 
comes from macrophages (Cheng et al. 1996). Administration of IGF-1 improves 
peripheral nerve regeneration following axotomy by stimulating axonal sprouting 
(Skottner et al. 1987; Kanje et al. 1989) and by promoting motor and sensory 
neuron survival (Neff et al. 1993; Vergani et al. 1998). IGF-1 indirectly enhances 
nerve regeneration by stimulating fibroblasts and macrophages to produce a 
number of neurotrophic factors, adhesion molecules and cytokines (Caroni & 
Grandes, 1990). In addition to a mitogenic effect on SCs it stimulates their 
differentiation through IGF binding protein-5 (IGFBP-5) which increases the 
myelination markers P0 and myelin basic protein (Cheng & Feldman, 1997). 
Rabinovsky et al. (2002) demonstrated enhanced peripheral nerve and muscle 
regeneration following the targeted expression of an IGF-1 transgene to skeletal 
muscle in a mouse model of peripheral nerve injury.
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1.8.2 Mechano-Growth Factor (MGF)
IGF-1 is a major regulator of skeletal muscle growth and maintenance. During 
growth IGF-1 is produced by the liver in response to pituitary-derived growth 
hormone. Whilst systemic IGF-1 controls growth of the body, some tissues are 
subject to a local system of growth regulation, as seen in skeletal muscle which 
becomes hypertrophic in response to overload (Goldspink, 1999). The IGF-1 
gene is alternatively spliced in response to different signals resulting in different 
peptides which vary in their mode of action and their specific target tissues. The 
IGF-1 gene contains two promoters initiating at the 5' end of the gene (Figure 
1.3). Transcripts initiating at promoter 2 are common in the liver and are highly 
growth hormone dependent, whilst transcripts initiating at promoter 1 are 
expressed in skeletal muscle. Following mechanical stimulation of muscle Yang 
and co-workers (1996) demonstrated the expression of an isoform of IGF-1 that 
appears to be responsible for local hypertrophy of muscle in response to overload 
via paracrine/autocrine routes. Because the expression of this isoform is 
mechanosensitive it has been termed mechano-growth factor (MGF). The MGF 
isoform results from a novel splice acceptor site in the intron preceding exon 6 
leading to MGF cDNA differing from its liver type counterpart by the presence of 
a 49 base pair insert from exon 5 in man and a 52 base pair insert in the rat. These 
inserts result in a reading frame shift and a different C-terminal peptide sequence 
(Yang et al. 1996; McKoy et al. 1999; Yang & Goldspink, 2002). MGF 
expression rises significantly over other IGF isoforms in skeletal muscle after 
high resistance exercise in young subjects (25-36 years) but not the elderly (70-82 
years) which is consistent with age-related desensitivity to mechanical loading
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(Hameed et al. 2003). In vitro studies have shown that MGF stimulates muscle 
satellite cell (residual myoblast) proliferation whilst inhibiting terminal 
differentiation. These effects are seen in the presence of IGF-1 receptor blockade 
indicating that MGF acts through a signalling pathway independent of the IGF-1 
receptor (Yang & Goldspink, 2002).
Hormonal effect 
on the liver
L.IGF-1 Eb
L.IGF-1Ea (systemic)
Promoter 1 Promoter 2
IGF-1 gene
52 base
insert
Mechanical signals 
including local cell 
damage
MGF (autocrine) 
reading frame shift
Figure 1.3 Diagrammatic representation of the alternative splice variants of the 
IGF-1 gene. IGF-1 (insulin-like growth factor-1), L.IGF-1 (liver insulin-like 
growth factor-1), MGF (mechano-growth factor). A 52 bp insert occurs in rat 
MGF whilst a 49 bp insert occurs in human MGF. Reproduced with permission 
by Dr S. Yang.
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1.8.3 Delivery of neurotrophic factors
Whilst neurotrophic factors appear to be ideal adjuvant treatments for peripheral 
nerve injuries there are a number of practical problems faced in their 
implementation in the clinical setting. Systemic administration of neurotrophic 
factors yields undesirable side effects such as anorexia and weight loss (Penn et 
al. 1997). Local delivery has been achieved through the use of osmotic pumps 
(Santos et al. 1998), bioresorbable materials such fibronectin mats (Whitworth et 
al. 1996), fibrin glue (Yin et al. 2001) and hydrogels (Mohanna, 2003). However 
such modes of delivery are suboptimal because growth factors have an inherently 
short half-life due to pharmacokinetic and biological breakdown and are therefore 
are not available throughout the full time-course of regeneration. Attention has 
subsequently turned to gene delivery and the transplantation of cells genetically 
engineered to produce specific growth factors at the site of injury. Genes may be 
introduced directly to cells via plasmid mediated transfer which requires physical 
and chemical means to temporarily breach the plasma membrane to allow entry of 
the plasmid. Indirect transfer involves the use of viral vectors which actively 
infect the cells, this technique is more efficient than plasmid mediated transfer and 
when retroviral vectors are used causes permanent incorporation of the DNA 
within the cell’s genome. Fibroblasts genetically engineered to produce NGF have 
been shown to increase neurite outgrowth following transplantation into the 
lesioned spinal cord (Tuszynski et al. 1996) whilst cultured SCs have been 
successfully engineered to produce BDNF and NT-3 (Sayers et al. 1998). Growth 
factor cDNA may also be transferred directly to the peripheral nerve via retroviral 
and adenoviral vehicles (Gravel et al. 1997; Glatzel et al. 2000; Young et al.
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2000) however concerns have been raised about their long-term safety. Direct 
cDNA transfer via a plasmid delivery vehicle within a suitable matrix has been 
achieved and seems a more clinically acceptable alternative to viral vehicles 
(Andree et al. 2003). Such a delivery mechanism would be advantageous for the 
treatment of peripheral nerve injuries as growth factor cDNA is highly stable and 
therefore could be stored for prolonged periods of time. Once delivered, the 
cDNA is internalised at the site of injury and can potentially reach target organs 
and neuronal cell bodies via anterograde and retrograde transport respectively, 
following which the gene product can be manufactured without permanent 
incorporation within the genome.
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1.9 Hypothesis
The transplantation of cultured SCs improves peripheral nerve regeneration, and 
labelling of transplanted cells is necessary to define their behaviour and 
interaction with regenerating axons. Hence labelling should be optimised so that 
it can be incorporated within the standard immunofluorescent histological 
techniques used to assess peripheral nerve regeneration. The use of GFP as a 
label for transplanted SCs has not been well documented, a great advantage of 
GFP over lacZ labelling would be the ability to assess fluorescence in vitro 
without need of a substrate, detriment to the cultures or the need for fixation. 
Experiments are described in this thesis which looked at the use of GFP as a label 
for tracking SCs in bio-engineered conduits.
Bone marrow stromal cell progenitors have shown great unorthodox plasticity in 
their differentiation abilities. It may be possible that these cells could be induced 
to differentiate along a glial cell lineage. The transplantation of marrow stromal 
cells in vivo has demonstrated their ability to integrate and differentiate within 
different injured tissues. These cells may be used as an alternative to cultured 
SCs in bio-engineered nerve conduits and therefore may have a therapeutic role in 
peripheral nerve regeneration.
The benefit of transplanting cultured SCs in bio-engineered nerve conduits is well 
established. However it is still unclear whether the culturing of SCs may effect 
some of their intrinsic properties, such as CAM expression. This may have 
important implications for their efficiency in sustaining regeneration following
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transplantation. Extracellular matrix molecules play an important role in 
supporting axons and SCs following injury. Addition of these molecules to 
bioengineered nerve grafts may therefore enhance peripheral nerve regeneration. 
Also, it is not known if the transplantation of cultured SCs into bio-engineered 
conduits and the pre-coating of such conduits with ECMMs such as laminin, 
fibronectin and collagen influences the expression of axonal CAMs such as 
NCAM, LI and N-cadherin.
A large number of growth factors have been identified as having neurotrophic 
effects during regeneration and may therefore be of therapeutic benefit. 
Administering a sustained level of growth factor peptide is problematic but may 
be achieved through gene transfer. The neurotrophic effects of IGF-1 have been 
well documented however little is known about the potential effect of MGF on 
peripheral nerve regeneration, however a pilot study showed that MGF may 
restore or maintain muscle function following injury either directly or indirectly 
through a neurotrophic effect on regenerating peripheral nerve.
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1.10 Aims
The aims of the experiments described in this thesis are as follows:
1. Establish a protocol for labelling SCs with green fluorescent protein to aid 
their identification in combination with histological immunfluorescent 
staining used to assess peripheral nerve regeneration.
2. Assess the ability of marrow stromal cell progenitors to undergo glial 
differentiation in vitro, characterise this differentiation at a molecular, 
phenotypical and functional level, and to assess the ability of transplanted 
marrow stromal cells to support peripheral nerve regeneration through a 
PHB conduit in vivo.
3. Define the effects of the extracellular matrix macromolecules laminin, 
fibronectin and collagen on Schwann cell growth in vitro, and the effect of 
pre-coating PHB fibres with these molecules on peripheral nerve 
regeneration and cell adhesion molecule expression in vivo.
4. Investigate the potential of MGF to stimulate peripheral nerve 
regeneration and improve functional muscle re-innervation following 
delivery of MGF cDNA via a plasmid vector to the site of injury.
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Chapter 2
Materials and Methods
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2.1 Schwann cell culture
2.1.1 Nerve harvesting
Day 1 Schwann cells (SCs) were harvested from the sciatic nerves of Sprague- 
Dawley rats according to the following protocol (Brockes et al. 1979; Mosahebi et 
al. 2001). Twenty1 1-2 day old inbred neonatal pups were collected from between 
1-2 litters giving a total of 40 nerves. Animals were terminated by cervical 
dislocation and then washed in alcoholic chlorhexidine solution to sterilise skin. 
Under an operating microscope (Zeiss, X I0 magnification), a skin incision was 
made across the dorsum of the animal in the lumbar region, the skin was then 
pulled distally to reveal the musculature of the thighs and lower legs. A muscle 
splitting incision was then made posterior to the femur of each thigh to expose the 
sciatic nerve. The nerve was gently dissected from the sciatic notch to the 
popliteal fossa, and taking care not to incorporate any muscle or connective tissue 
was divided at each end, removed from the animal and then placed in chilled 
Dulbecco’s Modified Eagle’s Medium (DMEM) plus HEPES buffer with 
penicillin and streptomycin (cf. Appendix A). Instruments were washed in 
alcoholic chlorhexidene between each animal.
2.1.2 Nerve Digestion
Following collection the nerves were transferred to the tissue culture laboratory
for digestion and plating. The medium was replaced with 2mls of fresh
DMEM/HEPES. Five hundred /d of collagenase I and 250/d of trypsin (cf.
Appendix A) was added to the suspension and incubated at 37°C for 15 minutes.
1 An absolute minimum o f 10 animals (20 nerves) are needed for successful SC harvesting as SCs 
are veiy sensitive to plating density when cultured. Low SC plating density also increases the risk 
of early fibroblast overgrowth.
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2
The medium was then aspirated taking care not to remove any nerve tissue , and 
then replaced with 2ml of fresh DMEM/HEPES and fresh enzymes as before. 
This cycle was repeated a further 2 times (4 in total), on the 3rd and 4th cycles the 
medium was not discarded in order to retain the maximum number of SCs. At the 
end of the 4th cycle 1 Omls of cell growth medium (cf. Appendix A) was added to 
neutralise the enzymes to prevent SC damage. The mixture was triturated 3 times 
through a 21G needle followed by 3 times through a 23G needle and then passed 
through a 70//m filter (Falcon) to remove debris and undigested fragments of 
tissue. The resulting suspension was centrifuged at 800rpm (cf. Appendix A) for 
5mins, the medium was carefully aspirated to conserve the cell pellet, replaced 
with 5ml of fresh cell growth medium, plated on a 25cm flask coated with poly- 
D-lysine (Appendix A) and placed in an humidified incubator at 37°C and 
5%C02.
2.1.3 Schwann cell purification and maintenance
Day 2 Twenty-four hours after plating the SC culture flask was checked for cell 
attachment and infection using an inverted microscope (Olympus). The medium 
was aspirated and the cells washed with DMEM/HEPES. The medium was 
replaced with 5ml of fresh cell growth medium containing IOjjM of the cytotoxic 
agent cytosine-p-D-arabinoside (Arac C; Appendix A), which causes death of 
proliferating cells. The culture at this stage contains a mixture of SCs and 
fibroblasts, the latter proliferate more rapidly than SCs and are therefore more
2 Removal o f medium at this stage was performed with a manual pipette as aspiration via vacuum 
pump can easily cause accidental irrecoverable removal o f semi-digested nerves.
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sensitive to the cytotoxic effects of Arac C. With time the number of fibroblasts 
decreases leaving a greater proportion of SCs.
Day 3 The flask was inspected for fibroblast over-growth and the medium was 
replaced with fresh cell growth medium containing Arac C. This was repeated for 
a further 2 days. The number of days requiring Arac C addition may vary 
depending on the number of fibroblasts seen and SC death. If significant SC 
death is seen shortly after Arac C addition then the investigator should proceed 
directly to immuno-depletion of fibroblasts.
Day 6 Fibroblast immuno-depletion. When the SC-fibroblast culture was 
sub-confluent the culture was trypsinised by first aspirating the medium and 
washing with 5ml of Hank’s medium to remove traces of serum, Mg2+ and Ca2+ 
which neutralise the trypsin enzyme. The Hank’s medium was removed and 
0.25% trypsin/EDTA (2ml for a 25cm2 flask, 4ml for a 75cm2 flask) was added 
and the culture incubated at 37°C for 5mins. The flask was then lightly tapped 
and examined under an inverted microscope to check for SC detachment, 
following which 5ml of cell growth medium was added to neutralise the trypsin. 
SCs will detach from tissue culture plastic more easily than fibroblasts, therefore 
vigorous tapping should be avoided as this will increase the load of contaminating 
fibroblasts in the trypsinised cell suspension. The cell suspension was then 
aspirated from the flask and placed in a 20ml universal sample bottle and 
centrifuged at 800rpm for 5 minutes. The supernatant was aspirated and the 
resulting cell pellet was resuspended in 500[A of mouse anti-rat Thy 1.1 (dil. 
1:500 in DMEM) and incubated at 37°C for 10 minutes. Thy 1.1 antibodies will 
bind specifically with fibroblasts and cause cell lysis in combination with
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complement. Fresh rabbit complement was prepared (Appendix A) and 250/d 
were added to the cell suspension and incubated for 30 minutes at 37°C with 
gentle agitation every 10 minutes. Ten ml of cell growth medium was then added 
to the cell suspension which was centrifuged at 800rpm for 5 minutes. The 
supernatant was aspirated and the cell pellet re-suspended in 5ml of SC growth 
medium (Appendix A) and plated in a PDL-coated 25cm flask and placed in an 
incubator. SC purity following immuno-depletion should reach 99% (Brockes, 
Lemke, et al. 1980 80 /id). Fibroblast contamination is detected due to the 
different morphology between both cell types, SCs are spindle-shaped bipolar 
cells which align parallel to each other in characteristic whorls when confluent 
(Figure 2.1; for review of SC morphology in culture see Scarpini et al. 1993). 
Fibroblasts have large granular cell bodies, numerous short cytoplasmic processes 
and distinct nuclei under phase contrast microscopy. If fibroblast overgrowth 
recurred in culture the process was repeated.
When SC cultures were confluent they were washed with Hank’s medium, 
trypsinised with 0.25% trypsin/EDTA for 5 minutes at 37°C, resuspended in 
lOmls of medium in a universal container and centrifuged at 800rpm for 5 
minutes. Prior to centrifuging, a sample was taken to determine cell number with 
a haemocytometer. The cell pellet was resuspended in SC growth medium and 
plated on a PDL-coated flask (5 x 105cells/25cm2 flask, 1.5 x 106cells/75cm2 
flask) and returned to a 37°C incubator. Each flask was labelled with cell type, 
date of harvesting, date of immunodepletion and passage (trypsinisation) number, 
with ‘T l’ denoting cells which have undergone 1 passage, ‘T2’ for those which 
have undergone 2 passages and so on.
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Figure 2.1 Schwann cell 'culture displaying characteristic ‘whorled’ pattern at 
confluence. Note the bipolar spindle shape of the cells.
2.2 Bone marrow stromal cell culture
2.2.1 Bone marrow stromal cell harvesting
Bone marrow stromal cells (MSCs) were harvested from 3 adult male inbred
Sprague-Dawley rats. Following termination of the animal the lateral aspect of
each hind limb was shaved and washed with alcoholic chlorhexidine. The skin of 
the lateral thigh was split and the muscle dissected to expose the femur and tibia 
of each hind limb. The capsule of the hip joint was opened and the head of the 
femur was dislocated from the acetabulum. Muscle was stripped from the femur 
throughout its length, the ligaments of the knee joint were divided and the femur 
was removed. Similarly with the tibia, muscles were stripped away from the bone
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and the distal end of the tibia was dislocated from the talus after division of the 
ankle ligaments. The bones were placed in chilled DMEM/HEPES containing 
penicillin/streptomycin and transported to the tissue culture laboratory. In the 
tissue culture cabinet the distal ends of the long bones were removed with 
sterilised bone nibblers to reveal the marrow cavities. The marrow was flushed 
from each bone by aspirating 5mls of MSC growth medium (aMEM; 10% FCS; 
1% penicillin/streptomycin; Appendix A) through each marrow cavity using a 
5mls syringe and a 21G needle. The aspirated medium was triturated 3 times 
through a 21G needle followed by filtration through a 70/un filter to remove any 
bone fragments and other debris. The cell suspension was centrifuged in a chilled 
centrifuge at 800 rpm for 5 minutes. The supernatant was aspirated and the cell 
pellet was resuspended in 20mls of MSC growth medium with lOmls of the 
suspension being plated into a 75cm tissue culture flask. The flasks were 
transferred to a 37°C, 5% CO2 incubator. After 24hrs the flasks were examined 
under an inverted microscope. The cells present at this stage are a mixture of 
adherent marrow stromal cells and non-adherent haematopoietic cells, dead cells 
and debris. The non-adherent cells were removed by washing the flask with 
DMEM/HEPES 3 times, following which lOmls of MSC growth medium was 
added. Washing was repeated every 24hrs until all non-adherent cells were 
removed. The cells were left to reach confluence (Figure 2.2), at this stage they 
were trypsinised, counted and re-plated at a concentration of 3.75 x 105 
cells/75cm flask. Cells were also stored at each passage stage to build cell stocks 
(cf. 2.4).
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Figure 2.2 Confluent marrow stromal cells displaying typical heterogeneous 
morphology.
2.2.2 Stimulation of glial differentiation of bone marrow stromal cells
MSCs were stimulated towards glial differentiation through the following 
protocol (Dezawa et al. 2001). Sub-confluent T5 MSCs were cultured in MSC 
growth medium containing \/jM  beta-mercaptoethanol for 24hrs. After 24hrs the 
cells were washed and the medium replaced with MSC growth medium 
supplemented with all-/nms-retinoic acid (35ng/ml) for 3 days. The cells were 
washed and replaced with MSC growth medium supplemented with platelet- 
derived growth factor (PDGF; 200ng/ml), basic fibroblast growth factor (bFGF; 
lOng/ml), 5pM forskolin, and glial growth factor (GGF; 126ng/ml) (cf. Appendix
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A), and incubated for 14 days with replacement of fresh medium containing the
above growth factors every 72hrs.
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Figure 2.3 Summary of steps required to harvest and culture MSCs.
2.2.3 Clonogenic assay of bone marrow stromal cells
To determine the clonogenic ability of cultured MSCs the plating efficiency 
(colony forming ability) was determined where:
No. of co lon ies formed 
Plating efficiency = X 100
No. of cells plated
Confluent MSCs were trypsinised with 0.25% trypsin/EDTA, suspended in lOmls 
of MSC growth medium and counted. MSCs were plated at various 
concentrations (Table 2.1) in 6-well plates and incubated for one week following 
which the plates were stained with 1% Azure blue (cf. Appendix C) and the
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number of distinct colonies (> 50 cells) counted with the aid of an inverted 
microscope (Figure 2.4).
Cells/cm2 Cells/well (10cm2/well)
100 1000
80 800
60 600
40 400
20 200
4 40
Table 2.1 Plating densities of MSCs in each well of 6-well plates to quantify 
clonogenic ability (plating efficiency).
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Figure 2.4 MSCs plated on 6-well plates and stained with Azure blue to 
quantify colony forming ability (arrow and inset).
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2.2.4 Clonal selection of bone marrow stromal cells
Confluent MSCs were trypsinised with 0.25% trypsin/EDTA, suspended in lOmls 
of MSC growth medium and counted. The cell concentration of the suspension 
was reduced to 500 cells/ml by serial dilution. The cells were seeded in 96-well 
plates (50 cells/1 OOpl/well) to isolate cells with clonogenic capacity. The medium 
was left on the cells for one week so as to not wash away any locally produced 
growth factors which may be involved in autocrine and paracrine growth circuits. 
The cells were not removed from the incubator for examination during this period 
as a fluctuation in temperature can arrest the cell cycle (Freshney, 2000). Wells 
were examined at the end of the first week and those containing single colonies 
(Figure 2.5) were marked, wells containing more than 1 colony were excluded. 
Upon the appearance of a colony in a well, the well was washed with Hank’s 
medium, 50/d of 0.25% trypsin/EDTA was added and incubated at 37°C for 5 
minutes. Following incubation, 100/d of MSC growth medium was added to the 
well to neutralise the trypsin following which the cell suspension was transferred 
to a single well of a 24-well plate with 900/d of MSC growth medium and placed 
in an incubator. When confluent, each well was trypsinised and transferred to a 
25cm2 flask and again left to grow until confluent.
Figure 2.5 Phase contrast 
photomicrograph of a colony 
of marrow stromal cells seeded 
in a 96 well plate.
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2.3 Cell transduction with Green Fluorescent Protein
Retroviral transduction is the most efficient means of introducing foreign genetic 
material into a cell. To transduce cells with green fluorescent protein (GFP) a 
Moloney Murine Leukaemia retrovirus (MMLV) containing the GFP sequence 
was used. A mouse embryonic fibroblast cell line (PT67) was used to package the 
virus and produce a high viral titre. The retrovirus genome consists of a single 
strand of RNA which is transcribed into double-stranded DNA by the enzyme 
reverse transcriptase. The double-stranded DNA, known as the provirus, 
integrates irreversibly into the cellular DNA and is hence replicated within the 
host’s genome. PT67 cell lines contain exons for the protein core of the virus 
(gag), reverse transcriptase (pol), envelope proteins (env) and the packaging 
sequence (\j/), however the retrovirus produced is deficient in the packaging 
sequence so that when it infects a target cell it is incapable of replicating 
(replicative incompetent), thus preventing transduced cells from infecting other 
cells.
2.3.1 Production of MMLV-GFP-PT67 cell line
The MMLV-GFP-PT67 cell line was produced by D. Mann (Queen Victoria 
Hospital, East Grinstead, UK) using the following protocol: The ViraPort™
retroviral reporter vector pFB-hrGFP (Stratagene), containing the humanised form 
of green fluorescent protein from the sea pansy Renilla reniformis, was used to 
transfect a RetroPack PT67 packaging cell line (Clontech) for higher titre viral 
production. Co-transfection of 15pg of pFB-hrGFP and 1.5pg pSV2neo was 
carried out according to the manufacturer’s instructions using Lipofectamine
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Plus™ reagent (Gibco). Transfected producer cells were selected for the 
neomycin pSV2neo resistance marker using 800pg/ml Geneticin (G418 Sulphate; 
Gibco) 3 days after selection. Cells were continually cultured under selective 
pressure in DMEM with glutamax, sodium pyruvate and 4.5 g/ml glucose (Gibco) 
and 10% FCS. Fluorescent colonies were isolated, expanded and screened for the 
production of virus containing the hrGFP protein (Figure 2.6). PT67pFB-hrGFP 
Clone A2 was reselected using HAT supplements (Gibco) according to the 
Clontech protocol to ensure the retention of the viral genes.
Figure 2.6 (A) PT67 cells under phase contrast microscopy and (B) green 
fluorescence under blue light.
2.3.2 Cell transduction
PT67 cells were grown in 75cm2 flasks with medium consisting of DMEM high 
glucose, 10% fetal calf serum and penicillin and streptomycin. At 70% 
confluence the medium was changed to target cell growth medium and the cells 
were transferred to 32°C and incubated for 72hrs. The medium (containing a high
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concentration of retrovirus) was collected and filtered through a 0.45/mi filter to 
remove any suspended PT67 cells. The filtrate was added to a 70% confluent 
culture of target cells (SCs or MSCs), and the cells placed in an incubator at 32°C 
for 24hrs. The target cells were then placed in their normal growth medium and 
incubated at 37°C for 24hrs. This cycle was repeated with the same target cells a 
further 2 times, making a total of 3 transduction cycles. Target cells were 
assessed for successful transduction by examining for green fluorescence under 
blue light with a fluorescence microscope (Olympus BX60) (Figure 2.7). 
Following confirmation of transduction, normal medium was added to the 
transduced cells and incubated for 24hrs at 32°C, the medium was removed, 
filtered and added to a second batch of non-transduced cells for 24hrs to ensure no 
transduction had taken place due to viral contamination of the conditioned 
medium.
Murine leukaemia retrovirus *GFP
•o®
a**, A  Incubation
©
Green fluorescence 
under blue light
PT67 cell line
Figure 2.7 Retroviral transduction of target cells (red) using a PT67 cell line 
which packages a Moloney Murine Leukaemia retrovirus containing the gene for 
green fluorescent protein. Transduced cells are examined for green fluorescence 
under blue light.
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2.3.3 Measurement of transduction efficiency
To measure transduction efficiency (percentage of cells transduced per total 
number of cells), transduced cells were trypsinised and plated on a chamber slide 
(Labtek) and incubated at 37°C in appropriate medium for 24hrs. The medium 
was then replaced with fresh medium containing 10/d/ml of Hoescht which labels 
cell nuclei and incubated at 37°C for 15 minutes. The chamber slide was then 
washed with PBS, covered with fluorescence mounting medium (Vectashield®) 
and a coverslip, and then examined under a fluorescence microscope (X20 high 
power field). A digital image was captured of cell nuclei under a rhodamine filter, 
the filter was then changed to blue light to capture a corresponding image of GFP- 
transduced cells in the same field (Figure 2.8). The images were transferred to 
image analysis software (Image-ProPlus®, Media Cybernetics, USA) in which the 
total number of cells were counted by counting blue Hoescht-labelled cell nuclei. 
The number of GFP+ve cells was counted and the corresponding transduction 
efficiency calculated. This was repeated in 10 randomly picked high power fields.
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Figure 2.8 MSCs labelled with GFP (green) and the Hoescht nuclear marker 
(blue) to calculate transduction efficiency.
2.4 Cryopreservation of cells
Cells were frozen at regular intervals to build-up a stock for further use and 
analysis. When confluent, cultured cells were trypsinised (cf. 2.1.3), diluted in 
lOmls of cell growth medium and sampled for counting. The cells were divided 
into aliquots containing ~2 x 106 cells/aliquot which were then centrifuged at 
800rpm for 5 minutes. This is the minimum number of cells/ml that should be 
frozen, lower concentrations yield fewer surviving cells on thawing. The 
resulting cell pellets were then each suspended in 1ml of chilled cell freezing 
medium (cf. Appendix A) and placed in cryovials for freezing. The active 
constituent of cell freezing medium is dimethylsulphoxide (DMSO) which 
prevents intracellular ice crystal formation on freezing. DMSO above 5°C is toxic
to cells and therefore should always be chilled when added to cells prior to 
freezing. The cryovials were transferred to an isopentane flask which was placed 
in a -70°C freezer overnight to allow slow freezing of the cells. Rapid freezing 
causes cell damage, the isopentane flask ensures slow freezing of cells at a rate of 
~-l°C/min. The following day the cryovials were transferred to the gas phase 
compartment of a liquid nitrogen freezer for long-term storage.
2.5 Thawing of frozen cells
To thaw frozen cells, a cryovial was removed from the liquid nitrogen freezer and 
transferred to the tissue culture cabinet. The frozen cells were allowed to thaw at 
room temperature following which they were immediately transferred to a 20mls 
universal container. The cells were then slowly diluted with 1 Omls of chilled cell 
growth medium at a rate of lml/min to prevent osmotic damage to the cells. The 
suspension was centrifuged and washed to remove all traces of DMSO, re­
suspended in suitable cell growth medium, plated in a tissue culture flask and 
transferred to the incubator.
2.6 Alamar Blue™ assay
Alamar Blue™ (Serotec) was used to measure the metabolic activity of non­
transduced and GFP-transduced SCs in vitro. Alamar Blue™ is a colorimetric 
growth indicator solution that changes colour in the presence of REDOX reactions 
(blue to red) which occur during cell metabolism with colour change being 
quantified by measuring the difference in spectral absorbance (5-absorbance) 
between 570 and 600nm wavelengths of light. Cells from each line at the same 
passage stage were seeded in 6 wells of a 12-well plate (PDL-coated) at a
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concentration of lx l0 5 cells per well. A further 4 wells contained media but no 
cells to act as a baseline control. One ml of SC growth medium containing 10% 
alamar Blue™ was added to each cell line well on day 1 and the cells incubated at 
37°C, 5%C02, 99% humidity. At 4, 8, 12, 24 and 48 hours, 50/d of medium was 
taken from each well (including the control wells), placed in a 96-well plate and 
assayed with a spectrometer (Multiskan) to measure 8-absorbance, this being 
directly proportional to metabolic activity.
2.7 Cell growth curves
To construct a Schwann cell growth curve, cells were plated in a PDL-coated 24 
well plate. Cells were plated in each well at a concentration lx 105 cells/ml/well. 
At 24 hrs (day 1) 3 wells were trypsinised and each well individually counted with 
a haemocytometer. This was repeated each day for a further 8 days. Data was 
plotted and best-fit growth curve constructed (GraphPad Prism, GraphPad 
Software, San Diego, California).
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2.8 Preparation of PHB conduits
PHB conduits were made from sheets of sterile PHB (Astra-tech, Sweden) under 
aseptic conditions in a tissue culture cabinet. PHB sheets are manufactured by 
compressing two layers of PHB fibres together. The fibres of each layer are 
unidirectional (Figure 2.9A) and the layers are orientated so that when they are 
pressed together they run in perpendicular directions. It was therefore necessary 
to separate the layers before further use. To separate the layers, one corner of a 
sheet was gently separated using a pair of jewellers forceps (Mercian, UK) to 
develop a plane between the layers which were then slowly pulled apart (Figure 
2.9B). One sheet is patterned from the pressing process and the other is smooth, 
the patterned sheet was discarded. To make a 1.4cm conduit for the rat sciatic 
nerve gap model a PHB sheet was cut into a rectangle measuring 1.4 x 0.8cm 
using a sterile scalpel blade. It is important that the direction of the fibres is 
parallel to the long axis of the conduit. The PHB was then soaked in sterile water 
to prevent excessive melting during heat-sealing. The sheets were then wrapped 
around a 16G intravenous cannula and welded along the points where the sheets 
overlap using a fine-tipped soldering iron (Figures 2.9C, D). It is important that 
the smooth side of the sheet forms the inner wall of the conduit. The resulting 
conduit is 1.4cm in length with an internal diameter of 1.6mm which allows 
adequate space for post-injury swelling of the rat sciatic nerve. Each conduit was 
then placed in an individual well of a sterile 24-well plate for storage.
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Figure 2.9 (A) E.M. photomicrograph of PHB fibres and (B) splitting of 
PHB sheet into 2 layers. (C) Rolling of PHB sheet and (D) welding of conduit
2.9 Silicone conduits
Pre-formed silicone tubing was used for silicone conduits (internal diameter 1mm; 
Philip Harris Scientific Supplies). The conduits were sterilised with gamma- 
irradiation (3MRad. for 50hrs) and cut to a desired length.
2.10 Loading of conduits with matrices for cell and growth factor 
suspension
2.10.1 Loading PHB and silicone conduits with alginate hydrogel
PHB and silicone conduits were pre-soaked in normal saline to enhance 
penetration of CaCL. Using a Hamilton syringe, 30/d of 1.8% alginate (Pronova, 
Oslo) was injected into a conduit taking care not to introduce air bubbles into the
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alginate. The conduit was then placed in 0.1M CaCl2 for 2 minutes to gel the 
alginate prior to grafting.
2.10.2 Loading of PHB and silicone conduits with collagen gel
Neutralised collagen solution (Vitrogen) was prepared (cf. Appendix A) and 2mls 
was placed in a 5ml bijou bottle. Empty conduits were placed vertically in the 
collagen and submerged until one end of the conduit rests on the surface of the 
collagen with the remainder of the conduit completely submerged (Figure 2.10 
and 2.11). The bijou bottle was then sealed and placed in a 37°C incubator in the 
absence of CO2 . After 2 hrs, when the collagen surrounding the conduits was 
completely gelled, 30/d of collagen (with or without a suspension of cells) was 
injected into the conduit using a Hamilton syringe. The gelled collagen 
surrounding the conduits prevents leakage of the collagen solution from inside the 
conduit. The bijou bottle containing the conduit was then placed back into a 37°C 
incubator (no CO2 ) and incubated for lhr to gel the collagen within the conduits, 
the conduits were then removed from the bijou and transferred to the operating 
theatre for grafting.
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Collagen gel
PHB/silicone
conduits
Figure 2.10 Conduits are placed in a collagen solution which is then 
gelled in a 37°C incubator in the absence of CO2 . When the collagen 
surrounding the conduits has set the conduits can be filled with collagen 
solution (± cell suspension) and gelled at 37°C.
Figure 2.11
Conduits following collagen gelling.
2.10.3 Loading PHB conduits with dissociated PHB fibres
Mats of unidirectional dissociated (un-pressed) fibres of PHB were obtained from 
Astra-tech (Sweden). Under aseptic conditions in a tissue culture cabinet, strips 
of a mat were cut (2 x 20mm, varying thickness to provide a range of fibre 
densities) with the longitudinal axis parallel to the direction of the fibres (Figure 
2.12). Conduits containing different fibre densities were assessed to define the
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optimum number of fibres per conduit (cf. Chapter 7). A 9/0 ethilon suture 
(Ethicon) was secured to one end of the strip of fibres and the opposite end of the 
suture was secured to a sterilised darning needle. A 2cm length of a plastic 16G 
cannula was passed into the lumen of a PHB conduit. The needle was used to 
pass the suture connected to the fibres through the cannula, the strip of fibres were 
then gently drawn into the cannula. Holding the fibres with a pair of fine forceps 
at one end, the opposite end of the cannula was held with a pair of forceps and 
gently pulled out of the conduit leaving the fibres inside (Figure 2.13A,B,C and 
D). The fibres extending from the conduit at each end were trimmed and the 
conduit stored in a well of a sterile 24-well plate in preparation for grafting.
Figure 2.12 Strips of dissociated 
PHB fibres were cut into 2cm 
lengths.
87
Figure 2.13 Steps involved in loading a PHB conduit with dissociated PHB 
fibres. (A) A 2cm length of 16G plastic cannula is inserted into the conduit and 
used to guide the entry of PHB fibres (*). (B) A needle connected to the fibres 
with a 9/0 suture is used to pull the fibres through the plastic cannula. (C) The 
plastic cannula is removed to leave the PHB fibres within the conduit. (D) A 
transverse section of the conduit demonstrating intraluminal fibres in comparison 
with an empty conduit.
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2.11 Operative procedures
2.11.1 Anaesthesia
All procedures were carried out in compliance with the regulations specified in 
the Animals (Scientific Procedures) Act 1986 (UK Home Office). Inbred adult 
male Sprague-Dawley rats (Harlan, UK; 6-8 weeks old; weights 200-250gms) 
were used in all experiments. For recovery procedures animals were 
anaesthetised with halothane gas: The animal was placed in an induction chamber 
connected to an anaesthetic circuit. Oxygen was delivered at 2L/min following 
which 4% halothane was added for 1-2 minutes. The anaesthetised animal was 
then removed from the induction chamber and its left thigh was shaved and 
washed with alcoholic chlorhexidine. The animal was then placed on sterile 
drapes covering a heated mat on an operating table. Anaesthesia was maintained 
by reconnecting the animal to the anaesthetic circuit via a face mask with oxygen 
flow rate set to 500ml/minute and halothane concentration set to 1.5%. Depth of 
anaesthesia was regularly assessed by monitoring the animal’s respiratory rate, 
heart rate and response to pain (tail pinch) with the halothane concentration being 
adjusted accordingly. Following the operative procedure to expose, axotomise 
and graft the sciatic nerve (cf. 2.11.3), muscle edges were re-opposed with a 4/0 
vicryl suture (Ethicon) and the skin was closed with a subcuticular suture.
On completion of the operation lOmcg of intramuscular temgesic was 
administered, the tail was marked with an indelible pen and the animal was placed 
on its right side on soft bedding in an individual cage. The animal was placed in a 
32°C incubator and regularly monitored until it was fully conscious, following 
which it was transferred to a recovery room for 24hrs prior to re-colonisation.
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Animals were monitored daily for general health and morbidity associated with 
sciatic nerve surgery such as wound dehiscence, infection and autophagy.
2.11.2 Termination
Animals were terminated in accordance with Schedule 1 of the Animals 
(Scientific Procedures) Act 1986. Animals were killed by CO2 narcosis by 
placing the animal in a CO2 chamber. The concentration of CO2 was 
automatically increased until the animal had stopped making any respiratory effort 
for more than 1 minute. Termination was then confirmed by cervical dislocation. 
In non-recovery procedures requiring physiological measurements (terminal 
anaesthesia) animals were anaesthetised with an intra-peritoneal injection of a 
lethal dose of sodium pentobarbitone (0.5ml/kg). After measurements had been 
taken the animal was terminated by cervical dislocation.
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2.11.3 Gap repair (1cm) of the sciatic nerve
To expose the sciatic nerve a 4cm skin incision was made over the left gluteal 
region 3mm posterior to the long axis of the femur, starting at a point posterior to 
the level of the greater trochanter. A muscle splitting incision in the long axis of 
the fibres was then created in biceps femoris to expose the sciatic nerve. Muscle 
and skin edges were retracted to allow adequate operative exposure (Figure 2.19). 
Under an operating microscope (Zeiss, X I0 magnification) the nerve was gently 
mobilised and divided 5mm from the sciatic notch. Following division, the sciatic 
nerve retracts to leave a gap between the proximal and distal stumps, to increase 
this gap to 1cm, nerve tissue (~5mm) was resected from the distal stump. A 
conduit of either PHB or silicone was placed in the operative field. For a 1cm gap 
a 1.4cm conduit is used, with each nerve end being placed 2mm into each end of 
the conduit, therefore leaving a 1cm gap between the nerve ends within the 
conduit. At each end the nerve is sutured to the conduit with a 9/0 epineural 
suture (Figure 2.20).
91
Figure 2.19 Exposure of the rat sciatic nerve*
Figure 2.20 Insertion of PHB conduit and placement 
of 9/0 sutures (arrows).
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2.12 Tissue collection
2.12.1 Tissue collection for immunostaining (nerve)
Following termination, the grafted conduit together with proximal and distal 
sections of nerve, were exposed using an operating microscope (Zeiss, X I0 
magnification). The sutures at either end of the conduit were removed to prevent 
tearing of tissue during cryosectioning. For immunohistochemistry the conduit 
and nerve at either end were removed en bloc, pinned out on plastic to prevent 
shrinkage and distortion and placed in Zamboni’s fixative (cf Appendix C) 
overnight at 4°C. Over the following days (~3) the specimen was washed in PBS- 
sucrose (Figure 2.21) until the solution became clear and the tissue had sunk to 
the bottom of the container. The specimen was then blocked in OCT with a piece 
of fixed rat liver at the proximal end to aid orientation during microscopical 
examination, and slowly frozen by gently immersing in liquid nitrogen. The 
frozen block was then stored at -40°C.
For cryosectioning, a frozen specimen block was transferred to a cryostat 
(Albright) and left for 30 minutes to let the temperature equilibrate between the 
block and the cryostat. The block was slowly trimmed in the desired orientation 
until the lumen of the conduit was reached in-continuity with proximal and distal 
nerve stumps. Cryosections were taken at 15/^m thick and placed on Vectabond 
coated glass slides (Appendix C). The sections were allowed to dry in a 37°C 
oven overnight. Sections were either immuno-stained the next day or wrapped in 
aluminium foil and placed in a —40°C freezer for staining within a maximum of 7 
days.
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Figure 2.21 Ex-planted PHB conduit following fixation and washing.
2.12.2 Tissue collection for semi-thin sections
Semithin sections were used to assess nerve regeneration in long-term (> 6 weeks) 
studies. Tissue specimens from nerve distal to the nerve conduit (Figure 2.22) 
were placed in E.M. grade 2.5% glutaraldehyde following harvesting. The 
specimens were processed by the Electron Microscopy Unit, Royal Free Campus, 
where they underwent osmium tetroxide fixation, ethanol dehydration and resin 
embedding followed by staining with methylene blue-azure II and basic fuchsin 
(Humphrey’s stain) in preparation for sectioning (l-2//m) on an ultramicrotome.
2.12.3 Tissue collection for immunostaining (skin)
Lateral paw skin was collected from the ipsilateral side to the sciatic nerve 
axotomy and pinned on plastic to prevent retraction. The skin specimen was 
placed in Zamboni’s fixative and left for 24hrs at 4°C. The specimen was then 
washed in PBS-sucrose daily until the solution was clear of discoloration. The 
specimen was then blocked in OCT (cf. 2.12.1).
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Distal s tu m p
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Figure 2.22 Semithin sectioning of distal nerve to assess axonal counts 
following regeneration through the nerve conduit.
2.13 Histological analysis
The majority of tissue collected in the experiments performed was examined 
using immunofluorescent histochemical techniques. As transplanted cells 
examined in the study were labelled with green fluorescent protein (GFP) these 
cells could be identified by direct fluorescence under blue light. Antigen 
expression was identified using antibody-mediated immunofluorescence. To 
prevent bleaching of fluorescence labelled antibodies and GFP in natural light, 
slides were kept in the dark at all times. Haematoxylin and eosin staining was 
carried out on random sections from each animal group to ensure correct 
orientation of sections prior to immunostaining and to assess general histology 
and morphology.
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2.13.1 Immunostaining of ex-vivo nerve tissue for S100 I PGP I 
N-cadherin / NCAM / GFAPI Thy 1.1
Following cryostat sectioning (cf. 2.12.1), sections were prepared for indirect 
immunohistochemical analysis. If sections had been frozen they were thawed at 
room temperature for 3 hours. The slides were outlined with a hydrophobic pen 
(Dako) to prevent antibody solutions spreading and dripping off the slides. The 
sections were first permeabilised in 10% Triton-X-PBS for lhr followed by 
washes in PBS (3 x 5mins). The sections were then incubated in a humid 
chamber with normal goat serum (dil. 1:100; lhr at RT) to decrease non-specific 
attachment of second layer antibodies. The blocking solution was tipped off the 
slides and primary antibodies to either SI00 (for the detection of Schwann cells); 
PGP9.5 (for the detection of nerve fibres), GFAP, Thy 1.1, N-cadherin or NCAM 
were applied (see Appendix A for details) to the sections and incubated at 4°C in a 
humid chamber overnight. Following 3 PBS rinses, Cy3- or FiTC-labelled 
secondary antibody (see Appendix A) was applied and incubated for 2hrs at room 
temperature in the dark. Following 3 further PBS washes, the sections were 
mounted with fluorescence mounting medium (Vectashield) and glass coverslips, 
and examined under fluorescence light using a green filter to identify Cy3 
labelling (red fluorescence) and a blue filter to identify transplanted GFP-labelled 
cells or FiTC secondary antibody (green fluorescence). Slides were stored at 4°C 
and images captured within 24hrs to attain maximum fluorescence.
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2.13.2 Immunostaining of skin
Skin specimens were stained for PGP9.5, a constitutive cytoplasmic component of 
all nerve fibres. Following permeabilisation of the sections in Triton-X-PBS for 1 
hour (cf. 2.12.1), the skin sections were counterstained in Pontamine Sky Blue for 
30 minutes. Following washes in PBS (2 x 5mins) the sections were 
immunostained using a PGP9.5 antibody (rabbit polyclonal; see Appendix A). An 
FiTC-labelled goat anti-rabbit secondary antibody was then applied (cf 2.12.1). 
Slides were examined and images captured within 24 hours to avoid fading of 
fluorescence.
2.13.3 Immunostaining of cell cultures
To immunostain cultures, cells were plated on chamber slides (Labtek) pre-coated 
with poly-D-lysine. The chamber slides were placed in an humidified incubator at 
37°C, 5% CO2 in appropriate medium for 2 days to allow the cells to settle and 
adhere. Following examination under an inverted microscope to confirm 
adequate plating the cells were washed with PBS twice and the nuclei stained with 
Hoechst dye (dil. lOyUg/ml in PBS) for 15 minutes at 37°C. The cells were then 
fixed with 4% paraformaldehyde for 20 minutes at room temperature followed by 
PBS washes (2 x 3mins). Primary antisera was then applied (either SI00, GFAP 
or Thy 1.1) to the cells and incubated for 30 minutes at room temperature. The 
cells were then washed twice with PBS, the appropriate fluorochrome-conjugated 
secondary antibody applied and incubated at room temperature in the dark for 
2hrs. The cells were then washed twice with PBS, the plastic walls of the 
chamber slide and the rubber gasket were removed and a cover slip mounted with
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fluorescent mounting medium (Vectashield). The slides were examined and 
images captured with a fluorescence microscope and stored for further use at 4°C.
2.13.4 Histochemical staining of marrow stromal cell cultures
To examine cultured marrow stromal cell (MSC) morphology, MSCs were plated 
in chamber slides and incubated for 2 days. Prior to staining the plastic walls and 
rubber gasket of the slides were removed as the protocol required exposure to 
alcoholic solutions. The slides were placed in a Coplin jar and the cultures 
washed twice with PBS, they were then dehydrated in 99% methanol for 6 
minutes. The cultures were then stained with a Giemsa solution (cf. Appendix C) 
for between 15-60 minutes at room temperature, being washed and examined 
under a microscope at 15 minute intervals to prevent over-staining. The slides 
were finally washed with de-ionised water, allowed to air dry, and then mounted 
with coverslips using Canada Balsalm (Sigma) as DPX melts chamber slide 
plastic.
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2.14 Image capture and Quantification
2.14.1 Measurement of axonal and Schwann cell regeneration 
distance
To measure axonal and Schwann cell regeneration distances in the grafted 
conduits, immunostained sections were examined. Under a X I0 objective lens 
with a graticuled eye-piece, the distance of the most distal regenerating fibre in 
the regeneration front from the proximal stump (a point 2mm from the proximal 
end of the conduit) was measured (Figure 2.3).
Q A
Distal Proximal
stump stump
Figure 2.23 Measurement of axonal and Schwann cell regeneration distances. 
(A) Represents the starting point of the proximal stump (2mm from the proximal 
end of the conduit), (B) the point of the most distal regenerating fibre, and (C) the 
regeneration distance.
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2.14.2 Quantification of NCAM and N-cadherin expression
NCAM and N-cadherin expression was quantified as intensity of staining per unit 
area (Thornton et al. 2005). All images were taken in monochrome to minimise 
loss of signal. Images were taken within 48 hours of staining to minimise decay, 
importantly the exposure of each section to fluorescent light was kept to an 
absolute minimum to prevent photo-bleaching. At a set distance (measured with a 
graticuled lens) from the tip of the regenerating front, images were captured at the 
regeneration front, proximal stump and distal stump at X40 magnification (see 
figure 2.24). The image capture region corresponding to the regeneration front 
was a point 2mm from the most distal regenerating fibre (as determined by co- 
staining with SI00) and that corresponding with the proximal stump was 2mm 
from the most distal regenerating fibre. The distal stump capture area was a point 
2mm from the distal stump axotomy. Images were analysed as shown in Figure 
2.25. After the application of threshold values to define areas of staining, the 
intensity of staining per unit area within each highlighted area was calculated and 
expressed in arbitrary units (intensity/unit area).
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Figure 2.24 Image capturing to quantify N-cadherin and NCAM expression 
within a PHB conduit. The tip of the regenerating front is represented at (A). 
Images of CAM expression were captured at the regeneration front (B), the 
proximal stump (C), and the distal stump (D). A sequential set of monochrome 
images were taken across the width of the section at each point.
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Figure 2.25 Screen capture during quantification of NCAM expression at the 
proximal stump. Threshold values (right panel) are set to highlight areas of 
NCAM expression. Areas of artefact or background staining are manually 
removed. The staining within the highlighted areas is then automatically analysed 
by the software to measure the intensity of expression per unit area (arbitrary 
units).
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2.14.3 Quantification of semithin sections
Semithin sections were examined under bright field light microscopy using an 
Olympus BX60 microscope. Under low magnification (X4), an image of the 
complete transverse section of the nerve was captured (Figure 2.26) using a 
monochrome digital camera (Evolution QE, DataCell). From each section, 3 
random high power images (X40) were captured. Within image analysis software 
(Image-ProPlus®, Media Cybernetics, USA) the low magnification image was 
first calibrated according to the number of pixels per unit length (wm).and the total 
cross-sectional area calculated (Figure 2.27). Calibrated high power images were 
used to measure axon number, axon diameter, myelin thickness and fibre diameter 
(figures 2.28-2.30). Measurement data was transferred to a spreadsheet for 
statistical analysis. An estimate of the total number of axons per nerve was 
derived from calculating the number of axons per unit area and the total cross- 
sectional area of the nerve.
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Figure 2.26 Monochrome photomicrograph of a transverse semithin section of 
rat peripheral nerve stained with thionine and acridine orange (X4).
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Figure 2.27 The total cross-sectional area of the nerve was calculated by 
manually outlining the nerve (red shading). Following calibration a value in 
is obtained.
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Figure 2.28 Image-Pro® Plus software assigns a number to each pixel in an 
image between 0 and 256, with 0 representing white, 256 representing black and 
the numbers between representing 255 shades of grey between white and black. 
The software can then be manually set (right panel) to highlight structures within 
an image which have a specific range of grey values, as in the above case where 
the myelin sheaths surrounding axons are highlighted.
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Figure 2.29 Manual editing of the selected structures was performed to 
eliminate highlighted background or to split two adjacent structures.
Figure 2.30 Measurements of fibre diameter (A), axon diameter (B), and 
myelin thickness (C) were automatically made by the software programme.
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2.14.4 Quantification of skin immunostaining
Following staining of skin (cf. 2.13.2), fluorescence images were captured with a 
X20 objective lens, aligning the uppermost epidermis with the top border of the 
captured image field (Figure 2.31 A). Six non-consecutive images were captured 
from each section, keeping the settings within a similar range. The images were 
converted to greyscale and the frame area of immunostaining manually outlined. 
An intensity threshold was set to highlight PGP9.5-immunostained fibres, while 
artefacts and background interference were manually removed and the area of 
staining automatically calculated (Figure 2.3 IB, C). The area of immunostaining 
was expressed as the fractional area of immunostaining.
Figure 2.31 Quantification of PGP9.5 skin immunostaining. (A) Captured 
image, (B) selection of frame area, (C) conversion to greyscale, and (D) 
thresholding of stained fibres following removal of artefact.
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2.15 Myophysiological measurements
Measurements of tibialis anterior (TA) muscle activity following sciatic nerve 
stimulation were made under terminal anaesthesia (cf. 2.11.2). The procedure was 
carried out in a dedicated electrophysiology laboratory (Figure 2.32) in 
collaboration with Dr Shi Yu Yang and Professor G. Goldspink, Department of 
Anatomy, Royal Free and University College Medical School. Animals were 
placed on a platform maintained at 37°C with a temperature-controlled 
homeothermic blanket. The tibialis anterior (TA) muscle and tendon was 
dissected from its distal insertion, taking care to avoid damage to the 
neurovascular pedicle. The distal tendons of the TA were fixed to an isometric 
transducer that was linked to a PC. The muscles were activated indirectly by 
delivering supramaximal electrical stimuli (square pulses, 0.2-msec pulse 
duration, 8 V and 50 Hz) to the sciatic nerve proximal to the nerve graft. Stimuli 
were generated by a dual impedance research stimulator (Harvard) and delivered 
with a shielded bipolar silver electrode (Figure 2.33). Optimal muscle length (L0) 
was determined by measuring the length of the TA muscle at which the strongest 
twitch contractions were generated following supramaximal stimuli. Maximum 
muscle tetanic force was measured and recorded using a Spike2 program (Figure 
2.34; Cambridge Electronic Design Limited). Muscle fatigue resistance was 
determined by measuring the time to the half isometric tension of the muscles. 
Throughout the physiological evaluation, the TA muscle and sciatic nerve were 
regularly bathed in warm mineral oil. Muscle temperature was monitored and 
maintained between 35 and 37°C. For the purpose of comparison, all the 
physiological measurements from re-innervated muscle were presented as the
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percentage compared to the mean values recorded from the contralateral 
innervated muscle.
Figure 2.32 Laboratory for myophysiological measurements. (A) Jig to support 
animal containing nerve stimulator and force transducer, (B) operating 
microscope, (C) multichannel stimulator, (D) PC for recording data.
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Figure 2.33 Arrangement of nerve 
stimulator (A), tibialis anterior muscle 
(B), and force transducer (C).
Half-life
Max. tetanic 
force
Figure 2.34 Data from the force transducer is represented on a waveform over 
time. The maximum tetanic force can be measured, and the half-life (fatigability) 
can be calculated when tetanic force falls to half its maximum value.
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2.15.1 Wet muscle weights
Following termination, TA muscle was harvested from both sides and weighed 
immediately using an electronic balance.
2.16 Statistical analysis
Statistical analysis for each experiment was performed using a Sigmastat® 
software program (SPSS Science, USA).
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Chapter 3
Retroviral Transduction of Schwann cells 
with Green Fluorescent Protein
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3.1 Introduction
Following injury to a peripheral nerve, Schwann cells (SCs) play a vital role in 
promoting the regeneration of axons by providing both physical support and 
neurotrophic guidance (Hall, 1986; Sherer 1997). The addition of unlabelled 
cultured SCs has been shown to improve nerve regeneration through bio­
engineered nerve grafts (Guenard et al. 1992; Levi et al. 1994; Rodriguez et al. 
2000). A bio-engineered system containing cultured cells which is transferred 
from an in vitro to an in vivo setting requires initially a method of labelling the 
transplanted cells as a means to assess their survival and integration within the 
host upon ex vivo histological analysis. As fluorescent immunohistochemical 
techniques are commonly used to assess nerve regeneration through bio­
engineered conduits, it would therefore be advantageous to label transplanted SCs 
within these conduits with a fluorescent marker that can be visualised in 
combination with fluorochrome labelled antibodies.
Green fluorescent protein (GFP) (Shimomura et al. 1962) is a 
bioluminescent protein found in a number of marine organisms such as Aequorea 
victoria (crystal jellyfish) and Renilla reniformis (sea pansy) (Morin & Hastings, 
1971; Tsien, 1998). Depending on their species, these organisms emit green light 
having accepted energy from luciferases or photoproteins. Isolated GFP is excited 
by blue light (absorbance peak 395nm) to emit green light at an emission 
maximum of 508nm (Cubitt et al. 1999). Following cloning of its gene (Lorenz et 
al. 1991; Prasher et al. 1992) GFP has rapidly become a useful tool in many areas 
of cellular biology, it has been used to identify transformed cells, measure gene 
expression, label and locate fusion proteins, and to study intracellular protein
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traffic (Prasher, 1995). The use of GFP as a label for transplanted SCs has not 
been well documented. This study assessed the efficiency of labelling and cell 
vitality after labelling in vitro, and ease of identification of labelled cells in vivo in 
combination with immunofluorescent histochemical protocols.
3.2 Materials and Methods
3.2.1 In vitro study of SC vitality and viability following retroviral 
transduction
SC harvesting and retroviral transduction with GFP were carried out according to 
the protocols set out in sections 2.1 and 2.3 respectively. Prior to transduction 
SCs were split into 2 cell lines, one of which was transduced, while the other cell 
line acted as a control for vitality and viability measurements. Non-transduced 
SCs (ntSCs) and GFP transduced SCs (GFP-SCs) were cultured in identical 
conditions. Transduction efficiency was measured at 1 week and 6 weeks 
following transduction (cf. 2.3.3). As a measure of cell vitality cell growth curves 
for ntSCs and GFP-SCs were constructed 1 week following transduction (cf. 2.7). 
Cell viability was assayed using an alamar Blue™ indicator solution (cf. 2.6). In 
vitro fluorescent immunohistochemistry was performed to examine SC 
morphology (cf. 2.13.3).
3.2.2 In vivo study of GFP-SCs transplanted in PHB conduits
This study was performed to determine the ability to detect GFP-SCs following in 
vivo transplantion in association with fluorescent immunohistochemical 
techniques. GFP-SCs were transplanted into a 1cm rat sciatic nerve gap model
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spanned by a PHB conduit. Two experimental groups (a cellular group containing 
GFP-SCs and an acellular control group) were constructed (n=5) using adult male 
Sprague-Dawley rats (weights 200-250gm; Harlan). Conduits were constructed as 
described in section 2.10. In the cellular group conduits were filled with GFP- 
SCs suspended in 1.8% LVM alginate at a concentration of 80 X 106 cells/ml 
followed by gelling for 2 minutes in 0.1M CaCb (cf. 2.10). Anaesthetic and 
operative procedures were carried out according to the protocols described in 
section 2.11. Conduits were harvested after 2 weeks and processed for fluorescent 
immunohistochemsitry for axonal (PGP) and Schwann cell (SI00) regeneration 
following conjugation with a Cy3-labelled secondary antibody (cf. 2.13.1). 
Sections were examined under a fluorescence microscope (Olympus BX60) and 
images captured using a cooled digital camera (Evolution QE). Axonal and 
Schwann cell regeneration distances were measured to quantify regeneration (cf. 
2.14.1).
3.3 Results
3.3.1 In vitro studies
Cultured SCs displayed classical spindle-shaped morphology on immunostaining 
(Figure 3.1 A). SC cultures transduced with GFP (GFP-SCs) were found to 
exhibit bright green fluorescence in vitro (Figure 3.IB). The number of cells 
expressing GFP as a percentage of the total number of cells in culture 
(transduction efficiency) was 39.4% at week 1, this value being maintained at 
37.9% up to week 6 (Figure 3.2). This result indicates that the transduced cells 
were stably transfected and that they continued to divide generating further cells
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expressing GFP without significant dilution of transgene expression. The 
intensity of fluorescence did not qualitatively deteriorate between week 1 and 
week 6. It was found that the cells were susceptible to photobleaching more 
rapidly when exposed to blue fluorescent light than that seen with an FiTC 
fluorochrome, however fluorescence recovered completely if the cells were 
returned to dark culture conditions. When monitoring GFP-SC cultures, it was 
found that removing culture medium and replacing with warmed (37°C) sterile 
phosphate buffered saline (PBS) reduced the background auto-fluorescence seen 
under the microscope caused by components of the culture medium (Billinton & 
Knight, 2001). The PBS was replaced with cell culture medium prior to returning 
the cells to the incubator.
The alamar Blue™ assay (Figure 3.3) indirectly measures the metabolic 
activity of cultured cells. Measurements were collected over a period of 48hrs. 
There was a significant difference in activity between GFP-SC and ntSC cultures 
at t=8hrs (P<0.05; paired t-test) and t=12hrs (P<0.01; paired t-test), however at 24 
and 48hrs GFP-SC activity had increased to levels comparable to ntSCs. Linear 
regression analysis was applied to the values plotted, no significant difference was 
found between the slopes of the GFP-SC and ntSC curves indicating comparable 
metabolic rates. Growth curves were constructed comparing the growth of ntSCs 
and GFP-SCs over a 7 day period in vitro (Figure 3.4). The exponential (rapid 
division) phase of growth began at day 3 in ntSCs and at day 4 in GFP-SCs. The 
plateau (confluence) phase of growth was reached at day 6 in ntSCs and day 7 in 
GFP-SCs. At confluence, ntSCs and GFP-SCs reached a comparable cell number 
(9.05 vs. 8.4x105 cells/ml respectively). These measurements of vitality and
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growth have shown that GFP-SCs are initially slower to establish themselves in 
culture following passage but that following this initial period they achieve 
comparable profiles to that of non-transduced cells.
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Figure 3.1 (A) Cultured non-transduced Schwann cells stained with an S100- 
Cy3 conjugate (red) and Hoechst nuclear stain (blue). The classical spindle- 
shaped bipolar morphology of Schwann cells is clearly visible (X40). (B)
Cultured Schwann cells following retroviral transduction with GFP. Cells are 
approaching confluence and display normal morphology (X10), inset (x40).
117
50
■a
(/>
40
>*0 c
■5 30
1
I  20O
10
1 week 6 weeks
Figure 3.2 Histogram illustrating the mean transduction efficiency (% GFP 
labelled cells of the total number of cells per 10 high power fields) at 1 week 
(39.4%) and 6 weeks (37.9%) following transduction. This indicates no 
significant dilution of GFP transgene expression with time. Error bars indicate 
standard deviation.
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Figure 3.3 Metabolic activity over time as assessed by the alamar Blue™ assay 
comparing Schwann cells transduced with GFP (GFP-SC) and non-transduced 
Schwann cells (ntSC). Control -  assay of media without cells. GFP-SCs were 
found to lag behind ntSCs in the first 12hrs following passage, however by 24hrs 
they had achieved comparable levels. Error bars indicate standard deviation. 
**P<0.05 at 8hrs; *P<0.001 at 12hrs, paired t-test. Linear regression analysis 
detected no significant differences between the slopes of the GFP-SC and ntSC 
curves.
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Figure 3.4 Graph illustrating growth curves of transduced (GFP-SC) and non- 
transduced (ntSC) cells over a 7 day period (mean values plotted). A -  Beginning 
of exponential growth phase; B -  Plateau phase (confluence). GFP-SCs take 
longer to reach the beginning of their exponential growth phase (4 vs. 3 days) and 
plateau phase (7 vs. 6 days) in comparison with ntSCs but achieve comparable 
confluence densities by day 7.
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3.3.2 In vivo studies
3.3.2.1 GFP fluorescence on histological analysis
At high magnification GFP-labelled cells were easily identifiable on histological 
sections under blue fluorescence light. Staining with an S100-Cy3 conjugate 
showed co-localisation of red and green fluorescence, thus indicating GFP- 
labelled cells were transplanted GFP-SCs (Figure 3.5). GFP-SCs were located 
evenly throughout the length of the conduit, being as expected at this short time 
point as cells were initially transplanted in a uniform suspension of alginate. 
GFP-SCs at the regeneration front of the proximal stump were found exhibiting 
extensive bipolar cytoplasmic processes in close association with regenerating 
axonal fibres indicating active integration in the regenerative process. When 
taken in association with the significant improvement in the regeneration 
distances (see below) this indicates GFP-SCs were contributing to the 
regenerative process. The inherent fluorescence of GFP-labelled cells greatly 
simplified the staining procedure required to analyse sections. The MMLV is 
rendered replicative incompetent due to the absence of the \|/ packaging signal. 
GFP-SCs are therefore incapable of producing functional GFP-containing 
retrovirus, it can therefore be assumed that visible cell labelling was restricted to 
transplanted cells with no contamination of surrounding tissues, as is frequently 
seen in chemical labelling methods (Iwashita et al. 2000).
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3.3.2.2 Nerve regeneration
Regeneration was assessed by measuring axonal (PGP-staining) and Schwann cell 
(SlOO-staining) regeneration distances through the lumen of the conduits from the 
proximal stumps (Figure 3.6). The transplantation of GFP-SCs significantly 
improved the rate of nerve regeneration in comparison with the control group 
(Figure 3.7). Both axonal and Schwann cell regeneration distances were 
significantly better in the GFP-SC groups (3.3+/-0.45 vs. 2.4 +/- 0.14mm; P<0.05 
and 3.55+/-0.62 vs. 2.55+/-0.21mm; P<0.05 respectively; paired t-test). Indirect 
comparison of the effect of GFP-SC transplants on nerve regeneration with 
previous studies from our laboratory which used lacZ-SC transplants in the same 
model of nerve injury (Mosahebi et al. 2001; Mosahebi et al. 2002; Mosahebi et 
al. 2003) showed a comparable benefit between the labelling methods used. This 
indicates that GFP transfection had no detrimental effect on SC physiology in vivo 
in comparison with lacZ labelling.
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Figure 3.5 Fluorescent immunohistochemical image from within lumen of 
conduit containing GFP-SCs. SI00 staining (red, open arrow) is seen to co- 
localise with the green fluorescence of transplanted Schwann cells (closed arrow). 
Schwann cell nucleus indicated by asterisk.
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Figure 3.6 Section of a proximal stump within a PHB (blue) conduit at 2 weeks 
stained with S100-Cy3 to visualise Schwann cell regeneration (red). 
Regeneration distance is measured from the point of insertion of the proximal 
stump to the tip of the most distal regenerating fibre (asterisk) using a graticuled 
lens.
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Figure 3.7 Bar chart representing regeneration distances of SI00 and PGP at 2 
weeks following surgical grafting of conduit. Alg -  control group containing 
alginate only; Alg/SC -  group containing alginate and Schwann cells. SI00 
and PGP regeneration distances were significantly better in the Alg/SC group in 
comparison to the Alg group. Error bars indicate standard deviation. *P<0.05, 
paired t-test.
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3.4 Discussion
This study has shown that it is possible to transfect efficiently and stably primary 
SC cultures with GFP using a retroviral vector, and that established cultures of 
transduced cells expressing GFP display similar vitality and viability profiles to 
that of non-transduced cells (Tohill et al. 2004). A great advantage of GFP over 
lacZ labelling is the ability to assess fluorescence in vitro without detriment to the 
cultures or the need for fixation. Over a 6 week period involving multiple 
passages, primary cultures displayed no significant dilution of GFP expression, 
thus indicating permanent expression of the transgene in the SC genome and 
offering a distinct advantage over exogenous fluorescent cell labelling. It was 
shown that GFP-SCs lagged temporally in metabolic activity and exponential 
growth when compared to ntSCs. However, this effect was only seen shortly after 
passage in vitro and therefore would be negligible in longer term in vivo 
experiments. The MMLV-based retroviral vector facilitates long-term transgene 
expression without causing apparent significant toxicity or pathogenicity to 
primary SC cultures. Overall, transduction efficiency and growth kinetics were 
seen to corroborate with the results of previous reports which used a similar 
retroviral vector for GFP transfer in ovine endothelial cells (Afting et al. 2003) 
and corneal fibroblasts (Gatlin et al. 2003). However, this is the first study to 
describe oncoretroviral transduction of primary SCs with GFP. Our group has 
used the MMLV vector to transduce SCs with the lacZ reporter. On indirect 
comparison there was no apparent difference in growth kinetics between GFP-SCs 
and lacZ-SCs in vitro. Higher transduction efficiencies were seen with lacZ 
labelling (-70%) but this is more likely due to variations in transgene promoter
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sequences affecting transcription activity and the addition of sequabrene in 
transduction cycles.
This study has shown GFP to be a suitable labelling method when used in 
conjunction with fluorescent immunohistochemical procedures used to assess 
peripheral nerve regeneration. The use of GFP is advantageous in such 
techniques as transplanted labelled cells can be visualised in combination with 
other fluorochrome-labelled antigens. For histological purposes GFP has many 
desirable properties as the fluorescence of the protein is unaffected by acids, weak 
alkalis, proteolytic enzymes and temperatures of up to 65°C (Bokman & Ward, 
1981), making it versatile in a wide range of procedures. The protein is highly 
soluble and therefore requires formaldehyde fixation prior to cryostat sectioning 
and staining (Jockusch et al. 2003). Most importantly, as shown in this study, 
GFP-labelled Schwann cells have significantly improved sciatic nerve 
regeneration across a 1cm gap. This is consistent and comparable with previous 
transplantation studies from using alternative labelling methods and supports the 
fact that, physiologically, the use of GFP as a cellular label has no measurable 
detrimental effect on in vivo regeneration studies. A number of recent studies 
have demonstrated successful transplantation and localisation of SCs labelled with 
GFP (Bachelin et al. 2005; Schaal et al. 2007).
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Chapter 4
Bone Marrow Stromal Cell Differentiation 
Following Exposure to Glial Growth Factor
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4.1 Introduction
The transplantation of cultured Schwann cells (SCs) into bio-engineered conduits 
has been shown to improve nerve regeneration in experimental models of 
peripheral nerve injury (Guenard et al. 1992; Mosahebi et al. 2001; Rodriguez et 
al. 2000). However, the use of autologous cultured SCs for the treatment of acute 
injuries may be impractical due to the technical difficulties and time required in 
harvesting and expanding such cells. The ideal ‘transplantable cell’ should be 
easily accessible, capable of rapid expansion in culture, immunologically inert, 
capable of long-term survival and integration in the host tissue, and amenable to 
stable transfection and expression of exogenous genes (Azizi et al. 1998). A 
suitable candidate for such a cell may be the bone marrow stromal cell. In 
addition to haematopoietic stem cells, bone marrow contains cells capable of 
providing mesenchymal precursors such as osteoblasts, chondrocytes, adipocytes 
and myoblasts (Prockop, 1997; Caplan, 1991; Owen & Friedentstein, 1988). 
These precursors have been named colony-forming unit fibroblasts, mesenchymal 
stem cells or marrow stromal cells (MSCs). Such cells have displayed 
unorthodox plasticity in their ability to trans-differentiate across what were once 
thought to be un-crossable oligolineage boundaries. When transplanted into 
models of injury they have been reported to differentiate into a variety of cell 
types including retinal cells (Tomita et al. 2002), astrocytes (Kopen et al. 1999), 
hepatocytes (Lagasse et al. 2003), myocardium (Orlic et al. 2001), and 
myelinating cells of the peripheral nervous system (Dezawa et al. 2001) and 
spinal cord (Akiyama et al. 2002). In vitro studies have shown that MSCs will 
differentiate into cells expressing neuronal cell markers when exposed to neuronal
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cell mitogens such as BDNF and NGF (Sanchez-Ramos, 2000; Kim et al. 2002) 
and (3-mercaptoethanol (Woodbury et al. 2000). Glial growth factor (GGF) is a 
Schwann cell mitogen which has been shown to stimulate peripheral nerve 
regeneration (Mahanthappa et al. 1996), and to restrict neural crest stem cells to a 
glial cell fate in vitro (Shah et al. 1994). This study examined the effect of GGF 
on adult rat MSC morphology and phenotypical expression in vitro, and the effect 
of transplanting differentiated (dMSCs) and undifferentiated marrow stromal cells 
(uMSCs) into a nerve gap conduit.
4.2 Materials and Methods
4.2.1 In vitro study
Schwann cells (SCs) and marrow stromal cells (MSCs) were harvested from 
inbred Sprague-Dawley rats (Harlan) and cultured as described in section 2.1 and 
section 2.2 respectively. For identification in combination with 
immunofluorescent histochemical analysis, the cells were retrovirally transduced 
with GFP (cf. 2.3). MSCs were differentiated towards a glial cell lineage by 
culturing the cells in the presence of forskolin, PDGF, bFGF and GGF for 2 
weeks (cf. 2.2.2) (Dezawa et al. 2001). MSCs were also cultured in the absence 
of GGF to produce a line of undifferentiated cells (uMSCs). The colony forming 
ability of freshly harvested MSCs was measured to indicate clonogenic capacity 
(cf. 2.2.3). At various stages of culture MSCs were plated on chamber slides for 
general morphology with a polychromatic blood stain (cf. 2.13.4) or fluorescent 
immunohistochemical phenotype characterisation with antisera to Thy 1.1 (a 
marker of undifferentiated MSCs), SI00 or GFAP, followed by incubation with
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secondary fluorochromes and a Hoechst nuclear marker to identify cell nuclei (cf. 
2.3.3; 2.13.3). Transduction efficiency was measured following transfection with 
the MMLV-GFP retrovirus (cf. 2.3.3). Stained cell cultures were examined under 
a fluorescence microscope (Olympus BX60) and images captured with a cooled 
digital camera (Evolution QE).
4.2.2 In vivo study
This study used a standardised 1cm nerve gap injury rat model spanned by a PHB 
conduit (Hazari et al. 1999; Mosahebi et al. 2001; Mosahebi et al. 2002). The 
conduits contained intraluminal dissociated PHB fibres which acted as a matrix 
for transplanted cells. There were 4 groups (n=5) as follows:
Group 1: Acellular control conduits
Group 2: Conduits containing cultured Schwann cells (SCs)
Group 3: Conduits containing undifferentiated marrow stromal cells (uMSCs) 
Group 4: Conduits containing differentiated marrow stromal cells (dMSCs)
Under aseptic conditions, conduits were constructed from a polyhydroxybutyrate 
(PHB) sheet to span a 1cm gap in the left sciatic nerve (cf. 2.8) (Mosahebi et al. 
2003). To support cellular transplants, loose unidirectional PHB fibres of a fixed 
weight were threaded through the lumen of the conduits (cf. 2.10.3). Cells were 
suspended in DMEM (HEPES modification; Sigma) at a concentration of 80 x 
106cells/ml (Mosahebi et al. 2001) prior to seeding within the conduit. The 
anaesthetic and operative procedures were performed as described in section 2.11.
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Following grafting of the conduit 30juL of cell suspension was injected into the 
lumen of the conduit by introducing the needle of a Hamilton syringe into the 
distal end of the conduit until the tip of the needle had reached the middle of the 
conduit, the cell suspension was then very slowly injected. At 2 weeks, conduits 
together with proximal and distal nerve ends were harvested and placed in 
Zamboni’s fixative in preparation for immunohistochemical staining with SI00 
and PGP9.5 anti-sera (cf. 2.12.1; 2.13.1). Sections were mounted in fluorescent 
mounting medium and examined under fluorescence light, in combination with a 
blue filter to identify GFP-labelled cells. Schwann cell (SI00) and axonal 
regeneration (PGP) distances (mm) were measured at low magnification with a 
graticuled lens (2.14.1). ANOVA and a Tukey’s test were applied using statistical 
analysis software (SPSS Inc.).
4.3 Results
4.3.1 Marrow stromal cell culture and phenotypical characterisation
Marrow stromal cells (MSCs) were collected by plating and culturing bone 
marrow aspirate. Colony formation was readily observed in the presence of (3- 
mercaptoethanol (cf. 2.2.3). Freshly harvested MSCs showed a high clonogenic 
ability (plating efficiency) which increased with plating density and approached 
-13% (Figure 4.1). Staining for Thy 1.1, the CD antigen expressed by 
undifferentiated marrow stromal cells, showed antigen expression in colony- 
forming cells but not by cells showing morphological signs of differentiation 
along one of the determined mesenchymal pathways (Figure 4.2A and B). MSCs 
grew rapidly in the presence of basic growth factors with a doubling time of
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48hrs. Uptake of green fluorescent protein to label MSCs prior to transplantation 
was highly efficient (80% transduction efficiency), this being due to their high 
mitotic rate which increases their sensitivity to retroviral transduction (Figure 
4.2C and E). Following 2 weeks exposure to GGF MSCs were found to 
express the glial cell markers SI00 and GFAP. A number of cells (approx. 10%) 
displayed the classical bipolar, spindle-shaped morphology of Schwann cells 
(Figures 4.3B,C and D). Thus, within the MSC population exposed to GGF there 
were cells displaying the phenotypical and morphological characteristics of glial 
cells.
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Figure 4.1 Clonogenic ability of freshly harvested MSCs in the absence of 
colony stimulating growth factors. Cells were seeded at set densities (x axis) and 
after 7 days the number of colonies per 10cm"" arising from each given seeding 
density were counted (y axis). Linear regression analysis calculated the slope of 
the curve (plating efficiency) which reached -13%.
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Figure 4.2 Marrow stromal cell colony immunostaining. (A) Colony stained 
with the Hoechst nuclear marker (B) Thy 1.1 -Cy3 conjugate (red) and (C) green 
fluorescence due to GFP labelling (A, B and C X20 magnification). (D) 
represents the area bounded by the box in (B) showing undifferentiated clonal 
cells expressing Thy 1.1 (non-specific CD marker expressed by undifferentiated 
MSCs) (X40). (E) Illustrates daughter cells of a GFP-labelled MSC at the end of 
cell division. The cells display a flattened heterogeneous morphology typical of 
differentiating MSCs and lack the expression of Thy 1.1 as displayed by the 
adjacent clonal cells.
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Figure 4.3 (A) Bone marrow mesenchymal stromal cells (MSCs) 5 days 
following harvesting. Large, densely staining nuclei indicate high cellular and 
mitotic activity. Giemsa stain (X40). (B) Schwann cells stained with an SI 00- 
Cy3 conjugate (red) and a Hoechst 33342 nuclear marker (blue). The 
characteristic spindle-shaped cell body (arrows) is clearly seen (X40). (C, D) 
MSCs following exposure to glial growth factor (GGF). Cells are double-stained 
with a GFAP-Cy3 conjugate (C, red) and an SlOO-FiTC conjugate (D, green). 
Arrows indicate spindle-shaped morphology as seen in Schwann cells.
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4.3.2 In vivo results
Immunohistochemical analysis of the conduits containing uMSCs and dMSCs 
identified transplanted cells due their expression of GFP, dMSCs were found to be 
present evenly throughout the lumen of the conduit (Figure 4.4). At the proximal 
end of the conduit dMSCs were found to be adherent to intraluminal PHB fibres 
(Figure 4.5A and B) and to be directly involved with axonal and Schwann cell and 
regeneration (Figure 4.4A and 4.5C respectively). In conduits containing uMSCs 
a small number of transplanted cells (as detected by their GFP fluorescence) at the 
proximal and distal ends of the conduit were found to express SI 00 (Figure 4.5D) 
indicating a possible effect of local cellular and humoral factors on marrow 
stromal cell differentiation.
Axonal regeneration distance (PGP; Figure 4.6) was significantly better in 
the Schwann cell seeded conduits in comparison to the control (empty), uMSC 
and dMSC conduits. The uMSC and dMSC transplants conferred some benefit on 
axonal regeneration in comparison with the control however this was not 
statistically significant. Schwann cell regeneration distance (SI00; Figure 4.6) 
was significantly better in the Schwann cell transplant group in comparison with 
the control group and the uMSC group. Schwann cell regeneration was better in 
the dMSC group in comparison with the control group. From these results it can 
be concluded that marrow stromal cells previously exposed to GGF and 
expressing glial cell markers prior to transplantation appear contribute to 
increased Schwann cell regeneration.
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Figure 4.4 Histological sections of conduits transplanted with differentiated 
marrow stromal cells (dMSCs) and labelled with GFP. (a) PGP-Cy staining of 
axons at the regeneration front of the proximal stump showing a close relationship 
with transplanted cells. The distribution of transplanted dMSCs with a conduit is 
illustrated in b,c and d. (b) Proximal end of conduit, (c) middle of conduit, and (d) 
distal end of conduit. Scale bar = 100//m.
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Figure 4.5 Histological sections of grafted conduits stained with SI00 
antibodies to detect Schwann cells. The same section shows: (A) GFP-labelled 
differentiated marrow stromal cells (dMSC; green) in close association with 
intraluminal PHB fibres (blue); (B) SI00 staining (Schwann cell specific; red); 
(C) Digital combination of figures A and B, where the arrow indicates co­
localisation (yellow) of SI00 staining by a dMSC and involvement in Schwann 
cell regeneration. (D) Conduit containing undifferentiated marrow stromal cells 
(uMSC) labelled with GFP and stained with SI00. Co-localisation of 
fluorescence (open arrow) indicates that cells are expressing S100 that was absent 
prior to transplantation.
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Figure 4.6 Histogram illustrating axonal (PGP) and Schwann cell (S100) 
regeneration distance (mean ± standard deviation) in each group. Con - Control -  
no transplanted cells; uMSC -  undifferentiated marrow stromal cells; dMSC -  
differentiated marrow stromal cells; SC -  Schwann cells. * P < 0.05; ** P < 0.01; 
***p < o.OOl. One way ANOVA and Tukey’s post test.
4.4 Discussion
This study has shown that bone marrow stromal cells (MSCs) express 
morphological glial cell markers upon exposure to GGF in vitro and that, when 
transplanted into a model of peripheral nerve injury, they confer a benefit on 
Schwann cell regeneration. Undifferentiated and transplanted MSCs, which were 
not exposed to GGF in vitro, were subsequently found to express SI00 following 
transplantation (Tohill et al. 2004). This corroborates with previous reports of 
MSC glial differentiation in the presence of neuregulin and Schwann cell 
conditioned medium in vitro (Dezawa et al. 2001) and following transplantation in 
a peripheral nerve crush injury (Cuevas et al. 2002).
Glial growth factor is a well known Schwann cell mitogen (Minghetti et 
al. 2006) and has been shown to stimulate neural crest stem cells towards a glial 
cell lineage (Shah et al. 1994). Previous studies have shown that growth factors 
can effect directed differentiation or cell selection in stem cell populations to 
produce cells from all germ layers but that no one factor causes differentiation 
exclusively to one cell type (Schuldiner et al. 2000). Therefore, GGF might act 
on MSCs by stimulating transcription of glial lineage genes with or without 
suppression of mesenchymal lineage genes or by promoting proliferation in 
subpopulations of truly totipotential cells while indirectly inducing death of other 
cell types.
Characterisation of dMSCs, and indeed all differentiated stem cells, 
remains problematic, and care must be taken in interpreting the results of 
phenotypical markers as determinants of cell differentiation. Glial fibrillary acidic 
protein (GFAP), present on cells of a glial lineage (Jessen & Mirsky, 1999), has
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been found on a number of non-glial somatic cells, including fibroblasts 
(Hainfellner et al. 2001). It is still unclear how a stimulation process might direct 
a cell towards a given phenotype and morphological shape, and whether 
phenotypical and morphological expression really equates with functional ability. 
The interpretation of the results of this study is dependent upon the assumption 
that marrow stromal cells have become glial-type cells following in vitro 
differentiation and transplantation, acquiring Schwann cell marker expression and 
morphology. Hence, if they were functional Schwann cells, their effect on 
improving regeneration is consistent with studies of Schwann cell physiology 
following injury and transplantation (Hall, 1986; Guenard et al. 1992; Mosahebi 
et al. 2001). However, if we assume that differentiated cells are non-functional 
cells expressing glial cell markers, their benefit on nerve regeneration may be 
derived from some basic structural or humoral support such as the production of 
basement lamina, extracellular matrix macromolecules or non-specific growth 
factors. Caddick (2006) recently described morphological and phenotypical 
characterisation of MSCs following exposure to GGF. Increased expression of 
GFAP and p75 was detected histologically and phenotypically in comparison with 
cells not exposed to GGF. In addition, co-culture of glial-differentiated MSCs 
with chick embryo dorsal root ganglia (DRG) improved parameters of neurite 
growth indicating differentiated MSCs are functionally competent. The ability of 
MSCs to transdifferentiate into glial cell-like lineages has been confirmed by 
several authors (Keilhoff et al. 2006; Hou et al. 2006; Keilhoff et al. 2006 296).
It is thought that the microenvironment of a tissue has an important role to 
play in the control of tissue-specific adult stem cells (Morrison et al. 1997). Stem
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cells are normally quiescent in tissues such as the brain, but are capable of 
constant renewal and replenishment in epithelia and of tissue repair following 
injury. The microenvironment is thought to control stem cell behaviour due to a 
combination of locally secreted factors (Jan & Jan, 1998), cell-cell interactions 
mediated by integral membrane proteins, and the extracellular matrix (Artavanis- 
Tsakonas et al. 1999). We cannot exclude that these factors may be responsible 
for some of the undifferentiated marrow stromal cells showing expression of S100 
in vivo. Homeostatic controls, such as from the local existing population of stem 
cells, will also influence the behaviour of the transplanted cells. It has also been 
suggested that stem cell migration to zones of injury is more likely due to local 
depletion of progenitors than due to increased availability of survival factors 
(Hinks et al. 2003).
Interpretation of these results is influenced by current theories on stem cell 
trans-differentiation, which is conflicting with previously established laws of 
lineage restriction (Anderson et al. 2001). However, continued evidence for the 
ability of marrow stromal cells to transdifferentiate (Caddick et al. 2006) will 
highlight their potential use for therapeutic strategies in a wide range of injuries 
and diseases. Further transplantation study will need to identify more clearly the 
difference observed between transplants of differentiated and non-differentiated 
cells, and to characterise at the molecular and functional level the phenotypically 
transformed cell.
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Chapter 5
Functional and Histological Assessment of 
Nerve Regeneration Following the Delivery of 
Mechano-Growth Factor cDNA
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5.1 Introduction
Peripheral nerve regeneration has been augmented by the application of 
neurotrophic factors at the site of injury (Terenghi 1999; cf. 1.8). The sustained 
delivery of neurotrophins is hindered by their pharmokinetic profiles such as short 
half-life, diffusion into a large volume of distribution and biological breakdown. 
For maximal effect the availability of neurotrophins should run parallel to the time 
course of regeneration, which by definition is prolonged. The application of 
neurotrophin gene transfer techniques to provide sustained availability of growth 
factor is a promising solution to this problem.
IGF-1 is a potent neurotrophin (cf. 1.8.4) and its splice variant MGF 
(mechano-growth factor) has been shown to induce muscle hypertrophy following 
exercise (Goldspink, 1999; Yang & Goldspink, 2002; cf. 1.8.5). Prelimary data 
has indicated that the delivery of MGF cDNA has a neurotrophic effect on 
regeneration when locally delivered to nerve gap injuries at a short time point (2 
weeks). The following study was performed to investigate the effect neurotrophin 
plasmid delivery (MGF cDNA) on nerve regeneration over a long time frame and 
to assess both functional and histological outcomes of regeneration.
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5.2 Materials and Methods
MGF cDNA was provided by Dr Shi Yu Yang and Mr David Sutton, Department 
of Anatomy, Royal Free and University College Medical School. A short nerve 
gap model (2mm) spanned by a silicone conduit was used in the study (Figure
5.1). Three experimental groups were constructed using inbred Sprague-Dawley 
rats (weights 175-218gms; n=6 each group) as follows:
Group 1: Alginate only group (sham treatment -  control 1)
Group 2: Vector + alginate group (control 2)
Group 3: Vector containing MGF cDNA + alginate
All anaesthetic and operative procedures were carried out according to the 
protocols described in section 2.11. Gamma irradiated 6mm length silicone 
conduits were used to span the 2mm gap in the mid-thigh section of the rat sciatic 
nerve. Prior to grafting the conduits were filled with 1.8% LVM alginate 
(Pronova) containing either a suspension of vector or vector + MGF cDNA 
(lyUg///L). The conduits were then gelled in 0.1M CaCh for 2 minutes. At 14 
weeks the animals underwent terminal anaesthesia and myophysiological 
measurements of the tibialis anterior muscle were recorded on the denervated and 
contralateral sides (cf. 2.15). The conduits were harvested together with a section 
of distal nerve (Figure 5.2) and fixed in preparation for transverse semithin 
sectioning (2//m), staining (cf. 2.12.2) and quantification of distal nerve 
regeneration (cf. 2.14.2). Lateral foot pad skin from the denervated and 
contralateral sides were collected and prepared for immunohistochemical
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quantification of skin innervation (cf. 2.13.2; 2.14.3). Statistical analysis used 
ANOVA using SPSS software.
Silicone conduit
2mm
Alginate gel
MGF gene
Figure 5.1 Schemmatic diagram illustrating the 2mm sciatic nerve gap model 
spanned by a silicone conduit containing alginate gel as a matrix for gene vector 
delivery.
Figure 5.2 Silicone conduit and adjacent nerve stumps prior to fixation.
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5.3 Results
5.3.1 Muscle physiology
5.3.1.1 Wet muscle weight
Measurement of TA wet muscle mass showed a significant reduction in all 
experimental groups in comparison with normal (innervated) muscle (Figure
5.3.1). The mean muscle mass in the MGF cDNA treated group (as a percentage 
of normal muscle mass) was 61.6% vs. 53.3% (control denervated muscle) and 
53.0% (vector treated group).
5.3.1.2 Muscle maximum tetanic force
Maximum muscle tetanic force, which is the most definitive measurement of 
functional re-innervation, showed that the strength of the muscles in the MGF 
treated group was markedly better than that in the vector and alginate alone 
treated groups (Figure 5.3.2). In the MGF group the maximum muscle tetanic 
force of the re-innervated TA muscle was 99.4% compared to that of its 
contralateral innervated muscle. In the vector group in which the empty vector 
was included in the silicon tube, the maximum muscle tetanic force of the re­
innervated TA muscle was 72.3% of its contralateral muscle; and in the alginate 
group in which only alginate was included in the silicon tube it was 71.5% to its 
contralateral side.
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5.3.1.3 Muscle half-life (fatiguability)
Muscle fatigue resistance (measured as the time to half maximum isometric 
tension c.f. 2.34) was increased significantly within the MGF treated group 
compared to the vector and alginate groups (Figure 5.3.3). Although muscle 
fatigue resistance was increased in both control (187.9%) and vector groups 
(192.7%) compared to their contralateral control, this increase was significantly 
higher (P<0.01) in the MGF treated group (245.3%).
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Figure 5.3.1 Denervated muscle mass (mean ± S.D.) as a percentage of the 
contralateral normal innervated muscle mass. All masses in the experimental 
groups were significantly lower than those of normal muscle (P<0.001).
150
*140 n
120
100 -
o 80
© 4 0o
20 -
100
71.5 72.3
99.36474
I
C Normal
■ Control
■ Vector
■ MGF
GROUPS
Figure 5.3.2 Muscle maximum tetanic forces (mean ± S.D.) represented as the 
percentage force of the contralateral normal (innervated) muscle forces. The MGF 
cDNA treated group approached that of normal muscle and was significantly 
better than the vector treated and control axotomised nerve groups (*P<0.05).
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Figure 5.3.3 Histogram of half-life (fatiguability) of normal muscle and 
experimental groups. Half-life is calculated from the length of time taken for 
muscle tetanic force to fall to half maximum force (cf. Figure 2.34). All 
denervated muscles displayed longer half-lives than normal muscle. The control 
denervated muscle and the MGF cDNA treatment group were significantly longer 
(*P<0.05; **P<0.001). There was no significant difference between the 
experimental groups.
152
5.3.2 Semithin nerve quantification
Semithin (2^m) transverse sections of nerve, 2mm distal to the silicone conduit, 
were quantified for axon diameter, fibre diameter, myelin thickness and total axon 
count (cf. 2.14.2). Figure 5.4A and B are photomicrographs of normal nerve and 
regenerating nerve respectively illustrating the difference in morphology.
Figure 5.4 Photomicrographs of semithin (2^m) sections of peripheral nerve 
stained with thionine and acridine orange. (A) Normal nerve displaying 
characteristic morphology of large and small diameter fibres and unmyelinated 
Remark fibres (red arrow) and (B) regenerating nerve displaying a large number 
of small diameter fibres.
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5.3.2.1 Axon diameter, myelin thickness and fibre diameter
The mean (± S.D.) values for axon diameter, myelin thickness and fibre diameter 
are shown in Table 5.1. Normal nerve contains a predominance of large diameter 
axons surrounded by thick myelin sheaths and therefore contains a predominance 
of large diameter fibres (axon diameter + myelin thickness) with a smaller number 
of small diameter fibres. The mean values for all these parameters were greater in 
normal nerve when compared to the experimental groups. Regenerating nerve 
contains a predominance of immature small diameter fibres with associated small 
diameter axons with thin myelin sheaths. With maturity regenerating nerve fibres 
enlarge as they reach an appropriate target organ. Figures 5.5.1-5.5.3 illustrate 
frequency histograms of fibre and axon diameter and myelin thickness for normal 
nerve and each experimental group. For each parameter normal nerve displays a 
bimodal distribution concentrated around small and large diameters whilst 
regenerating nerves display a unimodal distribution concentrated around small 
diameters. This is typical of both normal and regenerating nerve. The data in the 
Figures 5.5.1-5.5.3 is not normally distributed however following non-parametric 
tests (Mann-Whitney) no significant differences between the experimental groups 
was found.
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Group Fibre diameter Axon diameter Myelin thickness
(pm) (pm) (pm)
Normal 8.02 ±3.52 5.13 ±2.41 1.45 ±0.72
-ve control 3.16 ± 1.74 2.20 ±1.05 0.75 ± 0.32
Vector 4.15 ± 1.70 2.45 ± 1.29 0.85 ±0.38
MGF 3.44 ± 1.38 2.05 ± 1.10 0.63 ± 0.29
Table 5.1 Summary data (mean ± S.D.) of measurements of transverse sections 
of peripheral nerve distal to conduit (with exception of normal nerve). Normal 
(normal nerve), -ve control (alginate only), vector (vector ± alginate), MGF (MGF 
cDNA + vector + alginate).
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Figure 5.5.1 (A) Frequency histogram of fibre diameter in normal nerve and 
regenerating nerve 14 weeks following axotomy. In normal nerve a characteristic 
bimodal distribution of axon diameters is seen whilst in regenerating nerve there 
is a unimodal distribution concentrated around small diameter axons. On 
comparing the axotomised control, vector and MGF groups (B) the distribution of 
axon diameters was similar in all regenerating groups (cf. Figure 5.4).
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Figure 5.5.2 (A) Frequency histogram of axon diameter in normal nerve and 
regenerating nerve 14 weeks following axotomy. In normal nerve a characteristic 
bimodal distribution of axon diameters is seen whilst in regenerating nerve there 
is a unimodal distribution concentrated around small diameter axons. On 
comparing the axotomised control, vector and MGF groups (B) the distribution of 
axon diameters was similar in all regenerating groups (cf. Figure 5.4).
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Figure 5.5.3 (A) Frequency histogram of myelin thickness in normal nerve and 
regenerating nerve 14 weeks following axotomy. In normal nerve a characteristic 
bimodal distribution of myelin thickness is seen whilst in regenerating nerve there 
is a unimodal distribution concentrated around small diameter axons. On 
comparing the axotomised control, vector and MGF groups (B) the distribution of 
myelin thickness was similar in all regenerating groups (cf. Figure 5.4).
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5.3.2.2 Axon number per nerve
As expected, mean axon counts (Figure 5.6) showed a significantly greater 
number of axons in the experimental groups in comparison with normal nerve. As 
regeneration matures axons that do not reach an appropriate target organ die back 
in a process called ‘pruning’ (cf. 1.3). Most importantly, the mean axon count 
was significantly greater in the MGF cDNA treated group in comparison with the 
control axotomised nerve group and the vector/alginate alone treated groups 
indicating a direct influence of MGF cDNA on regenerating nerve.
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Figure 5.6 Total axon counts per nerve (mean ± S.D.). The experimental groups 
(MGF, vector, alginate control) have a significantly greater number of axons per 
nerve than normal nerve (**P<0.001). MGF cDNA treated nerve has a greater 
number of axons than the vector treated nerve and the alginate control axotomised 
nerve (*P<0.05).
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5.3.3 Skin analysis
Lateral foot pad skin was harvested and prepared for immunohistochemical 
staining to identify nerve innervation using a PGP primary antibody and an FiTC 
secondary antibody to give green fluorescence (Figure 5.7). As expected the area 
of PGP staining was significantly reduced in the denervated groups (alginate 
control, vector and MGF) in comparison with normal innervated skin (Figure 5.8). 
There was a slight increase (not significant) in fractional immunostaining in the 
MGF group in comparison with the control and vector groups (0.046±0.01 vs. 
0.039±0.007 and 0.036±0.01 respectively).
Figure 5.7 PGP-FiTC (green fluorescence) immunostaining of skin. (A) 
Normal skin showing dense immunostaining of PGP positive fibres within the 
dermis of the skin with extension of fibres into the epidermis (*). (B) Skin at 14 
weeks following axotomy showing reduced intensity and density of nerve fibres. 
Scale bar = 40/^m.
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Figure 5.8 Fractional immunostaining (area of PGP staining as a fraction of the 
total area of staining; mean ± s.d.) in normal skin, control denervated skin and 
denervated skin in the vector and MGF groups (cf. Figure 5.7). The area of PGP 
staining in the denervated groups is significantly less in comparison to normal 
skin. There was a slight increase (not significant) in fractional immunostaining in 
the MGF group in comparison with the control and vector groups (0.046±0.01 vs. 
0.039±0.007 and 0.036±0.01 respectively). * P < 0.001.
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5.4 Discussion
The results of this investigation have shown that the delivery of MGF via gene 
transfer to the site of peripheral nerve injury significantly improves nerve 
regeneration. The myophysiological measurements performed showed a 
significant improvement in muscle maximum tetanic force and a reduction in 
muscle fatigability. Biochemical assays of muscle performed by co-investigators 
(Dr. S. Yang and Mr D. Sutton) in this study showed a significant increase in 
mitochondrial enzyme activity in the MGF cDNA treated group. There was a 
significant increase (229.2%) in muscle succinate dehydrogenase (SDH) activity in 
the MGF group over contralateral innervated control. SDH activity in vector only 
and alginate only groups were found to be 128.5% and 127.2% respectively. The 
functional improvement in muscle activity was corroborated by the histological 
quantification of nerve tissue distal to the conduits that identified a significant 
improvement in the number of regenerating axons present (19.7%). A smaller 
increase (non-significant) was seen in skin re-innervation in the footpad skin. 
These results lead to the conclusion that early restoration of muscle function has 
been as a result of improved axonal regeneration. The specific mechanism of 
action of MGF cDNA is however unclear. Whilst anterograde and retrograde 
transport of molecules along an axon may lead to the theory that MGF cDNA 
could be transported to muscle and neuronal cell bodies for translation and 
transcription it is not clear as to the mechanism in this model. Following axotomy 
Wallerian degeneration leads to complete autolysis of the entire course of the 
distal nerve stump leading to interruption of the anterograde transport pathway. 
With respect to retrograde transport, preliminary data has shown that MGF RNA
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does not appear in tissue harvested from the dorsal root ganglia corresponding to 
an axotomised nerve transfected with MGF cDNA (labelled with a GFP exon). 
However Aperghis et al. (2004) have found that both MGF and IGF-I Ea cDNA 
constructs when injected into rat facial muscle were neuroprotective following 
avulsion of the facial nerve. In addition it has been reported that DNA constructs 
such as adeno-associated virus (AAV) vector can be retrogradely transported 
efficiently from muscle to motor neuron cell bodies in the spinal cord (Kaspar et 
al. 2002).
There is a possibility that MGF cDNA primarily acts at the site of injury. 
IGF-1 has been shown to have a mitogenic effect on Schwann cells (SCs) in vitro 
(Cheng et al. 1996) and has a potent neurotrophic effect both in vitro (Akahori & 
Horie, 1997) and in vivo following nerve injury (Skottner et al. 1987), therefore its 
MGF isoform is likely to have a similar effect although this has not been studied. 
SCs are known to secrete IGF-1 up to 7 days following nerve injury after which 
IGF-1 is produced by infiltrating macrophages (Cheng et al. 1996). In this study 
the delivery of MGF cDNA may have a direct and indirect action on stimulating 
nerve regeneration, both of which mediated by local SCs. Transfection of local 
SCs with MGF cDNA may lead to production of MGF peptide that in turn 
stimulates SC proliferation, thereby improving the environment for nerve 
regeneration. SC production of MGF may also directly stimulate nerve 
regeneration. In summary, MGF has a potential therapeutic role as an adjuvant 
treatment for peripheral nerve injuries and secondly, the use of a gene transfer 
technique has been shown to be efficacious method of providing prolonged 
delivery of growth factor.
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Chapter 6
Modulation of PHB Nerve Conduits with 
Extracellular Matrix Macromolecules
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6.1 Introduction
The major constituents of the peripheral nerve include Schwann cells (SCs), axons 
and the extracellular matrix (ECM). The ECM is comprised of basal lamina 
sheets that surround individual axon-Schwann cell units and collagen fibrils. The 
ECM is composed from 3 major classes of macromolecules: glycoproteins, 
collagens and proteoglycans. The ECM regulates cell morphology and tissue 
organization, SC and axon migration, SC proliferation and myelination (Reviewed 
by Chemousov & Carey, 2000). The major glycoproteins include laminin, 
fibronectin and tenascin. Laminin is a large glycoprotein consisting of 3 
disulphide-linked polypeptide chains, a, p, and y, and is the major constituent of 
the basal lamina. SCs secrete laminin-2 which they deposit into the ECM both in 
vitro and in vivo (Combrooks et al. 1983; Jaakkola et al. 1993 263). Fibronectin 
is a multidomain glycoprotein secreted into the ECM by SCs. It is found in the 
endoneurium of peripheral nerves in areas surrounding axon-Schwann cell units 
(Combrooks et al. 1983). A large number of collagens are secreted by SCs both 
in vitro and in vivo including collagen I and III which are involved in fibril 
formation; collagen IV, which is a structural constituent of the basal lamina, and 
collagen V which is prominent in developing nerve and has a high affinity for 
heparan sulphate (Chemousov et al. 1999). The proteoglycans are a more 
heterogeneous group of molecules which include: perlecan, a heparan sulphate 
proteoglycan which is found in the SC basal lamina and which binds to other 
ECMMs such as laminin, fibronectin and collagen (Fujiwara et al. 1984); agrin, a 
heparan sulphate proteoglycan (Tsen et al. 1995); collagen XVIII (Halfter et al. 
1998); and the chondroitin sulphate proteoglycans (Braunewell et al. 1995).
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A number of studies have identified the benefit of augmenting bio­
engineered nerve conduits with individual components of the ECM. Mosahebi et 
al. (2003) showed that the addition of fibronectin to an alginate-Schwann cell 
matrix suspension improved regeneration across a 1cm nerve gap spanned by a 
PHB conduit. Laminin-coated poly-L-lactide filaments have been shown to 
induce uni-directional neurite outgrowth in vitro (Rangappa et al. 2000). Tong et 
al. (1994) demonstrated significant axonal regeneration through 10mm collagen 
tubes loaded with unidirectional collagen fibres coated with laminin and 
fibronectin.
Axonal and SC regeneration responds to both trophic and physical cues. 
Contact guidance has been demonstrated in vitro on micropattemed surfaces for 
both neurite outgrowth (Miller et al. 2001) and SC proliferation (Miller et al. 
2000). This study aimed to investigate the ability of unidirectional dissociated 
PHB fibres within a PHB conduit to support nerve regeneration via contact 
guidance and secondly to investigate whether these fibres could act as a matrix for 
transplanted SCs (Figure 6.1). To augment axonal and SC regeneration the effect 
of coating these fibres with ECMMs was also studied. In vitro studies were first 
performed to characterise the effect of ECMM sustrata on SC growth on tissue 
culture plastic and pre-coated PHB fibres, followed by in vivo studies to 
investigate nerve regeneration through PHB conduits containing PHB fibres pre­
coated with ECMMs and seeded with GFP-labelled SCs.
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Figure 6.1 Schematic diagram representing a model of unidirectional 
intraluminal PHB fibres acting as a matrix for transplanted Schwann cells within a 
PHB conduit spanning a 1cm nerve gap in the rat sciatic nerve.
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6.2 Materials and Methods
6.2.1 In vitro study 1 -  Schwann cell growth on ECMM substrata
Tissue culture plates (24-well) were coated with either laminin, fibronectin or 
collagen (Appendix B) at the concentrations given in Table 6.1. A poly-D-lysine 
(PDL) coated plate was used as a control. Schwann cells (SCs) were seeded on 
the plates at a concentration of 1 X 105 cells/ml/well and incubated at 37°C, 5% 
CO2 . SC growth curves on each substrata were subsequently constructed using 
the protocol described in section 2.7. The growth curves for each ECMM 
substrata were repeated by coating 24-well plates with either laminin, fibronectin 
and collagen on plates initially coated with PDL.
ECMM Concentration
Laminin 2 2jug/cm2
Fibronectin 2/^g/cm2
Collagen 5 5 jug/cm2
Collagen 10 10jug/cm2
Table 6.1 Concentrations of ECMM substrata used to coat tissue culture plastic. 
Two concentrations of collagen were used as no optimal concentration was 
recommended in the manufacturer’s guidelines (Sigma) or published literature on 
SC culture.
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6.2.2 In vitro study 2 -  Schwann cell metabolic activity on ECMM 
pre-coated PHB fibres
Dissociated PHB fibres were pre-coated with either laminin, fibronectin or 
collagen at the concentrations given in Table 6.1, following which 1cm2 squares 
of PHB were placed in each well of a 24-well plate. A suspension of SCs (1 XI05 
cells/ml/well) was then added to each well and incubated at 37°C, 5% CO2 . After 
24hrs the medium was replaced with SC growth medium containing 10% alamar 
Blue™ indicator solution. The cultures were placed in the incubator and the 
medium was sampled each day for 7 days to measure metabolic activity (cf. 2.6). 
Cultures were immunostained with an S100-Cy3 conjugate to assess SC 
attachment to PHB fibres (cf. 2.13.3).
6.2.3 Intraluminal PHB fibres
Polyhydroxybutyrate (PHB) conduits were constructed as described in section 2.8. 
Dissociated PHB fibres were used as a matrix for transplanted SCs by threading 
PHB fibres through conduits prior to transplantation (cf. 2.10.3). To determine a 
suitable density of fibres a number of conduits were constructed and sectioned in 
transverse and cross-sectional directions (Figure 6.6). Conduits containing 
0.35mg dissociated fibres per conduit were chosen on an arbitrary basis. Low 
PHB fibre concentrations were excluded as these were expected to be ineffectual 
as a matrix for capturing transplanted SCs. Similarly, high concentrations were 
excluded as these were thought to be likely to cause obstruction.
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6.2.3.1 Pilot in vivo testing of intraluminal PHB fibres within a PHB 
conduit
Prior to a full scale in vivo experiment, a PHB conduit containing 0.35mg 
dissociated PHB fibres was grafted into a 1cm gap in the rat sciatic nerve. The 
conduit was seeded with cultured rat primary SCs at a concentration of 80 X 
106cells/ml suspended in SC growth medium by injecting 30//L of cell suspension 
into one end of the conduit using a Hamilton syringe. The conduit was harvested 
at 2 weeks and prepared for immunohistochemical staining to assess transplanted 
SC capture (cf. 2.13.1).
6.2.3.2 in vivo assessm ent of intraluminal PHB fibres pre-coated 
with ECMMs
An in vivo experiment was performed to determine the ability of dissociated 
intraluminal PHB fibres to act as a matrix for transplanted SCs within a PHB 
conduit spanning a 1 cm gap in the rat sciatic nerve. In addition fibres were pre- 
coated with either laminin, fibronectin or collagen (c.f. 6.2.2). Groups (n=5) were 
constructed as follows:
Group 1 : Control (uncoated fibres)
Group 2 : Laminin-coated fibres (2jig/cm2)
Group 3 : Fibronectin-coated fibres (2pg/cm2)
Group 4 : Collagen-coated fibres (5pg/cm2)
Operative and anaesthetic procedures were carried out according to the protocols 
described in section 2.11. Following grafting of the conduits SC (transduced with
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GFP) suspensions were transplanted into the conduits (cf. 6.2.3.1). Nerve 
conduits, together with proximal and distal stumps, were harvested at 2 weeks and 
fixed in preparation for immunohistochemical staining (cf. 2.12). Nerves were 
immunostained stained with PGP9.5 antisera to detect axonal regeneration and 
SI00 antisera to detect Schwann cell regeneration (cf. 2.13.1). Axonal and 
Schwann cell regeneration distances were quantified (cf. 2.14.1) and compared 
using ANOVA.
6.3 Results
6.3.1 In vitro assessm en t of Schwann cell growth on ECMM 
substrata
Initial studies of SC growth on ECMM substrata (Figure 6.2) showed improved 
growth at all time points for SCs grown on laminin, fibronectin and poly-D-lysine
'y
(PDL). Collagen substrata at 5 and 10 jig/cm performed unexpectedly poorly. It 
was noticed that a large number of cells failed to adhere to the tissue culture 
plastic in the collagen substrata groups. The experiment was repeated, however 
the protocol was altered by pre-coating all tissue culture plastic with PDL 
followed by the application of either laminin, fibronectin or collagen. The 
resulting growth curves (Figure 6.3) showed increased cell numbers at all time 
points for PDL-laminin, PDL-fibronectin and PDL-collagen (5 and 10 ^g/cm2) 
substrata when compared to substrata not pre-coated with PDL (Figure 6.2). The 
primary effect of PDL is to remove the electrostatic charge present on tissue 
culture plastic thereby facilitating SC attachment. Pre-coating with PDL prior to 
the application of the above ECMMs potentiates their effects by maximising SC
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attachment. In addition to their effects on SC growth, laminin and fibronectin 
may have properties similar to that of PDL whilst collagen does not.
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Figure 6.2 Schwann cell growth curves (mean values with non-linear regression 
curves) on initial testing of laminin, fibronectin, collagen and poly-D-lysine 
(PDL; control) substrata. Laminin, fibronectin and PDL improve growth over 
both concentrations of collagen.
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Figure 6.3 Schwann cell growth curves (mean ± S.D.) on tissue culture plastic 
initially coated with PDL followed by the addition of either laminin, fibronectin 
or collagen substrata. Pre-coating tissue culture plastic with PDL improved the 
Schwann cell growth curve of low concentration collagen (5jug/cm2) when 
compared to collagen alone as shown in Figure 6.2. At 10 days there were 
significantly higher Schwann cell numbers on laminin, fibronectin and collagen 
(5//g/cm ) in comparison with PDL alone and collagen (10//g/cm ). The final cell 
numbers of all groups (with the exception of PDL alone) were higher when tissue 
culture plastic was initially treated with PDL (cf. Figure 6.2).
• Laminin
T Fibronectin
• PDL
A Collagen 5 
° Collagen 10
173
6.3.2 In vitro assessm ent of Schwann cell metabolic activity on 
ECMM-coated PHB fibres
Following seeding of SCs on PHB fibres coated with either laminin, fibronectin or 
collagen in vitro metabolic activity was assessed over a 6  day period using the 
alamar Blue™ assay (Figure 6.4). It was found that laminin, fibronectin and low 
concentration collagen (5//g/cm ) improved SC activity at early time points over 
high dose collagen (10//g/cm ); however, by day 6  the activity of SC cultures on 
high dose collagen was comparable. Histological examination of cultures (Figure 
7.5) showed attachment and growth of SCs to PHB fibres in vitro. When SCs 
were cultured with uncoated PHB fibres measured metabolic activity was poor 
although an increase was detectable by day 6 . This probably reflects either a 
sampling error when applying a SC suspension to the uncoated fibres or a 
temporal delay in SC attachment and growth due to the hydrophobic electrostatic 
charge present on PHB fibres.
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Figure 6.4 Schwann cell metabolic activity (mean ± S.E.M.) when cultured on 
PHB fibres pre-coated with either laminin, fibronectin or collagen as assessed via 
the alamar Blue™ assay (cf. 2.6). Schwann cell metabolic activity at day 6  was 
similar in laminin, fibronectin and collagen pre-coated PHB fibres when 
compared to uncoated PHB fibres. The poor performance of uncoated PHB fibres 
was attributed to either the native electrostatic charge of PHB preventing 
adherence of Schwann cells or more likely a sampling error when initially 
applying Schwann cells to the PHB fibres at the beginning (day 0) of the 
experiment. A small increment is seen at day 6  and it is possible that with 
continued measurement beyond this time point continued metabolic activity 
would have been identified.
Ecoh-
ooJO
(DO
C
(0
-D
i -O
0)-Q
<0
Time (days)
175
Figure 6.5 GFP-labelled Schwann cells cultured on PHB fibres (blue) in vitro. 
Cultures were stained with an S100-Cy3 conjugate (red) to identify all Schwann 
cells, co-localisation with GFP fluorescence appears yellow (asterisk). Schwann 
cells are shown to be concentrated around PHB fibres.
6.3.3 In vivo assessm en t of the dissociated intraluminal PHB fibres 
as a matrix for transplanted Schwann cells
Four PHB conduits were constructed containing dissociated intraluminal PHB 
fibres at the concentrations given in Table 6.2. The conduits were embedded in 
OCT, frozen at —40°C, sectioned at 15/mi and examined under phase contrast 
microscopy (Figure 6 .6 ). Fibre weights per conduit of 0.35mg (Figure 6 .6 C; 
-1015 fibres/conduit) were chosen for the in vivo experiment.
Longitudinal Transverse
Figure 6.6 See overleaf for detailed legend
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Figure 6.6 legend
Phase contrast histology of PHB conduits threaded with dissociated PHB fibres 
(cf. 2.10.3). Conduits were constructed with 4 different dissociated fibre 
concentrations (based on weight). Following construction of the conduits they 
were embedded in OCT, frozen and sectioned at 15/un. Fibre numbers per unit 
cross-sectional area were counted using image analysis software (Table 6.2).
Figure label Fibre weight(mg) No. of fibres per 
conduit
6.6 A 0.15 564
6.6 B 0.25 875
6.6 C 0.35 1015
6.6 D 0.50 1471
Table 6.2 Fibre weights and number of fibres per unit cross-sectional area for 
conduits 6 A-6 D (cf. Figure 6 .6 ).
3 Fibre numbers per cross sectional unit area were counted using image analysis software 
(ImagePro Plus).
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Preliminary in vivo testing of a conduit with transplanted SCs showed an even 
distribution of SCs throughout the length of the conduit. SCs were found to be 
closely related to the intraluminal PHB fibres (Figure 6.7A, B and C). SCs were 
also found to be integrated with regenerating axons (Figure 6 .8 ) and host SC 
regeneration (Figure 6.9) at the regeneration front of the proximal stump.
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Figure 6.7 Sections of a PHB conduit containing intraluminal PHB fibres (blue) 
transplanted with Schwann cells and stained with an S100-Cy3 conjugate (red). 
Schwann cells are clearly seen to be associated with PHB fibres and are evenly 
distributed throughout the length of the conduit. (A, X10; B, X20; C, X40).
Figure 6.8 Section of an explanted 
conduit seeded with GFP-Schwann 
cells. A GFP-Schwann cell 
(asterisk) is shown associated with a 
regenerating axon immunostained 
with a PGP9.5-Cy3 conjugate (red). 
The axon and Schwann cell are 
shown to be closely aligned with 
intraluminal PHB fibres (blue 
autofluorescence).
Figure 6.9 Section of a PHB conduit containing GFP-Schwann cells (GFP-SC) 
immunostained with a S100-Cy3 conjugate (red). Integration of transplanted 
Schwann cells is clearly shown with host regenerating Schwann cells.
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6.3.4 In vivo assessm ent of intraluminal PHB fibres pre-coated with 
ECMMs
Following the preliminary results discussed in section 6.3.2 an in vivo experiment 
was performed using PHB fibres pre-coated with ECMMs as described in section 
6.3.2.1. At 2 weeks the mean Schwann cell regeneration distances were 
significantly greater in the laminin and fibronectin coated groups in comparison 
with the uncoated control (P<0.05; Figure 6.10), with the distances between 
laminin and fibronectin being comparable. Similarly, mean axonal regeneration 
distances were significantly greater in the laminin and fibronectin groups when 
compared to the uncoated control group (P<0.05; Figure 6.11). Mean axonal 
regeneration distance was slightly better in the laminin coated group when 
compared to the fibronectin coated group although this was not statistically 
significant.
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Figure 6.10 Schwann cell regeneration distances (mean ± S.D.). Distances were 
measured from the insertion of the proximal stump to the tip of the most distal 
regenerating fibre. Regeneration distances were significantly greater in the 
laminin and fibronectin groups when compared to the control group (uncoated 
fibres). *P<0.05; ANOVA.
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Figure 6.11 Axonal (measured via PGP9.5 immunoreactivity) regeneration 
distances (mean ± S.D.). Distances were measured from the insertion of the 
proximal stump to the tip of the most distal regenerating fibre. Regeneration 
distances were significantly greater in the laminin and fibronectin coated groups 
when compared to the uncoated control group. *P<0.05; ANOVA.
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6.4 Discussion
This study has shown that (a) laminin, fibronectin and to a lesser extent collagen, 
promote SC growth in vitro both as tissue culture plastic substrata and when pre- 
coated on PHB fibres, (b) dissociated intraluminal PHB fibres within a PHB 
conduit can successfully act as a matrix for transplanted SCs and (c) that 
intraluminal PHB fibres pre-coated with laminin or fibronectin significantly 
improve axonal and SC regeneration in comparison with uncoated controls at a 2 
week time point.
Mimicking the internal milieu of any tissue is fundamental to building bio­
engineered systems. Extracellular matrix macromolecules (ECMMs) play an 
important role in the ultra-structure and homeostasis of all tissues. Molecules 
such as laminin, fibronectin and collagen closely interact with and support cellular 
elements in vivo (Ide, 1996). The beneficial effect of ECMMs on SC proliferation 
and axonal regeneration within a bio-engineered nerve supports the need for an 
engineered extracellular matrix. ECMMs are known to promote cellular adhesion 
and proliferation and to influence the expression of cell adhesion molecules. The 
component molecules within the matrix do not operate as individual units but as 
part of a highly organized macromolecular complex. The assembled ECM is 
likely to have biochemical and physical properties that are not manifested by 
individual ECM molecules alone (Chemousov & Carey, 2000). Further 
characterisation of the effect of these molecules at the cellular and molecular 
level, and further studies involving combinations of molecules, will lead to 
important information relating to, and advances in, the behaviour of cellular 
transplants within bio-engineered systems and subsequent regeneration.
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Chapter 7
The Effect of Extracellular Matrix Macromolecules 
on NCAM and N-cadherin Expression in 
Bioengineered Nerve Constructs
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7.1 Introduction
The cellular responses following nerve injury are activated by a complex and 
heterogeneous array of signalling proteins located in the plasma membrane. 
Amongst these proteins are the cell adhesion molecules (CAMs). In addition to 
maintaining tissue architecture through cell-cell and cell-matrix adhesion, CAMs 
form important signalling interfaces between the environment and the cytoplasmic 
processes which control nerve development and the response to nerve injury and 
regeneration. CAMs are expressed in the developing CNS and PNS where they 
participate in neuronal cell migration, myelination, neurite outgrowth, and axonal 
guidance and fasciculation (reviewed by Fu and Gordon, 1997). The experiment 
described in this chapter examines the expression of two important CAMs (neural 
cell adhesion molecule (NCAM) and N-cadherin) at the regeneration front of a 
regenerating nerve within a bio-engineered nerve conduit containing a scaffold of 
fibres coated in various extracellular matrix macromolecules (laminin, fibronectin 
and collagen). Extracellular matrix macromolecules (ECMMs) are important 
components of the matrix and have been shown to stimulate neurite extension and 
modulate CAM expression in vitro (cf. chapter 6 ; Kiryushko et al. 2004; Burgess 
et al. 2007). Little is known regarding the expression of CAMs at the 
regeneration front of nerves regenerating through nerve conduits.
A detailed discourse on the molecular biology of CAMs in peripheral 
nerve regeneration is outside the scope of this thesis. In summary, CAMs are 
categorised into a number of major classes which include: The cadherins (e.g. N- 
cadherin); the immunoglobulin superfamily (e.g. NCAM); the integrins (which 
bind to laminin); and the selectins. Following injury, neurite induction and
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sprouting, the extracellular matrix (ECM) has a number of effects on the 
regeneration front. There are positive cues (permissive or attractive), negative 
cues (inhibitory or repulsive) or guiding cues (due to the physical environment). 
These signals come from macromolecules of the ECM, molecules on the surface 
of cells in the environment and diffusible factors such as growth factors and 
cytokines. The extent and success of regeneration will therefore depend on the 
balance between permissive and inhibitory cues (reviewed by Goodman, 1996).
N-cadherin is a transmembrane glycoprotein containing 5 cadherin 
domains mediating Ca -dependent homophilic interaction. N-cadherin interacts 
intracellularly with a- and p-catenins which in turn interact with the actin 
cytoskeleton (reviewed by Tepass et al. 2000). N-cadherin is highly expressed by 
Schwann cell precursors (SCPs) during embryonic nerve development with 
intense expression being seen at the regeneration front of the developing nerve, 
however the expression diminishes as SCPs differentiate into mature Schwann 
cells and as axons reach their target organs (Wanner et al. 2006). This down- 
regulation appears to coincide with architectural changes in the maturing nerve 
including increased connective tissue, blood vessel infiltration and the appearance 
of Schwann cell basal lamina (Wanner & Wood, 2002; Wanner et al. 2006). N- 
cadherin expression is up-regulated following peripheral nerve injury (Shibuya et 
al. 1995; Squitti et al. 1999; Thornton et al. 2005). This probably reflects the 
increased presence of dedifferentiated and immature Schwann cells associated 
with peripheral nerve regeneration (Mirsky & Jessen 1999). N-cadherin 
expression is increased during regeneration at axons-Schwann cell interfaces but
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is not expressed at points where axons and the basal lamina are in contact 
(Shibuya et al. 1995).
Neural cell adhesion molecule (NCAM) is a calcium-independent CAM 
and is comprised of 5 Ig modules and 2 fibronectin type III homology regions 
(Crossen & Krushel, 2000). Alternative splicing produces a large number of 
isoforms varying between 120 and 180kDa. NCAM-180 has large cytoplasmic 
extensions which bind to cytoskeletal proteins. NCAM can contain PSA 
(polysialic acid) which is highly expressed during development but whose 
expression diminishes with maturation (Rutishauser & Landmesser, 1996). 
Neurite extension on NCAM vs. NCAM-PSA substrata in vitro shows up to 80% 
increased growth on NCAM-PSA substrata (Doherty et al. 1992). Loss of PSA 
with maturation in the CNS appears to be associated with the less permissive 
environment of the CNS to regeneration following injury. The multidomain 
structure of NCAM leads to multiple binding sites. The extracellular region of 
NCAM hence mediates homophilic and heterophilic cis and trans interactions. 
NCAM is involved in heterophilic binding with heparin sulphate proetoglycans, 
chondroitin sulphate proteoglycans, laminin, the FGF receptor, integrins and the 
LI-CAM. NCAM is expressed by small unmyelinated fibres and non-myelinating 
Schwann cells (Le Forestier et al. 1993). NCAM is believed to be involved 
axonal network formation in the developing nervous system and is actively 
expressed in areas undergoing plasticity (e.g. the neurohypophysial system) in the 
adult brain (Aubert et al. 1998) or the paranodal areas of peripheral nerve (Rios et 
al. 2000). The addition of soluble forms of NCAM to Schwann cell cultures 
promotes cell migration, indicating that homophilic binding is likely to play an
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important role in the interaction between axons and Schwann cells following 
injury (Thomaidou et al. 2001), however the addition of antibodies to NCAM has 
been shown to have little inhibitory effect on neurite extension (Bixby et al. 
1988). Following injury NCAM levels rise in the immediate zone of injury, in the 
dorsal root ganglia and anterior horn of the spinal cord, and at the neuromuscular 
junction of denervated muscle (Daniloff et al. 1986; Saito et al. 2005). Tacke and 
Martini (1990) have shown that NCAM mRNA expression increases in the distal 
stump 2-3 weeks following transection. Thorton et al. (2007) have found that the 
administration of neurotrophins to the site of a peripheral nerve axotomy effect 
NCAM and N-cad expression at the proximal stump and that this coincides with 
an increase of respective mRNA expression in dorsal root ganglia. Following 
peripheral nerve injury myelinating Schwann cells dedifferentiate and start to 
express NCAM (Martini & Schachner, 1988). Saito et al. (2005) found that 
NCAM expression was initially high after transection but had fallen after 7 days.
Regenerating axons use adhesion molecules to navigate through the ECM 
and to extend along the Schwann cell column during regeneration. The 
experiment described aimed to investigate the expression of NCAM and N- 
cadherin at the regeneration front of regenerating nerves within bio-engineered 
polyhydroxybutyrate (PHB) nerve conduits pre-coated with either laminin, 
fibronectin or collagen. Quantitative assessment of CAM expression was 
performed using fluorescent immunohistochemical techniques previously 
optimised in our laboratory (Thornton et al. 2005). The expression levels were 
correlated with the regeneration distances measured in these nerve grafts (cf. 
chapter 6 ).
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7.2 Materials and Methods
In chapter 6  axonal and Schwann cell regeneration through nerve conduits 
containing PHB fibres coated with extracellular matrix macromolecules and 
seeded with cultured Schwann cells was measured at 2 weeks following axotomy 
and grafting. Using the same tissue from this previous experiment, further 
sections were collected and subjected to immunofluorescent histochemical 
analysis to quantify the expression of NCAM and N-cadherin in the 4 
experimental groups. The groups (n=5) were constructed as follows:
Group 1: Control (uncoated fibres)
Group 2: Laminin-coated fibres (2pg/cm2)
Group 3: Fibronectin-coated fibres (2pg/cm2)
Group 4: Collagen-coated fibres (5pg/cm2)
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7.2.1 In vivo expression of NCAM and N-cadherin
Nerve-conduit constructs were harvested, processed and cryosectioned as 
described in section 2.12.1. Nerves were immunostained to detect NCAM and N- 
cadherin expression (cf. 2.13.1). NCAM and N-cadherin expression was 
quantified at the proximal stump, regeneration front and distal stump using Image- 
Pro Plus image analysis software (Media Cybernetics, UK) as described in 2.14.2. 
NCAM and N-cadherin expression was quantified as intensity/unit area in 
arbitrary units (Thornton et al. 2005). Statistical analysis was performed using 
Sigmastat® software (SPSS Science, USA). Kruskal-Wallis one-way ANOVA on 
ranks was used to analyse the median values of intensity/ unit area of adhesion 
molecule expression in the proximal stump, regeneration front and distal stump. 
Experimental and control groups were compared using Dunn’s multiple 
comparisons test.
7.2.2 Quantification of NCAM and N-cadherin expression
NCAM and N-cadherin expression was quantified as intensity of staining per unit 
area. All images were taken in monochrome to minimise loss of signal. Images 
were taken within 48 hours of staining to minimise decay. Exposure of each 
section to fluorescent light was kept to an absolute minimum to prevent photo 
bleaching. At a set distance from the tip of the regenerating front images were 
captured at the regeneration front, proximal stump and distal stump (Figures 2.24 
and 2.25). The image capture region corresponding to the regeneration front was 
a point 2 mm from the most distal regenerating fibre (as determined by co-staining 
with SI00) and that corresponding with the proximal stump was 4mm from the
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most distal regenerating fibre. The distal stump capture area was a point 2mm 
from the distal stump axotomy.
7.3 Results
7.3.1 NCAM expression
The expression of NCAM was examined at the proximal stump (PS), regeneration 
front (RF) and distal stump (DS) within each group to identify a trend in the 
expression across the nerve construct, and between each experimental group at 
each point (PS, RF, DS) to identify the effect of the addition of ECMMs on 
NCAM expression.
Within each group there was a generalised reduction in the mean and median 
values of NCAM expression between the PS and the RF, and between the RF and 
the DS (Figure 7.2). In all groups the reduction in expression between the PS and 
DS was significant. There was a significant reduction between the PS and the RF 
in the control and fibronectin groups. There were no significant differences 
between the RF and DS in any of the groups.
On looking at the variation of NCAM expression at the PS between each 
group (Figure 7.2) there was a significant increase in the median values in the 
laminin and fibronectin groups in comparison with the control group but not with 
the collagen group. This is consistent with the increased PGP and SI00 
regeneration distances seen in these groups (cf. chapter 6 ). At the RF there was a 
significant increase in the range of NCAM expression in the laminin group in 
comparison with the control and fibronectin groups, although the median value of 
NCAM expression in the laminin group was comparable with these groups the
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mean value was increased (Figure 7.2). There were no significant differences in 
NCAM expression between each group at the distal stump.
Figure 7.1 NCAM staining at the proximal stump (a,), regeneration front (b) and 
distal stump (c). All images are X40 magnification. Scale bar = 50pm.
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Figure 7.2 NCAM expression (mean ± s.d.) at the regeneration front, proximal 
stump and distal stump in each experimental group. PGP and SI00 regeneration 
distances (mean values; cf. chapter 6 ) superimposed for comparison.
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7.3.2 N-cadherin expression
Within each group there was a generalised increase in the mean N-cadherin 
expression between the PS and the RF (Figures 7.4). This increase was 
significant in the control, laminin (most pronounced increase) and fibronectin 
groups but not in the collagen group. Between the RF and DS there was a slight 
decrease in mean and median N-cadherin expression in the control and fibronectin 
groups. Between groups at the PS there was a significant increase in N-cadherin 
expression in the laminin, fibronectin and collagen groups over the control group 
(Figure 7.4). There was also a significant increase in expression in the fibronectin 
group over the laminin and collagen groups. At the RF there was a significant 
increase in expression in the laminin and fibronectin groups over the control 
group but not the collagen group. This pattern was similar to that seen in the PGP 
and S 1 0 0  regeneration distances.
At the DS there was increased expression in the laminin, fibronectin and 
collagen groups over the control group, in addition there was a significant 
increase in the laminin group over the fibronectin group. The expression pattern 
closely followed the order of regeneration distances seen with PGP and SI00 
staining.
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Figure 7.3 N-cad staining at the proximal stump (a), regeneration front (b) and 
distal stump (c). All images are X40 magnification.
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Figure 7.4 N-cad expression (median ± 25-75 percentile range) at the 
regeneration front, proximal stump and distal stump in each experimental group. 
PGP and SI00 regeneration distances (mean values; cf. chapter 6 ) superimposed.
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7.4 Discussion
This experiment has shown that the addition of the extracellular matrix 
macromolecules laminin, fibronectin and collagen to a bioengineered nerve 
construct effects the expression of NCAM and N-cadherin on the proximal stump, 
regeneration front and distal stump. A generalised reduction in NCAM 
expression between the proximal and distal stumps was seen in all groups. 
Between the groups, NCAM expression was increased in the laminin and 
fibronectin groups at the proximal stump and in the laminin group at the 
regeneration front. In contrast, the expression of N-cadherin was increased 
between the proximal stump and regeneration front. The pattern of differences in 
expression between the regeneration front and distal stump was less clear. 
Between the experimental groups, ECMMs stimulated an increase in N-cadherin 
expression over the control group at each point in the nerve construct. Laminin 
and fibronectin appeared to have a greater effect on increasing N-cadherin and 
NCAM expression than collagen which appears to be linked to their effect on 
increasing PGP and SI00 regeneration distances. It appears that laminin and 
fibronectin have upregulated NCAM and N-cadherin expression at the proximal 
and distal stump, whilst they have not altered the general trend across the 
construct this upregulation appears to follow from or lead to enhanced nerve 
regeneration.
The regeneration front responds to contact-mediated attraction and 
repulsion (physical cues from tissue architecture) and chemo-attraction and 
chemo-repulsion (from growth factors and cytokines). This experiment has 
attempted to synthesize an environment containing physical and molecular cues
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within a nerve conduit which may promote nerve regeneration. Poly- 
hydroxybutyrate fibres have been used within the conduit to act as a scaffold 
along which axons may regenerate, this scaffold has been supplemented with 
extracellular matrix macromolecules to provide molecular cues to encourage 
regeneration (cf. chapter 6 ). Neurite outgrowth triggered by extracellular matrix 
macromolecules (ECMMs) is a result of both modulation of cell surface adhesion 
to the ECM and activation of cell surface receptors initiating intracellular 
signalling cascades. Increased expression of N-cadherin in the regeneration front 
of axons exposed to ECMMs indicates either a secondary response to regeneration 
or activation by shared common messenger systems (reviewed by Maness & 
Schachner, 2007).
The coating of substrata with ECMMs has been shown to enhance neurite 
outgrowth in vitro (Niere et al. 2005) and stimulates SC proliferation (cf. chapter 
6 ). Similarly, substrata containing synthesized CAMs support cell adhesion, 
migration and neurite outgrowth (Feri et al. 1992). In vitro studies have shown 
that as a substrata, laminin is superior to LI (Niere et al. 2005), however laminin 
is a complex macromolecule that will potentiate other cell types which may not be 
necessarily beneficial for nerve regeneration (e.g. fibroblasts), laminin may also 
be difficult to manufacture in a form of sufficient quality for bio-engineered nerve 
constructs. In contrast, CAMs can be manufactured using recombinant 
technology, are highly nerve specific and therefore would be an appropriate 
alternative to ECMMs. Nerve conduits coated with the LI-CAM have 
demonstrated increased regeneration (Xu et al. 2004).
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A traditional view of CAMs is that cell-cell and cell-matrix interactions 
mediated by these molecules establish a physical anchorage of these cells to their 
environment necessary for proliferation, growth and migration of cells. It is now 
established that CAMs can initiate intracellular signalling cascades (Kamiguchi & 
Lemmon, 2001). Adhesion and signalling therefore seem to be mutually 
interdependent. All NCAM isoforms can mediate cis-, trans-, homo-, and 
heterophilic interactions (Kiss et al. 2001) with NCAM interactions at the cell 
surface activating intracellular signalling cascades (reviewed by Manness and 
Schachner, 2007).
The method incorporated to quantify NCAM and N-cadherin expression is 
novel and subject to a number of factors which can adversely influence the results. 
The protocol for tissue collection, staining, image capture and quantification was 
previously developed and optimised in our laboratory by Thornton et al. (2005). 
Whilst it has been shown that immunoflorescent histochemical techniques can be 
successfully used to assess CAM expression both qualitatively and quantitatively, 
they are not sufficient on their own. Thornton et al. 2007 confirmed that NCAM, 
N-cadherin and LI mRNA expression follows a similar pattern to that seen at the 
proximal stump following neurotrophin delivery at the site of an axotomy. 
Indicating a retrograde passage of neurotrophin and possibly anterograde delivery 
of cell adhesion molecule mRNA to the regeneration front.
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Chapter 8
General Discussion
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Engineering the ideal nerve graft requires optimisation of the key elements of the 
construct i.e. the conduit, the matrix, transplanted cells and/or growth factors. It is 
envisaged that ultimately an ‘off-the-shelf graft will be available in specialist 
centres for the reconstruction of peripheral nerve injuries. The ideal conduit 
material must be practical for use in the clinical setting, non-immunogenic, and 
biodegradable, however this may not be an absolute pre-requisite if its persistence 
does not interfere with function. Poly-hydroxy-butyrate (PHB) appears to satisfy 
most of these requirements when used in our animal model. A limited clinical 
evaluation in the human has been performed with sheets of PHB being used as a 
‘wrap around’ repair around injured nerves. The number of patients recruited has 
been small as numerous criteria must be met before entry into the study, however 
initial results have not revealed any significant problems with rejection of PHB or 
detriment in recovery in comparison with patients treated with direct apposition of 
nerve stumps.
An additional structural component of the nerve graft of importance is the 
matrix within the conduit. The matrix provides signal inputs from the 
extracellular space and not only supports transplanted cells and growth factors but 
also provides mechanical cues which aid axonal growth. It has been shown that 
the matrix can influence axonal growth and the expression of cell adhesion 
molecules at the regeneration front. The complex molecular events occurring at 
the regeneration front during regeneration are slowly coming to light (reviewed by 
Maness & Schachner, 2007) and it is undoubted that understanding these events 
will lead to the design of more sophisticated matrices capable of supporting 
sustained regeneration.
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The goal of augmenting peripheral nerve regeneration is to enhance the 
speed of regeneration so that target organs can be re-innervated before permanent 
atrophic changes develop. The source of this support may either be derived from 
the addition of growth factors, SCs or stem cells. Cellular transplants may be 
genetically engineered to act a platform for the increased production of growth 
factors. Alternatively genetic constructs may be delivered directly to the site of 
injury which, following uptake by local cells lead to the temporary production of 
growth factors. SCs are the ideal cell to transplant into a nerve conduit however 
their harvesting and culture is time-consuming and impractical for the acute 
clinical setting. Results involving marrow stromal cells have been encouraging; 
these cells are accessible, abundant and relatively easy to culture. The future may 
involve harvesting and separation of these cells for transplantation at the time of 
nerve repair or banks of tissue-typed cells may be made available for immediate 
transplantation. The possibility of bone marrow stromal cells as an alternative 
cellular transplant to Schwann cells is receiving concentrated attention. Initial 
evidence of trans-differentiation towards a SC lineage and a beneficial effect 
following transplantation (Tohill et al. 2004) has been corroborated by a number 
of studies. These include studies of morphological and phenotypical 
differentiation (Caddick et al. 2006) and studies assessing regeneration following 
transplantation in a rat model (Mimura et al. 2004; Keilhoff et al. 2006) and in a 
primate model (Hu et al. 2007). It is likely that SC harvesting, culturing, and 
transplantation will cease to be seen as a practical therapeutic tool but as a control 
against which MSC trans-differentiation and transplantation will assessed.
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Histological examination will always remain an important part of 
assessing regeneration. As research focuses on cellular transplantation it is 
important that these cells can be tracked to evaluate their survival and integration. 
Fluorescent protein technology has great potential for the study of bio-engineered 
cellular systems. Developments have been aimed at producing a range of 
spectrally distinct fluorescent proteins to allow simultaneous multicolour tracking 
of separate genes, fusion proteins or labelled cells. Mutants of GFP are now 
available with enhanced fluorescence (EGFP) and emission spectra corresponding 
to blue (BFP), cyan (CYP) and yellow light (YFP) (Zimmer, 2002). The 
discovery of DsRed, a red fluorescent protein cloned from Discosoma coral 
significantly improves multicolour tracking due its much longer emission maxima 
of 558 and 583nm (Matz et al. 1999). Such a red-shift in emission spectra in 
comparison with GFP (509nm) not only improves spectral separation from 
autofluorescence and other fluorescent proteins but the longer wavelength also 
aids tissue penetration (Baird et al. 2000). More than 25 fluorescent proteins have 
been isolated from different marine organisms (Labas et al. 2002; Labas et al. 
2002). These technologies have far-reaching applications for the study of bio­
engineered nerve grafts. For example, cells could be labelled with one fluorescent 
protein for cell tracking following transplantation whilst secondary proteins could 
be tagged to a particular growth factor(s) enabling the measurement of gene 
expression within transplanted cells. New developments in imaging (Lippincourt- 
Schwartz & Patterson, 2003) will allow real time study of intracellular protein 
traffic in vitro revealing new insights into the complexities of Schwann cell- 
neuronal interactions and variations in gene regulation induced by growth factors.
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This approach would therefore simplify the complex process of in-situ 
hybridisation or northern blotting for measuring gene expression. Whilst a 
number of studies have described the use of viral-based transduction for labelling 
SCs with GFP (Tohill et al. 2004; Bachelin et al. 2005; Schaal et al. 2007) the 
development of transgenic animals expressing GFP (Radtke et al. 2005) will 
simplify transplantation studies.
The experiments described in this thesis used a 2 week time point to assess 
regeneration activity with the exception of the experiment described in Chapter 6 
which involved a 14 week time point. The aims of many studies related to 
peripheral nerve regeneration are to assess the ability of novel techniques to 
enhance regeneration but also to answer questions relating to the pathophysiology 
of nerve injury and regeneration. To assess the effect of an adjuvant treatment on 
the active regeneration front we have found that a 2 week time point is optimal 
because at this time the regeneration front is usually midway through a 1cm 
conduit. This allows the determination of the quality and quantity of regeneration, 
the expression of molecules known to play an important role in nerve regeneration 
and the integration of transplanted cells within the regenerating front. Indirect 
comparative analysis is also possible with previous studies from our laboratory 
incorporating the same model and time points (Mosahebi et al. 2001). The aims 
of experiments utilising longer time points have different objectives in that there 
is greater emphasis on defining the advantage conferred on functional outcome 
following axotomy and repair. The ideal assessment of regeneration involves a 
combination of qualitative and quantitative histological analysis correlated to 
measurements of functional outcome. Measurements of functional outcome
206
involve relatively simplistic parameters such as wet muscle weights, unreliable 
assessments e.g. walking track patterns, and the gold standard - measurements of 
neuro- and myophysiological function. Long time points are necessary when 
assessing functional outcome to allow time for regenerating axons to re-innervate 
their end organs, i.e. muscle and skin.
Long term animal experiments are expensive, it is therefore important that 
experiments planned for these studies are based on sound preliminary findings 
that justify initiating a full study. A preliminary study was performed to assess 
regeneration at a 2 month time point involving SC transplantation within a 1cm 
PHB or silicone conduit grafted into the rat sciatic nerve. Dissociated PHB fibres 
(cf. Chapter 7) or collagen gel was used as a matrix to support transplanted cells 
(cf. 2.8-2.10; 2.11.3). In collaboration with Miss Jenny Caddick (Blond Mclndoe 
Laboratories) regeneration was determined via immunohistochemical techniques 
to determine S I00 (Schwann cell) and PGP9.5 (axonal) staining at the proximal, 
middle and distal areas within the nerve conduit (cf. 2.13.1). Semithin sections 
from the distal stump were also examined to determine the degree of successful 
cross-over regeneration (cf. 2.12.2). It is not technically possible to cut and 
immunostain longitudinal sections of silicone conduits due to the nature of the 
material, therefore to assess regeneration semithin sections of the distal stump 
were used alone in these groups.
The study was limited as there was a higher than expected rate of 
autophagy of denervated limbs, this is a recognised complication of experiments 
involving axotomy of the sciatic nerve in the rat. It was necessary to perform 
premature termination of these animals to prevent undue suffering. This limited
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animal numbers and therefore made the interpretation of results difficult. 
Regeneration in the distal stump was found to be better in nerves grafted with 
silicone conduits in comparison with those grafted with PHB conduits. This may 
be due to the impervious nature of silicone providing an enclosed environment 
which concentrates local growth factors and molecules responsible for stimulating 
regeneration. A surprising finding was that conduits containing transplanted SCs 
displayed reduced regeneration in comparison to those without SCs. As the 
numbers in these groups were small (n=3) these findings must be interpreted with 
caution as they may either represent natural variation within the group or they 
may be due to an unexpected adverse effect of transplanted SCs over long periods 
of time. This may be due to an immune reaction as although the cells were all 
derived from the same inbred strain complete allogenicity cannot be guaranteed. 
It is also possible that there has been an adverse interaction between the collagen 
matrix (Vitrogen) and the transplanted SCs as detailed study of the vitality and 
viability of these cells within this gelled matrix were not performed in vitro. 
There is also the possibility that there was a technical error in SC preparation and 
transplantation at the time of grafting. It has therefore not been possible to draw 
an accurate conclusion from this preliminary long term experiment, further 
refinement of the model is necessary to optimise the conduit, matrix and cellular 
transplantation.
Successful nerve regeneration depends on the intrinsic growth capacity of 
the peripheral nervous system in addition to the permissive environment of the 
peripheral nerve (in comparison with the central nervous system). Peripheral
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nerve has the ability to regenerate however this is frequently ineffectual in the 
clinical setting. Further understanding of the pathophysiology of degeneration 
and regeneration, in addition to advances in conduit and matrix technology, 
growth factor delivery and stem cell biology will lead to advances in the treatment 
of peripheral nerve injury.
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APPENDIX A
1 Tissue culture
Reagent / Material
Acetic acid
alamarBlue™.....................................
Canada Balsalm mounting medium.
Cell filter (70pm).................................
Cell freezing medium..........................
Cell growth medium............................
Centrifuge............................................
Chamber slides (2,4,8 chambers).......
Class II ventilated laminar flow tissue
culture hood.......................... ..............
CO2 incubator (37°C)..........................
CO2 incubator (32 °C).........................
Collagen (Type I, from rat tail)...........
Collagenase I.......................................
Complement, rabbit anti-mouse
Cryovials
Supplier (code) 
Stock I working solution
Sigma (46928)
Serotec (BUF012A)
Sigma
Falcon (2350)
Cell growth medium + 10% DMSO 
DMEM + 10% FCS + 
penicillin/streptomycin 1 OOi.u.-1 OOpg 
Labnet, USA
Lab-Tek (Nalge Nunc International) 
MDH, InterMed
Shelab, Model: TC2323, BoroLab
EcoCell
Sigma (27666)
Worthington Biochemicals 
(CLS-I, 125U/mg)
1 % working solution made with DMEM 
and aliquoted in 300pl, stored at -20°C. 
Cederlane Labs (CL3051)
2 vials reconstituted at a time, kept on 
ice at all times, 1ml sterile water added 
to each vial, filtered through a 0.45 pM 
filter, stored in liquid nitrogen as 250pl 
aliquots.
Falcon
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Cytosine-p-D-arabinofuranoside..........
DMEM high glucose (4.5g/L glucose)..
DMEM + Glutamax...............................
DMEM with HEPES.............................
DMSO (dimethylsulphoxide)...............
Electronic Pipette Aid............................
Fetal Calf Serum (FCS).........................
Fibroblast Growth Factor (FGFb).........
Filters: 0.8, 0.45 and 0.2pm...................
Forksolin.................................................
Gentamicin 50mg/ml.............................
Glial Growth Factor II (GGF)..............
Haemocytometer....................................
Hank’s medium (balanced salt soln.)...
Hoechst nuclear labelling solution.......
Isopentane flasks....................................
Laminin (mouse)....................................
Marrow stromal cell growth medium...
a-MEM (Modified Eagle’s Medium)...
B-mercaptoethanol.................................
Microscope (inverted tissue culture)....
Mouse anti-mouse/rat Thyl .1...............
Needles 19, 21 and 23 G....................... .
Sigma (C l768) Stock solution ~ ImM: 
2mg dissolved in 4 ml PBS, filtered 0.2 
pm and stored at -20°C, 250pl aliquots 
Gibco (31966-021)
Gibco (21885-025)
Gibco (22320)
Sigma (D2650)
IBS, Integra Biosciences 
Gibco (10108-165)
Heat de-activated at 56°C for 35 
minutes, stored at -20°C 
Pepro Tech (100-18B)
Nalgene
Calbiochem (344270)
5mM stock solution made by dissolving 
2.0525 mg/ml in DMSO, stored at 
-20°C, 50/1 OOpl aliquots 
Gibco
CeNeS Pharmaceuticals 
Batch no. rhGGF2/030-040 
Weber
Gibco (14170-088)
Sigma (H33342)
Bicell, Nihon Freezer Company Ltd. 
Sigma (L2020) 
a-MEM + 10% FCS + 
penicillin/streptomycin 1 OOi.u.-1 OOpg 
Invitrogen (22571020)
Sigma (M7522)
Nikon
Serotec (MCA04G)
Sherwood Medical
248
Penicillin/Streptomycin
Plastic Pipettes: 1,5,10,25 ml...............
Plate Reader (96-well)...........................
Platelet-Derived Growth Factor(PDGF)
Poly-D-Lysine.......................................
PT67 packaging cells............................
PT67 packaging cells (with GFP)........
PT67 packaging cell growth medium.
all-trans retinoic acid ...........................
Schwann cell growth medium...............
Syringe: 2, 5, 10ml..................
Tissue culture flask (25cm2). 
Tissue culture flask (75cm2)., 
Tissue Culture Plates (24-well) 
Tissue Culture Plates (6-well).. 
Tissue Culture Plates (96-well) 
Trypsin 2.5%; lypophilised.....
Trypsin 0.25% / EDTA 0.02% 
Universal container 30, 50 ml. 
Water, tissue culture grade......
Gibco (15070-022)
Working solution: 100 iu-100 pg/ml:
2ml of stock solution to 100ml of cell
growth medium
Falcon
Labsystem, MultiSkan MS 
Pepro Tech (100-13 A)
Sigma (P7280)
Clontech
Miss Dawn Mann,
Queen Victoria Hospital, East Grinstead
DMEM(4.5g/L) + 10%FCS + 
penicillin/streptomycin 1 OOi.u.-1 OOpg 
Sigma (22301-8)
Cell growth medium + 5 pM forskolin 
+ GGF 126 ng/ml. To 100ml of cell 
growth medium 112 pi of forskolin 
stock 3 pi of GGF added 
Becton & Dickenson 
Greiner Labortechnik (690175)
Greiner Labortechnik (658175)
Falcon
Falcon
Falcon
Gibco (610-5095 AE)
Rehydrated with Dulbecco’s Phosphate 
Buffered Saline (without Ca2+ & Mg2+) 
800 pi aliquots stored at -20°C 
Gibco (45300-019)
Falcon
Sigma (W3500)
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2 Matrices
Alginate (LVM / MVM)..............
Autoclave.....................................
Calcium Chloride.........................
Collagen (Type I, from rat tail)...
Collagen gel (for conduits)..........
Fibronectin (from bovine plasma)
Laminin.........................................
3 PHB and silicone conduits
Hamilton syringe (50pl)....................
Polyhydroxybutyrate sheets and
dissociated fibres (PHB)....................
Soldering iron, gas powered.............
Silicone conduits...............................
4 Animal model
Micro-instruments..............................
Chlorhexidine gluconate 0.5% w/v in
70% IMS.............................................
Halothane............................................
Oxygen................................................
Operating microscope.........................
Rats, male Sprague Dawley,
6-8 weeks old, 200-250gms...............
Suture, 9/0 nylon.................................
Suture, 4/0 vicryl................................
Temgesic.............................................
Pronova Biomedical, Oslo, Norway
Boxer, Borolabs, UK
Sigma
Sigma (27666)
Vitrogen
Sigma (F4759; lmg)
Reconstituted in 1ml of 0.9% NaCl. 
Store at -20°C 
Sigma (L2020)
Stock: 1 mg/ml in Tris buffered NaCl 
stored at -20°C.
Hamilton, USA
Astra-tech, Sweden 
Maplin, UK
Philip Harris Scientific (y-irradiated)
Mercian, UK
Adams Healthcare, UK 
Nicholas, UK 
BOC, UK 
Zeiss, Germany
Harlan, UK 
Ethicon, UK (W2898)
Ethicon, UK (W9825)
Phoenix Pharmaceuticals, UK
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5 Tissue processing
Cryotome................................................
Dako hydrophobic pen...........................
Glass slides (+ Vectabond®).................
OCT compound.....................................
Sucrose/PBS...........................................
Triton-X.................................................
Zamboni’s fixative.................................
6 Protein Quantitation
NanoOranage® Protein Quantitation
Kit...........................................................
PhastGel electrophoresis system...........
7 Immunohistochemistry
7.1 Primary antibodies
Glial fibrillary acidic protein (GFAP;
rabbit polyclonal)...................................
Protein gene product
(PGP9.5; mouse monoclonal)................
Protein gene product
(PGP9.5; rabbit polyclonal)...................
Neural cell adhesion molecule (NCAM;
rabbit polyclonal)...................................
N-cadherin (NCAD; rabbit
polyclonal..............................................
S100 (mouse monoclonal).....................
S100 (rabbit polyclonal).......................
Thy 1.1....................................................
Bright, UK 
Dako (S2002)
Lab stock
Tissue-tek, Sakura, Japan 
Lab stock 
Sigma (XI00)
Lab stock (see Appendix C)
Molecular Probes, Holland 
Pharmacia
Supplier Dilution I
Incubation
Sigma (G9269) 1:80 2hrs RT
Biogenesis, UK 1:2000 2hrs RT
Affiniti, UK 1:1200 2hrs RT
Chemicon, UK 1:500 2hrs RT
Santa Cruz 1:20 2hrs RT
Biotechnology, USA
Affiniti (SA2102) 1:500 2hrs RT
Dako (Z311) 1:1000 2hrs RT
Serotec (MCA04G) 1:500 2hrs RT
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7.2 Secondary antibodies
Cy3 goat anti-mouse............................... Amersham 1:100 2hrs RT
(PA43002)
Cy3 goat anti-rabbit............................... Amersham 1:100 2hrs RT
(PA43003)
FiTC anti-mouse secondary...................  Vector labs (FI2000) 1:100 2hrs RT
FiTC anti-rabbit secondary....................  Vector labs (FI 1000) 1:100 2hrs RT
7.3 Additional materials
Antibody diluent........................
Digital camera...........................
Fluorescence mounting medium
(Vectorshield®)..........................
Giemsa stain
Micoscope...............
Normal goat serum.. 
Normal rabbit serum 
Syringe driver..........
Lab stock
TMSpot , Diagnostic Instruments Inc., 
USA
Vector Labs, UK 
Sigma (GS-500)
Stock 0.4%w/v in phosphate buffered
methanol. Working solution: 5% (of
stock) in distilled water
Olympus BX60, Japan
Sigma
Sigma
Genie UK
7.4 Software
Image-Pro® Plus version 4.0.................  Media Cybernetics, USA
GraphPad Prism version 4.0.................  GraphPad Software, San Diego,
California, USA
Spike 2 program..................................... Cambridge Electronic Design Limited,
UK
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APPENDIX B
Preparation of coated tissue flasks
Poly-D-lysine (PDL)
0.1 mg/ml of PDL (Sigma) was prepared with culture grade distilled water. One 
ml of PDL solution was put in a 25cm flask (or 2 ml in a 75cm flask), the flask 
was gently shaken to cover the entire surface evenly. The flask was kept flat at 
room temperature for 15 minutes then washed twice with sterile water and left to 
dry in the hood. Coating of chamber slides (Lab-Tek, Nalge Nunc International) 
was similarly carried out, using PDL solution sparingly. The PDL coated flasks 
were stored at room temperature and used for up to 6 months following coating.
PDL and laminin (double coating)/ Laminin alone
First the culture flask is coated with PDL as above, 20 pg/ml solution of natural 
mouse laminin (Sigma) was prepared in DMEM, and 0.1 ml solution/cm2 of the 
flask was used to coat the surface area. The flask was gently shaken to spread the 
solution evenly and kept flat in a CO2 incubator at 37°C, for 45 minutes, without 
letting the laminin to dry.
Fibronectin
Fibronectin was dissolved in Hank’s medium to give a concentration of 20pg/ml.
The surface are of the tissue culture plastic to be covered was calculated and the
• • • 2corresponding volume of fibronectin solution added to give a coating of 2pg/cm .
The plate/flask is then incubated at room temperature for one hour following 
which the solution is aspirated and washed with distilled water. The plates/flasks 
are either used immediately or air dried and stored at 2-8°C.
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Collagen
For coating tissue culture plastic collagen was dissolved in 0.02N acetic acid to 
give a concentration of 50pg/ml. The area of the culture dish to be plated was
calculated and the corresponding amount of collagen solution was added to give
2 2coating at 5pg/cm or lOpg/cm . The collagen solution is left on the culture dish 
for one hour at room temperature. The collagen solution is then aspirated and the 
culture dish washed with PBS. The dish is then air dried and used immediately or 
stored under sterile conditions at 2-8°C for up to one week.
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APPENDIX C
Silanisation
Growth factors tend to adhere to surfaces by electrostatic interaction, all glassware 
and plasticware including polypropylene pipette tips and Eppendorfs for handling 
and storage were silanised to minimise adsorption. The silanisation was carried 
out by a published methods (Molecular Cloning: A Laboratory Manual, eds: 
Sambrook, Fritsch & Manniatis):
Put 1 ml of dichlorodimethylsilane in a small bowl inside a large desiccator with 
the items to be silanised. Attach a vacuum pump to the desiccator in an extraction 
hood and apply suction until the dichlorodimethylsilane starts to boil and clamp 
and switch off the pump. Leave for two hours and open the desiccator under an 
extraction hood. Rinse the items 3 times with distilled water and dry overnight. 
Sterilise with gamma-irradiation camera.
Vectabond™ coated slides
The slides were treated to improve adhesion of sections and prevent loss of tissue 
as a result of washes required for immunohistochemistry protocols. Place clean 
slides in metal slide racks. Immerse slides in acetone for 5 minutes, then remove 
and drain well. Prepare Vectabond™ reagent treatment solution by adding 7 ml 
of reagent to 350 ml acetone and mixing well. Immerse slides in Vectabond™ 
reagent treatment solution for 5 minutes, then remove and drain well. Rinse slides 
by dipping rack several times into distilled water over 30 seconds. Avoid the 
creation of bubbles during this process. Tap slide rack before drying to remove 
excess water droplets. Dry slides at 37°C.
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General laboratory solutions
Antibody diluent
0.3% Triton X-100; 0.1% bovine serum albumin (BSA); 0.1% sodium azide.
For 1200ml: O.lg BSA, O.lg sodium azide, 30pl Triton X-100.
Dissolve in 100 ml of PBS.
4% Paraformaldehyde
Dissolve 40g of paraformaldehyde in 800 ml PBS at 60°C and stir until solution is 
clear. If necessary, add a few drops of 10M NaOH to clear the solution. Adjust
volume to one litre and allow to cool before use. Store at 4°C and use within 24
hours. Alternatively, divide into aliquots and keep frozen at -20°C until required. 
Defrost at room temperature or by immersing in a beaker of hot water. Once 
defrosted, do not re-freeze.
Phosphate buffered saline (PBS)
To make 10 litres:
Add the following to 5 litres of distilled water:
NaCl 87.9g;
KH2P04 2.72g;
NaHP04(H20) 12:3.9g.
Stir and leave for 2 hours, then add 5 litres of distilled water. Check pH and 
adjust to pH 7.3. Use 8 hours after mixing.
Sucrose-PBS
15% sucrose + 0.1% sodium azide in PBS.
For one litre: 150g sucrose; lg sodium azide.
Dissolve in 700ml PBS and when dissolved make up to 1 litre.
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Zamboni’s solution
85ml of 2% paraformaldehyde in PBS.
15ml of saturated picric acid.
Dissolve 20g paraformaldehyde in 800ml PBS AT 60°C and stir until solution is 
clear. Adjust volume to one litre and allow to cool. Add appropriate amount of 
saturated picric acid and store at 4°C until use.
Haematoxylin and eosin staining
Place slides in haematoxylin for 30 seconds.
Rinse in tap water.
Wash in tap water.
Place in 0.15M eosin for 6 minutes.
Wash in tap water.
Place in 70% IMS for one minute, 100% IMS for one minute, and xylene for one 
minute. Mount with DPX and a coverslip.
Giemsa stain
Wash chamber slide with PBS. Remove rubber gasket before exposure to alcohol. 
Fix in 100% IMS for 6 minutes and air dry. Stain in Giemsa solution (see 
Appendix A) for 15-60mins. Wash in de-ionised water and air dry. Mount with 
DPX and a coverslip.
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